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Background: Individuals with psychosis are characterised by increased exposure 
and reactivity to psychosocial stressors and abnormal hypothalamic-pituitary-
adrenal (HPA) axis function [i.e., elevated cortisol levels, a blunted cortisol 
awakening response (CAR), and pituitary volume abnormalities]. The extent to which 
these features are present among at-risk individuals, prior to illness onset, is 
currently unclear. 
Aims: To determine whether putatively at-risk children who present multiple 
antecedents of schizophrenia (ASz) or a family history of illness (FHx) show 
increased susceptibility to psychosocial stressors and HPA axis abnormalities relative 
to typically-developing (TD) children. An additional aim was to explore associations 
between these measures and neurocognitive function. 
Methods: ASz (n=35), FHx (n=25), and TD (n=44) children were identified at age 9-
12 years using a novel community-screening procedure or as relatives of individuals 
with schizophrenia. Measures of psychosocial stress, salivary cortisol, pituitary 
volume, and neurocognitive function were obtained at age 11-14 years.  
Results: Relative to TD children, both ASz and FHx children reported greater 
exposure to psychosocial stressors and were more distressed by these exposures 
(d=0.55-1.02, p<0.05). Additionally, FHx children, but not ASz children, showed a 
blunted CAR compared to TD children (d=0.73, p=0.01), yet neither group were 
characterised by elevated diurnal cortisol levels or pituitary volume abnormalities. In 
exploratory analyses, more abnormal HPA axis function (i.e., higher diurnal cortisol 
levels and a more blunted CAR) was associated with greater neurocognitive deficits 
among FHx and ASz children, whilst experiences of psychosocial stress were 
associated with better neurocognitive performance.  
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Conclusions: Increased stress susceptibility and a blunted CAR may constitute early 
markers of psychosis vulnerability whilst other HPA axis abnormalities (i.e., elevated 
diurnal cortisol levels and abnormal pituitary volume) may emerge more proximally 
to disease onset. Interventions to help at-risk youth cope more effectively with 
psychosocial stress might alleviate further HPA axis abnormalities and avert 
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Aetiological theories of schizophrenia have been greatly influenced by the diathesis-
stress model (Rosenthal, 1970; Zubin & Spring, 1977), which proposes that 
psychosocial stress can lead to the onset of psychosis among individuals with an 
underlying biological vulnerability for the disorder. In support of the model, major 
life events, for example the death of a loved one, have been associated with psychosis 
onset and relapse in clinical populations (Brown & Birley, 1968; Canton & Fraccon, 
1985; Bebbington et al., 1993), and with the presence of psychotic symptoms in the 
general population (Johns et al., 2004; Lataster et al., 2012; van Nierop et al., 2012). 
Prospective studies of individuals with schizophrenia also indicate that minor daily 
hassles, such as those relating to work or family relations, are associated with illness 
relapse and symptom severity (Malla et al., 1990; Norman & Malla, 1994). 
Additionally, there has been considerable interest in the association between 
psychosis and traumatic experiences in childhood (e.g., physical and sexual abuse and 
neglect); with recent meta-analyses concluding that childhood trauma increases the 
risk for psychosis (Varese et al., 2012; Matheson et al., 2013a). Finally, there is 
evidence that stressful events elicit greater emotional reactivity in individuals with 
psychosis compared to healthy controls (Myin-Germeys et al., 2001).  
Research conducted over the past four decades has thus provided evidence that 
psychosocial stressors contribute to the development and maintenance of psychosis. 
However, until recently, a biological explanation for how stress might act on the brain 
to give rise to the clinical and neurobiological features of schizophrenia was lacking. 
It has been proposed that the hypothalamic-pituitary-adrenal (HPA) axis, the primary 
system involved in coordinating the physiological response to stressors, may play a 
key role in mediating the relationship between stress and psychosis (Walker & 
Diforio, 1997; Walker et al., 2008).  
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In brief, the HPA axis responds to stress by triggering a cascade of hormonal 
reactions, which results in the secretion of glucocorticoids (primarily cortisol) from 
the adrenal cortex. Glucocorticoids interact with various systems throughout the 
body, allowing the organism to respond both behaviourally and physiologically to 
stress. These hormones also cross the blood-brain barrier and act on cells expressing 
glucocorticoid receptors (Krugers et al., 2012); by binding to these receptors in the 
hypothalamus and pituitary, glucocorticoids dampen HPA axis activity via a process 
of negative feedback (Laryea et al., 2013). Glucocorticoid receptors are also 
expressed in the hippocampus and medial prefrontal cortex, and both regions play a 
crucial role in mediating HPA axis function (Herman et al., 2005).  
It is proposed that abnormal HPA axis function contributes to the clinical features 
of psychosis by augmenting the activity of dopamine (Walker et al., 2008), a 
neurotransmitter that has long been implicated in the pathogenesis of schizophrenia 
(Howes & Kapur, 2009). In support of this model, animal studies demonstrate that 
stressful experiences lead to increased synthesis and release of striatal dopamine 
(Howes & Murray, in press). Moreover, investigations in both animals and humans 
indicate that cortisol can enhance dopamine activity in certain brain regions, 
particularly the mesolimibic system (Walker et al., 2008). Thus, it is possible that the 
increase in presynaptic dopaminergic activity which has been consistently observed 
among individuals with schizophrenia (Howes et al., 2012) may be triggered by 
stress-induced HPA axis dysfunction. 
Accumulated evidence indicates that schizophrenia is characterised by abnormal 
HPA axis function. Studies measuring cortisol in blood plasma have observed 
elevated cortisol levels in individuals with chronic schizophrenia (Christie et al., 
1986; Gil-Ad et al., 1986; Whalley et al., 1989; Markianos et al., 1999; Muck-Seler et 
al., 2004; Zhang et al., 2005; Gallagher et al., 2007; Ritsner et al., 2007; Yilmaz et al., 
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2007; Venkatasubramanian et al., 2010), and antipsychotic-naive patients 
experiencing their first psychotic episode (Abel et al., 1996; Ryan et al., 2003; Ryan et 
al., 2004; Spelman et al., 2007; Kale et al., 2010). More recently, studies have used 
repeated saliva sampling to assess the cortisol awakening response (CAR), which 
refers to the sharp increase in cortisol that typically occurs within 15-40 minutes of 
waking. Using this methodology, patients with first-episode psychosis have been 
found to show a blunted CAR relative to healthy controls (Mondelli et al., 2010a; 
Pruessner et al., 2013b). Studies using repeated salivary cortisol measures also 
demonstrate that individuals with schizophrenia show a blunted cortisol response 
during psychosocial stressor tasks (i.e., tasks designed to elicit an increase in 
cortisol) relative to healthy controls (Jansen et al., 2000; Brenner et al., 2009).  
Whilst abnormal cortisol levels have also been observed among other psychiatric 
disorders, most notably, depression and post-traumatic stress disorder (PTSD), the 
specific patterns of abnormality that characterise these disorders are different to the 
pattern observed among individuals with psychosis. For example, patients with 
major depression typically show elevated diurnal cortisol levels (Stetler & Miller, 
2011) and an increased CAR (Bhagwagar et al., 2003; Dienes et al., 2013; Ulrike et al., 
2013), whilst PTSD is associated with decreased cortisol levels during the day 
(Morris et al., 2012) and a blunted CAR (Chida & Steptoe, 2009). Thus, by examining 
both the CAR and diurnal cortisol levels, it is possible to identify patterns of HPA axis 
abnormalities that distinguish between these disorders.  
Further evidence that psychosis is associated with abnormal HPA axis function 
has been obtained in studies examining pituitary gland volume. Cross-sectional 
investigations have reported pituitary volume differences in patients with psychosis 
relative to healthy controls, with a divergent pattern of volume increases or 
decreases dependent on stage of illness. Typically, larger volumes have been 
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observed among medicated patients with first-episode psychosis relative to healthy 
individuals (Pariante et al., 2004; Pariante et al., 2005; Büschlen et al., 2011; 
Takahashi et al., 2011) while smaller volumes relative to healthy individuals have 
been reported among those with established schizophrenia (Pariante et al., 2004; 
Upadhyaya et al., 2007). However, other studies have observed no differences 
between first-episode patients and healthy controls (Nicolo et al., 2010; Gruner et al., 
2012). Furthermore, longitudinal studies following individuals from the time of their 
first psychotic episode have observed pituitary volume increases (MacMaster et al., 
2007a) and decreases (Nicolo et al., 2010) following antipsychotic treatment; 
although these inconsistent findings are likely to relate to differences in medication 
types across studies. The pituitary volume enlargements observed among 
antipsychotic-naive first-episode patients are thought to reflect an increase in the 
size and number of corticotroph cells that produce HPA axis hormones (Pariante, 
2008). Although it is possible that the pituitary enlargements are due to increased 
secretion of other anterior pituitary gland hormones (e.g., prolactin, luteinising 
hormone, and follicle-stimulating hormone), these hormones have not been found to 
be elevated in first-episode populations relative to healthy controls (Pariante, 2008).   
As well as giving rise to the clinical features of psychosis, stress-induced HPA axis 
function may also contribute to some of the neurocognitive impairments that 
characterise individuals with schizophrenia. Animal studies indicate that behavioural 
stressors and persistently-elevated glucocorticoid levels can lead to structural 
changes in the hippocampus and medial prefrontal cortex (Sapolsky, 2000; Cerqueira 
et al., 2008). Thus, the deficits in memory and executive function which have been 
consistently observed among individuals with schizophrenia (Reichenberg & Harvey, 
2007), may, at least in part, be caused by HPA axis dysfunction triggered by 
psychosocial stress exposure. Indeed, among individuals with schizophrenia, 
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elevated cortisol levels have been correlated with poorer memory and executive 
function (Walder et al., 2000), and a study of individuals with first-episode psychosis 
observed that a more blunted CAR was associated with deficits in verbal memory 
(Aas et al., 2011b). Whether the observed associations between neurocognitive 
function and cortisol levels are indeed due to an excess of psychosocial stressors, 
however, is currently unclear. Whilst some studies of individuals with psychosis have 
reported that childhood maltreatment is associated with greater impairments in 
memory and executive function (Lysaker et al., 2001; Shannon et al., 2011), other 
studies examining the relationship between psychosocial stress exposure (including 
childhood maltreatment) and impairments in these specific domains have not 
(Schenkel et al., 2005; Aas et al., 2011b; Sideli et al., in press). Alternatively, abnormal 
neurodevelopmental processes (as opposed to psychosocial stress exposure) may 
influence the development of the brain regions that mediate both HPA axis function 
and these neurocognitive abilities.  
The studies described above suggest that individuals with psychosis are 
characterised by increased exposure and reactivity to psychosocial stressors and a 
distinct pattern of HPA axis dysfunction relative to healthy individuals. Moreover, 
abnormal HPA axis function (possibly caused by psychosocial stress exposure) may 
be associated with some of the neurocognitive impairments observed among 
individuals with schizophrenia. However, it is currently unclear as to whether these 
HPA axis abnormalities emerge prior to the first psychotic episode and thus 
contribute to the development of psychosis, or whether they are merely a 
consequence of the stress associated with illness onset. The study of individuals at 
elevated risk for schizophrenia offers the opportunity determine the temporal 
relationship between psychosocial stress susceptibility (exposure and reactivity), 




This thesis examines experiences of psychosocial stress and HPA axis function in 
children aged 11-14 years with different vulnerability profiles for schizophrenia: 
those at putatively elevated risk who present psychotic-like experiences and other 
antecedents of the disorder, and those with a family history of illness. The primary 
aim was to determine whether these children are characterised by increased 
susceptibility to psychosocial stress (i.e., greater exposure to psychosocial stressors 
and increased reactivity to these exposures) and biological markers of HPA axis 
dysfunction (i.e., elevated diurnal cortisol levels, a blunted CAR, and pituitary volume 
abnormalities) relative to their typically-developing peers. Additionally, the current 
study aimed to examine the relationship between experiences of psychosocial stress 
and HPA axis function, and investigate the association between these measures and 
current symptoms of psychopathology. A final aim was to explore the extent to which 
neurocognitive function is associated with experiences of psychosocial stress and 
cortisol levels among children at elevated risk for schizophrenia.   
Hypotheses 
Based on previous studies examining individuals with schizophrenia (described 
above) and those at elevated risk for the disorder (reviewed in Chapter 2), the 
following hypotheses were tested: 
With respect to experiences of psychosocial stress:  
1a. Children at elevated risk for schizophrenia will be exposed to higher levels of 
psychosocial stressors than typically-developing children.  
1b.  Compared to typically-developing children, those at elevated risk for 
schizophrenia will be more distressed by psychosocial stressors. 
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1c. Experiences of psychosocial stress (exposure and reactivity) will be more 
strongly associated with current symptoms of psychopathology among high-
risk children relative to typically-developing children. 
With respect to cortisol indices of HPA function: 
2a. Children at elevated risk for schizophrenia will show elevated diurnal 
cortisol levels and a blunted CAR relative to typically-developing children.  
2b.  Cortisol levels will be associated with exposure to psychosocial stressors 
and distress related to these exposures among high-risk children.  
2c.  Among children at elevated risk for schizophrenia, cortisol levels will be 
correlated with current symptoms of psychopathology.  
With respect to pituitary volume indices of HPA function: 
3a. Children at elevated risk for schizophrenia will show abnormal pituitary 
gland volume relative to typically-developing children.  
3b.  Among children at elevated risk for schizophrenia, pituitary volume will be 
correlated with salivary cortisol levels.  
3c.  Pituitary volume will be associated with exposure to psychosocial stressors 
and distress related to these exposures in high-risk children. 
3d.  No relationship between pituitary volume and current psychopathology will 
be observed among children at elevated risk for schizophrenia.  
With respect to neurocognitive function:  
4a. Experiences of psychosocial stress (exposure and reactivity) will be 
negatively associated with neurocognitive function in high-risk children.  
4b.  Among children at elevated risk for schizophrenia, more abnormal cortisol 




This thesis comprises eight chapters, a brief overview of each chapter is provided 
below.  
Chapter 1 describes established strategies for identifying individuals at elevated risk 
for schizophrenia and outlines the rationale for developing a novel method to identify 
putatively high-risk children who present multiple antecedents of the disorder.  
Chapter 2 comprises a systematic review of studies examining psychosocial stress, 
cortisol levels, and pituitary volume among individuals at elevated risk for 
schizophrenia. Methodological issues pertinent to the work presented in subsequent 
chapters are also discussed.   
Chapter 3 describes the methodology of the overall study, with particular focus on 
the recruitment procedure and assessment phases. Details of the measures used to 
assess sociodemographic characteristics and current psychopathology are provided 
(primary measures described in subsequent chapters) and the analytic strategy 
employed in subsequent chapters is described.  
Chapter 4 examines exposure to psychosocial stressors and distress relating to these 
exposures among children at elevated risk for schizophrenia and typically-developing 
children. This chapter also investigates whether the relationship between 
psychosocial stress and current psychopathology is associated with risk status.  
Chapter 5 investigates the extent to which children at elevated risk for schizophrenia 
are characterised by abnormal cortisol levels (elevated diurnal cortisol and/or a 
blunted CAR) relative to their typically-developing peers. This chapter also examines 
the extent to which cortisol levels are associated with experiences of psychosocial 
stress and current psychopathology among high-risk children.   
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Chapter 6 compares pituitary gland volume in children at elevated risk for 
schizophrenia and typically-developing children. The relationship between pituitary 
volume and cortisol levels, experiences of psychosocial stress, and current 
psychopathology among high-risk children is also investigated.  
Chapter 7 explores the extent to which experiences of psychosocial stress (exposure 
and reactivity) and more abnormal cortisol levels are associated poorer 
neurocognitive function among children at elevated risk for schizophrenia.  
Chapter 8 reviews the main findings of the study and discusses these results in the 
context of the study hypotheses. This chapter also provides a detailed description of 
the methodological issues that are relevant to the overall study. The contribution of 
the work presented in this thesis to existing scientific knowledge is discussed, as are 







DEFINITION OF RESEARCH TERMS 
Schizophrenia and psychosis 
Schizophrenia is a severe mental disorder characterised by episodes of psychosis 
(i.e., a loss of contact with reality), often expressed as hallucinations, delusions, and 
disorganised speech and behaviour (American Psychiatric Association, 2013). Whilst 
there has been some controversy surrounding the diagnostic construct of 
schizophrenia (van Os, 2009; Keshavan et al., 2011; Tandon et al., 2013), the disorder 
has been retained, albeit with some modifications to the criteria, in the Fifth Edition 
of the Diagnostic and Statistical Manual of Mental Disorders [DSM-5 (American 
Psychiatric Association, 2013)]. It is anticipated that next version of the International 
Classification of Disorders (ICD-11) will adopt a similar definition (Gaebel, 2012).  
The DSM-5 criteria for schizophrenia are provided in Box 1. Although these 
criteria attempt to delineate schizophrenia from other psychotic disorders (e.g., 
schizoaffective disorder, schizophreniform disorder, delusional disorder, brief 
psychotic disorder, affective psychoses, and substance-induced psychotic disorder), 
the extent to which these can be considered separate diagnostic categories has been 
questioned (van Os, 2009). Despite calls from some experts to replace the categorical 
diagnosis with a more dimensional approach, this has not been implemented in the 
DSM-5 (Heckers et al., 2013). However, the new DSM incorporates eight dimensional 
scales which assess the severity of the five core schizophrenia symptoms 
(hallucinations, delusions, disorganised speech, abnormal psychomotor behaviour, 
and negative symptoms) in addition to impaired cognition, depression, and mania 
(Barch et al., 2013). It is hoped that these scales will be clinically useful, and that 
adopting a dimensional assessment approach will support research efforts to 
elucidate the causes of psychosis (Heckers et al., 2013). 
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Box 1. DSM-5 criteria for schizophrenia  
 
Criterion A: Characteristic symptoms (two or more of the following, present for a significant 
portion of a one-month period, including at least one of symptoms 1-3): 
1. Delusions 
2. Hallucinations 
3. Disorganised speech 
4. Grossly disorganised or catatonic behaviour 
5. Negative symptoms (i.e., diminished emotional expression or avolition) 
Criterion B: Social/occupational dysfunction  
Criterion C: Duration of at least six months 
Criterion D: Schizoaffective and major mental disorder diagnoses excluded 
Criterion E: Disturbance not attributed to substances or other medical condition 
Criterion F: Relationship to global developmental disorder or autism spectrum disorder (i.e., 
if there is history of these disorders, an additional diagnosis of schizophrenia can only be 
made if prominent delusions or hallucinations are present for at least one month)  
  
Limitations notwithstanding, the validity of schizophrenia as a construct is 
supported by the fact that several risk factors (described below) have been 
consistently associated with the disorder (Tandon et al., 2013). Furthermore, 
prospective studies of individuals who have recently experienced their first psychotic 
episode indicate that schizophrenia exhibits high diagnostic stability over time 
(Haahr et al., 2008; Bromet et al., 2011), whereas the stability of other psychotic 
disorders is far lower. As such, this thesis is concerned primarily with the extent to 
which schizophrenia specifically (and vulnerability for this disorder) is associated 
with experiences of psychosocial stress and HPA axis dysfunction1.  
 
1 When describing the existing literature, the association between these factors and ‘psychosis’ is 
reported for studies that do not, or cannot, distinguish between specific psychotic disorders. For 
example, studies examining individuals who have recently experienced their first psychotic 
episode (herein referred to as individuals with ‘first-episode psychosis’) where the longitudinal 
course of illness and resultant diagnosis are not yet clear.    
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Schizophrenia is a relatively rare disorder, affecting approximately 0.4% of 
individuals during the course of their lifetime (Saha et al., 2005). Meta-analyses 
indicate that males are at greater risk for the disorder than females (McGrath et al., 
2004), and there is evidence that illness onset (which typically occurs during late 
adolescence and early adulthood) is also slightly earlier in males (Eranti et al., 2013). 
Furthermore, in the UK specifically, the incidence is also higher among individuals of 
black Caribbean and black African ethnicity relative to the white British population 
(Kirkbride et al., 2012). Family studies indicate that schizophrenia is highly heritable 
(Sullivan et al., 2003); however, the genetic underpinnings of the disorder have yet to 
be elucidated as it seems that multiple genes are involved (Tandon et al., 2009). A 
number of environmental risk factors for schizophrenia have also been identified, 
including, prenatal infection, perinatal complications, urbanicity, migration, and 
cannabis use (Matheson et al., 2011). It is likely that these environmental factors may 
act in combination with genetic vulnerability to give rise to the disorder; indeed, 
several studies have identified gene-environment interactions which may act to 
increase the risk for schizophrenia (Modinos et al., 2013).  
Despite advances in pharmacological and psychological treatments for 
schizophrenia, recent estimates indicate that only 1-2 individuals in every 100 
experience recovery during the first year of illness (defined as improvement in both 
clinical symptoms and social functioning), with approximately 14% expected to 
recover over 10 years (Jaaskelainen et al., 2013). Of even greater concern is the fact 
that the risk of mortality is 2.5 times higher among individuals with schizophrenia 
compared to the general population (Saha et al., 2007), a trend which has worsened 
in recent decades. These findings emphasise the need to develop early identification 
and intervention strategies, which may help to avert illness onset among those who 
are at elevated risk for the disorder.   
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Antecedents of schizophrenia  
This thesis examines children who may be at elevated risk for developing 
schizophrenia in later life because they present multiple antecedents of the disorder 
(Laurens et al., 2007; Laurens et al., 2011). Antecedents of schizophrenia are subtle 
developmental deviances which have been found to characterise individuals who 
later develop the disorder (Welham et al., 2009a). These characteristics are 
observable from infancy through to later life, and represent early expressions of 
schizophrenia. Thus, unlike other factors that have been associated with increased 
risk for the disorder (e.g., urbanicity, migration, and cannabis use), antecedents are 
on the aetiological pathway, and can be thought of as developmental precursors of 
later illness. Prospective longitudinal studies have identified a number of factors that 
may be considered childhood antecedents of schizophrenia, including, delays and 
abnormalities in speech development, motor dysfunction, social withdrawal and 
emotional problems, behavioural difficulties, intellectual and cognitive impairments, 
and psychotic-like experiences (Niemi et al., 2003; Welham et al., 2009a; Matheson et 
al., 2011; Dickson et al., 2012). It is thought that these antecedents are largely driven 
by genetic vulnerability factors, although environmental exposures may also 
contribute to their expression (Matheson et al., 2011). 
The rationale for developing a novel strategy to identify children who present 
multiple antecedents of schizophrenia is described in detail in subsequent chapters. 
In brief, a novel community-screening procedure was used to identify children aged 
9-12 years who present a triad of antecedents of schizophrenia (ASz) that could be 
assessed via questionnaire, including, (i) a speech and/or motor developmental delay 
or abnormality, (ii) a social, emotional, and/or behavioural problem, and (iii) a 
psychotic-like experience (Laurens et al., 2007). Throughout this thesis, the term ‘ASz 




Psychosocial stress is a broad concept that encompasses a wide range of experiences. 
In some studies, psychosocial stress refers to the specific exposures (or stressors) 
that are under examination (typically, events that are assumed to be stressful for the 
majority of individuals), whilst in other studies, the term is used to describe 
subjective feelings of ‘stress’ that result from these exposures (Cohen et al., 1995). 
Throughout this thesis, the terms ‘exposure’ and ‘reactivity’ are used to distinguish 
between these two measures of psychosocial stress. Thus, ‘psychosocial stress 
exposure’ is defined as the occurrence of a potentially stressful event, regardless of 
its actual impact, whilst ‘psychosocial stress reactivity’ refers to the distress or 
emotional reaction elicited in response to a psychosocial stressor. For brevity, the 
term ‘experiences of psychosocial stress’ is used to describe exposure and/or 
reactivity. Studies examining psychosocial stress exposures among individuals with 
schizophrenia have largely focused on major life events, minor daily hassles, and 
childhood trauma. These terms are defined as follows:  
Major life events are negative or positive events, of infrequent occurrence, that 
would be considered by most individuals to be of major significance. Examples 
include, divorce or separation, changes to employment status, financial difficulties, 
bereavement, and moving home. The frequency and impact of these events may be 
assessed over the total life span or during a defined period of time (e.g., events 
occurring within the past year).  
Minor daily hassles are common difficulties or challenges that occur throughout the 
course of daily life. Measures assessing daily hassles often include items relating to 
interpersonal relations (e.g., arguments with friends or family), work or school (e.g., 
problems with colleagues, peers, or teachers), and circumstance (e.g., transport 
problems or having to meet a deadline).   
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Childhood trauma is a broad term that is often used to refer specifically to 
experiences of childhood maltreatment (i.e., physical abuse, sexual abuse, neglect, 
and emotional abuse) but can also include other traumatic experiences that may 
occur in childhood, such as parental death or bullying.  
The current study examines experiences of major negative life events and minor 
daily hassles (i.e., exposure to these psychosocial stressors and reactivity to these 
exposures) among children at elevated risk for schizophrenia. The study also 
explores the association between schizophrenia risk status and exposure to physical 
punishment (i.e., being slapped, spanked, or hit with an object), which is thought to 
lie on a continuum with childhood maltreatment and has been associated with 
schizotypal personality disorder (Afifi et al., 2012).  
The hypothalamic-pituitary-adrenal (HPA) axis  
In mammalian organisms, the physiological stress response is coordinated by two 
biological systems: (i) the autonomic nervous system, and (ii) the HPA axis (Day & 
Pariante, 2012; Krugers et al., 2012), both of which are regulated by the 
hypothalamus. The first system to respond is the sympathetic branch of the 
autonomic nervous system; activation of this system results in the rapid release of 
adrenaline which has immediate effects on heart rate, vasoconstriction, and 
digestion. If the threat is maintained the HPA axis is then activated, triggering a 
cascade of hormonal reactions (described in detail below). Of the two systems, the 
HPA axis has received particular attention from psychopathologists in light the fact 
that several psychiatric disorders (e.g., psychosis, depression, and PTSD) have been 
associated with HPA axis abnormalities (Walker et al., 2008).  
The key components of the HPA axis are shown in Figure 1. In response to 
stressful stimuli, corticotrophin-releasing hormone (CRH) is secreted from the 
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paraventricular nucleus of the hypothalamus. CRH then triggers the release of 
adrenocorticotropic hormone (ACTH) from the anterior pituitary which in turn 
stimulates the secretion of glucocorticoids (primarily cortisol) from the adrenal 
cortex. Glucocorticoids allow the organism to respond both behaviourally and 
physiologically to stress; these hormones interact with various systems throughout 
the body, influencing glucose metabolism, immune and cardiovascular function, and 
brain function (Walker et al., 2008). The brain expresses two forms of glucocorticoid 
receptor: (i) high-affinity mineralocorticoid receptors (MRs) which are occupied at 
rest, and (ii) low-affinity glucocorticoid receptors (GRs) that are typically occupied 
only under high glucocorticoid conditions (Krugers et al., 2012). Glucocorticoids 
regulate HPA axis activity by binding to these receptors in the hypothalamus and 
pituitary where they inhibit the secretion of CRH and ACTH respectively by a process 
of negative feedback (Laryea et al., 2013).  
Other brain regions also play a crucial role in mediating HPA axis function. The 
hippocampus is densely populated with MRs (with specific regions expressing GRs), 
and also dampens HPA axis activity via negative feedback (Walker et al., 2008). There 
is also evidence that the medial prefrontal cortex and amygdala regulate HPA axis 
function (Herman et al., 2005; Cerqueira et al., 2008), although this complex process 
is not fully understood. Chronic stress and persistently-elevated glucocorticoid levels 
have damaging effects on the hippocampus, including, dendrite atrophy, suppression 
of long-term potentiation, inhibition of neurogenesis, and neuronal loss (Sapolsky, 
2000; Corcoran et al., 2003). Moreover, it has been recently shown that behavioural 
stress can lead to structural changes in the medial prefrontal cortex of rodents 
(Cerqueira et al., 2008). Thus, chronic exposure to stress may have damaging effects 





























Figure 1. Key components of the HPA axis 
Note. CRH: Corticotrophin-releasing hormone; 
ACTH: adrenocorticotropic hormone; mPFC: 

















HPA axis activity can be inferred from levels of cortisol and ACTH in bodily fluids; 
cortisol can be reliably measured in blood, urine, and saliva, whilst ACTH can be 
measured only in blood. Given the invasiveness of obtaining blood samples and the 
distress associated with this procedure, salivary cortisol is now commonly used to 
assess HPA axis function in research settings (Walker et al., 2008). Cortisol levels can 
be examined under basal conditions, in response to awakening, and following 
exposure to psychosocial stress or pharmacological challenge (Day & Pariante, 2012). 
Basal cortisol levels can be estimated by obtaining a single sample (saliva, urine, or 
blood) during the day. However, as cortisol exhibits a distinct circadian rhythm 
(levels are highest in the morning, gradually decline throughout the day, and rise 
again during sleep) measurements are greatly affected by the time of sampling, and 
studies often obtain multiple samples throughout the day to examine diurnal 
patterns of secretion. More recently, there has been substantial interest in the 
cortisol awakening response (CAR), which describes the peak in cortisol levels that 
typically occurs within the first 15-40 minutes after awakening (Pruessner et al., 
1997) and appears to be distinct from the circadian rhythm of cortisol (Fries et al., 
2009). Changes in HPA axis activity in response to acute stress can be examined using 
psychosocial stressor tasks. These experimental procedures typically involve 
assessing cortisol levels before, during, and after a potentially stressful task (e.g., 
public speaking or mental arithmetic) in order to assess the change in cortisol 
secretion. Finally, HPA axis function can be assessed using the dexamethasone 
suppression test, which involves administering dexamethasone (a synthetic 
glucocorticoid) in order to determine whether the negative feedback system is 
effective in suppressing cortisol secretion (Corcoran et al., 2003).  
Pituitary volume has also been used as a marker of HPA axis activity. Pituitary 
volume enlargements are thought to reflect an increase in the size and number of 
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corticotroph cells producing ACTH (Pariante, 2008), thus indicating increased HPA 
axis activity. Given that cortisol levels vary substantially throughout the day, it has 
been suggested that pituitary volume may provide a more stable measure of HPA axis 
function (Zipursky et al., 2011). Hypothalamic volume has also been employed as a 
measure of HPA axis function, albeit less commonly.  
The current study examines three biological markers of HPA axis activity: (i) 
salivary cortisol levels throughout the day, (ii) the increase in salivary cortisol in 
response to awakening, and (iii) pituitary gland volume. In order to facilitate 
comparisons between the pattern of cortisol secretion observed among children at 
elevated risk for schizophrenia and that which characterises individuals with 
established illness, the saliva sampling procedure employed in the current study was 
based on the protocol used in previous studies of individuals with first-episode 
psychosis (Mondelli et al., 2010a; Aas et al., 2011b). Consistent with previous studies 
of first-episode patients (Mondelli et al., 2010a; Aas et al., 2011a; Pruessner et al., 
2013b), cortisol data obtained at multiple time-points were then summarised using 
the two area under the curve (AUC) computations described by Pruessner et al. 
(2003). Similarly, the anatomical boundaries of the pituitary gland were determined 
using a protocol implemented in previous studies examining individuals with 
psychosis (Pariante et al., 2004; Pariante et al., 2005) and those at elevated risk for 




CHAPTER 1 Strategies for identifying individuals at elevated 
risk for schizophrenia 
1.1 Introduction  
In recent decades, there has been increased interest in developing strategies to 
identify individuals at elevated risk for schizophrenia (Yung & McGorry, 2007). There 
are two primary motivations for developing such methods. Firstly, a longer duration 
of untreated psychosis has been associated with more severe positive and negative 
symptoms, higher levels of global psychopathology, poorer social functioning, and 
higher rates of illness relapse and suicide (Marshall et al., 2005; Perkins et al., 2005; 
Farooq et al., 2009). These findings emphasise the importance of intervening early in 
the course of illness, if possible, even before the onset of psychosis. Secondly, the 
study of high-risk individuals offers the opportunity to identify disease 
characteristics that precede illness onset and contribute to the development of 
psychosis. The low base rate of schizophrenia in the general population requires that 
studies examining causal mechanisms in ‘unselected’ population cohorts assess large 
numbers of individuals, thereby imposing logistical limitations on the data that can 
be obtained. Samples enriched with individuals at high-risk for schizophrenia can be 
used to overcome the low base rate problem. These smaller ‘high-risk’ studies permit 
more complex and costly assessments (e.g., neuroimaging investigations) which 
provide important insights into the aetiology of schizophrenia. 
The notion that it might be possible to premorbidly identify individuals who will 
later develop schizophrenia is predicated on the neurodevelopmental hypothesis 
(Murray & Lewis, 1987; Weinberger, 1987). In essence, the theory proposes that 
schizophrenia is caused by a combination of genetic and early environmental insults 
which lead to an abnormal pattern of neurodevelopment commencing in early life. 
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Studies conducted over the past 25 years have provided overwhelming support for 
the genetic and environmental contributions underlying the neurodevelopmental 
hypothesis. Family studies indicate that schizophrenia is a heritable disorder 
(Tandon et al., 2009) and subsequent advances in molecular biology have identified a 
range of genetic variations which confer susceptibility for the disorder (Allen et al., 
2008; Schmidt-Kastner et al., 2012). In line with the suggestion that environmental 
factors operating in early life may contribute to schizophrenia, epidemiological 
studies have provided evidence that prenatal exposures (e.g. viral infections) and 
obstetric complications increase the risk for the disorder (Fatemi & Folsom, 2009). 
Prospective studies have also confirmed that subtle markers of abnormal 
neurodevelopment, for example, early developmental delays, cognitive impairments, 
and social, emotional, and behavioural problems, can be observed among children 
who later develop schizophrenia (Rapoport et al., 2005; Laurens et al., 2007). These 
findings indicate that it may be possible to identify individuals who are at increased 
risk for schizophrenia years before the onset of illness.  
Chapter aims 
The following chapter summarises existing strategies for identifying individuals at 
elevated risk for schizophrenia and describes a novel method that identifies children 
presenting multiple antecedents of the disorder. The specific aims were as follows:  
1. Describe established strategies for identifying high-risk individuals and 
evaluate the strengths and limitations of these approaches.  
2.  Provide an overview of the clinical staging model of schizophrenia.  
3. Outline the rationale for developing a novel to identify children at putatively 
elevated risk for schizophrenia who present multiple antecedents of the 
disorder and describe the characteristics of these children.  
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1.2 Established high-risk strategies  
1.2.1 Individuals with a family history of illness 
Background and rationale  
Traditionally, the identification of individuals at elevated risk for developing 
schizophrenia has focused on those with a family history of illness. This approach is 
based on the understanding that schizophrenia is a heritable disorder, an observation 
first noted at the beginning of the twentieth century (McGuffin et al., 1995). Early 
studies reported that the risk of schizophrenia among offspring and siblings of 
patients with the disorder (i.e., first-degree relatives) is approximately 10 times 
higher than the risk in the general population (Tsuang et al., 2001). Whilst these 
studies provided initial support for the notion that genetic factors may play a role in 
the development of schizophrenia, they were not able to disentangle the effect of 
shared environments. Twin and adoption studies have provided more robust 
evidence of a genetic contribution to schizophrenia. These studies demonstrate that 
monozygotic twins show far higher concordance rates for schizophrenia than 
dizygotic twins (46% vs. 14%) (Gottesman & Shields, 1982), and that offspring of 
individuals with schizophrenia who are adopted by healthy individuals remain at 
elevated risk for the disorder (Tienari & Wynne, 1994). Pooled data from these 
studies has since shown the heritability of schizophrenia to be approximately 80% 
(Sullivan et al., 2003).  
Genetic linkage studies and candidate gene approaches have led to the 
identification of several schizophrenia susceptibility genes, including, NRG1, 
DTNBP1, and COMT (Harrison & Owen, 2003). More recently, genome-wide 
association studies, capable of examining the entire genome, have been employed to 
identify genetic variants that distinguish between individuals with schizophrenia and 
healthy controls. These studies show that a range of common genetic variations of 
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small effect (odds ratios < 1.3) contribute to the risk of schizophrenia, as well as a 
number of relatively rare variants, known as copy number variations, which 
individually confer greater risks for the disorder (odds ratios range: 3-30) (van 
Winkel et al., 2010; Owen, 2012; Mowry & Gratten, 2013). Although the exact role of 
these genetic variants is currently unclear, a family history of illness remains one of 
the best-established risk factors for schizophrenia.  
Characteristics of individuals with a family history of illness 
Relatives of individuals with schizophrenia have been intensively studied over the 
past fifty years. Typically, these studies have focused on offspring of individuals with 
schizophrenia, following the development of these ‘genetic high-risk’ individuals 
from early life into adulthood. More recent cross-sectional studies have employed 
broader criteria for inclusion and have examined groups of siblings, parents, and 
second-degree relatives (e.g., grandparents, aunts and uncles, and half-siblings). 
Although the majority of individuals with a family history of illness will not go on to 
develop schizophrenia themselves, these individuals (regardless of their own illness 
outcome) share many characteristics with their affected relatives. There is consistent 
evidence that, relative to controls, individuals with a family history of illness are 
characterised by neuromotor abnormalities (Niemi et al., 2003), poorer performance 
on tests of cognitive function, particularly in the domains of verbal memory, 
executive function, and general intelligence (Sitskoorn et al., 2004; Agnew-Blais & 
Seidman, 2013), reduced grey matter in the anterior cingulate (Fusar-Poli et al., in 
press), altered brain activation, predominately in the temporal lobe (Cooper et al., in 
press), impaired psychosocial functioning (Owens & Johnstone, 2006), and deficits 
social cognition (Lavoie et al., 2013). The magnitude of differences between relatives 
and healthy controls on these measures is often smaller than the impairments 
observed among individuals with established illness. 
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Prediction of schizophrenia outcome 
Whilst there are now greater than 16 prospective genetic high-risk studies 
established in countries throughout the world (Niemi et al., 2003; Owens & 
Johnstone, 2006), relatively few have followed individuals past the age of peak illness 
onset (~30 years) to determine the proportion who go on to develop illness. 
Summarising data from five studies which assessed schizophrenia outcome at follow-
up, a recent study reported that between 5-26% of individuals with a family history 
of illness go on to develop psychosis (Goldstein et al., 2010). However, the elevated 
risk among those with a parental history of schizophrenia does not appear to be 
confined to psychotic disorders. A large population-based cohort study of individuals 
born in Denmark found that offspring of parents with non-affective psychosis were 
also at greater risk of developing bipolar disorder, depression, anxiety disorders, 
personality disorders, and substance misuse disorders (Dean et al., 2010). Among 
individuals with a family history of illness, those who later develop schizophrenia 
have been found to show more pronounced deficits in attention and verbal memory 
(Erlenmeyer-Kimling, 2000), social adjustment problems and behavioural difficulties 
(Niemi et al., 2003; Cannon & Clarke, 2005), neurological and neuromotor 
dysfunctions (Erlenmeyer-Kimling, 2000), and higher scores on psychosis-related 
personality scales (Carter et al., 1999; Bolinskey et al., 2001) relative to high-risk 
individuals who do not develop illness. As few genetic high-risk studies have 
prospectively followed individuals into adulthood, these factors may represent only a 
subset of those that confer additional vulnerability for schizophrenia. 
Strengths and limitations 
The genetic high-risk approach has been a highly successful research strategy which 
has helped to elucidate the role of genetic and environmental risk factors in the 
development of schizophrenia. One major advantage of the approach is that the 
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ability to identify individuals with a family history of illness in early life has enabled 
researchers to examine risk factors operating throughout childhood and adolescence. 
However, genetic high-risk studies have a number of limitations. Given that the 
majority of individuals with schizophrenia do not have a relative with the disorder 
(Gottesman & Shields, 1982; Mortensen et al., 2010), risk factors identified in these 
studies may relate to a more familial form of schizophrenia, which may not generalise 
to the majority of individuals who develop the disorder. In addition, many of the 
recent cross-sectional studies include relatives who have passed the age of peak risk 
for the development of illness (~30 years). Thus, factors distinguishing between 
these older relatives and healthy controls may not represent risk factors for illness 
onset, as by definition, these factors characterise those who have not developed 
schizophrenia (Cannon, 2005). Nonetheless, the family history approach is a useful 
strategy that enables the identification of disease characteristics that may be 
genetically-mediated.   
1.2.2 Youth at ultra high-risk for psychosis 
Background and rationale  
A more recent strategy for identifying individuals at elevated risk for developing 
schizophrenia focuses on help-seeking adolescents and young adults who are thought 
to be in the prodromal phase of illness that immediately precedes the onset of florid 
psychosis (Yung & McGorry, 1996). The approach draws on retrospective 
observations published over several decades which show that many individuals with 
schizophrenia experience a prodromal period characterised by non-specific 
symptoms (e.g., reduced concentration and motivation, depression, anxiety, sleep 
disturbances, irritability, social withdrawal, and poor functioning) and/or 
subthreshold psychotic symptoms. The Personal Assessment and Crisis Evaluation 
(PACE) clinic was established in Melbourne, Australia to provide treatment for youth 
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presenting with features consistent with the prodrome (Yung et al., 1996). It was 
anticipated that this ‘close-in’ strategy would identify individuals who were more 
proximal to illness onset than the traditional genetic high-risk approach (McGorry et 
al., 2003). As the prodrome can only be determined retrospectively, and not all 
individuals will develop psychosis, the terms ‘ultra high-risk’ (UHR, or clinical high-
risk in North American samples) and at-risk mental state (ARMS) have been used to 
describe those who present with potentially prodromal symptoms.  
UHR status is typically assessed using the Comprehensive Assessment of At-Risk 
Mental States (CAARMS) which requires the presence of at least one of the following 
features: (i) attenuated (subthreshold) psychotic symptoms during the past year, (ii) 
brief, limited, or intermittent psychotic symptoms (BLIPS; i.e., frank psychotic 
symptoms of short duration that spontaneously remitted), or (iii) a family history of 
psychosis or diagnosis of schizotypal personality disorder in combination with a 
decrease in functioning (Yung et al., 2005). Early identification centres have now 
been established throughout the world. North American sites have tended to use the 
Structured Interview for Prodromal Symptoms and the accompanying Scale of 
Prodromal Symptoms [SIPS/SOPS (Miller et al., 2003)] to identify these at-risk youth, 
which employ the same criteria as the CAARMS. A related approach, which aims to 
identify individuals earlier in the prodromal stage of illness than the UHR strategy, 
focuses on those presenting ‘basic symptoms’, defined as subjectively identified 
disturbances of thought processing, perception, language, and attention 
(Klosterkotter et al., 1996; Klosterkotter et al., 2001). Basic symptoms can be 
determined using the Bonn Scale for the Assessment of Basic Symptoms and the 
Schizophrenia Proneness Instrument (Schultze-Lutter et al., 2007) and are often 
assessed in conjunction with UHR criteria (Fusar-Poli et al., 2013).  
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Characteristics of UHR youth  
Recent meta-analyses indicate that UHR youth present neurocognitive impairments 
across a range of domains, including, general intelligence, memory, language 
function, attention, and executive function (Fusar-Poli et al., 2012b; Giuliano et al., 
2012). These deficits are typically small-to-moderate in magnitude (that is, smaller 
than those observed in patients with established illness but similar in magnitude to 
those seen in individuals with a family history of illness). Whilst the larger of these 
meta-analyses indicated that UHR youth are also characterised by moderate 
impairments in social cognition (Fusar-Poli et al., 2012b), a further review found 
mixed evidence for the presence of these deficits among UHR youth (Thompson et al., 
2011b). Structural brain abnormalities have also been examined extensively in this 
population. A recent meta-analysis, which included data from studies examining UHR 
youth and individuals reporting basic symptoms, observed reduced grey matter in 
the right middle and superior temporal gyri, the left anterior cingulate, and the right 
middle frontal gyrus in these youth relative to healthy controls (Fusar-Poli et al., 
2012c). In line with the suggestion that the basic symptom approach may capture 
individuals in an earlier phase of the prodrome than UHR criteria, comparatively 
smaller deficits in neurocognitive functioning (Frommann et al., 2011) and less 
widespread structural brain abnormalities (Koutsouleris et al., 2009) have been 
observed in youth experiencing basic symptoms. Studies also indicate that UHR 
youth are characterised by significant impairments in social and role functioning 
(Cornblatt et al., 2007a; Shim et al., 2008; Carrion et al., 2011; Hui et al., 2013) which 
have been associated with more pronounced neurocognitive impairments (Niendam 
et al., 2007; Carrion et al., 2011; Lin et al., 2011). There is also some evidence to 
suggest that, like individuals with schizophrenia, UHR youth show elevated striatal 
dopamine relative to healthy controls (Howes et al., 2009); however, replication of 
this finding is needed.  
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Prediction of schizophrenia outcome 
There has been considerable interest in the extent to which the UHR ‘close-in’ 
strategy identifies individuals at imminent risk of transitioning to psychosis. Early 
data from the original PACE clinic indicated that 41% of those meeting UHR criteria 
developed psychosis within one year (Yung et al., 2003). Similarly, a 12-month 
transition rate of 54% was reported in an early North American cohort of UHR youth 
(Miller et al., 2002). However, subsequent studies of UHR youth have reported lower 
transition rates. A review of studies from the PACE clinic found that the transition 
rate declined with each successive year, which was partially explained by the fact 
that UHR youth examined in more recent studies had experienced a shorter duration 
of symptoms prior to receiving help (Yung et al., 2007). This suggests that UHR youth 
are being detected and treated at an earlier stage of illness. A recent meta-analysis of 
27 studies from a range of clinics observed transition rates of 18% at six months, 
22% at one year, 29% at two years, and 36% at three years (Fusar-Poli et al., 2012a), 
and confirmed that more recent studies reported lower transition rates.  
A range of factors have been associated with transition to psychosis among UHR 
youth, including, a longer duration of symptoms prior to identification, social 
functioning deficits, genetic risk and functional decline, higher levels of suspicion and 
paranoia, unusual thought content, substance use, and negative symptoms (Cannon 
et al., 2008; Thompson et al., 2011a; Nelson et al., 2013). Those who transition to 
psychosis have also been found to show more pronounced deficits in neurocognitive 
function (Fusar-Poli et al., 2012b; Giuliano et al., 2012), and reduced grey matter 
volume in the temporal lobe, cingulate, insular, and prefrontal cortex (Smieskova et 
al., 2010) compared to UHR individuals who do not. Observational data indicates that 
UHR youth receiving antidepressants are less likely to develop psychosis (Cornblatt 
et al., 2007b; Fusar-Poli et al., 2007). However, randomised trials investigating the 
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extent to which antipsychotic medications and/or cognitive behavioural therapy 
(CBT) can reduce transition rates have provided mixed evidence (McGorry et al., 
2002; Morrison et al., 2004; McGlashan et al., 2006; Addington et al., 2011b). A meta-
analysis of 11 trials reported that there was moderate quality evidence for the ability 
of CBT to reduce transition at 12 months (but not at 18 months), low quality evidence 
for the effects of omega-3 fatty acids, and no reported benefits for antipsychotic 
medications (Stafford et al., 2013). Thus, the extent to which current treatments can 
successfully delay or avert transition to psychosis among UHR youth is unclear.  
Strengths and limitations 
The success of the UHR approach cannot be disputed; over past 15 years high-risk 
centres have been established in countries throughout the world and ‘attenuated 
psychosis syndrome’ was recently considered for inclusion in the DSM-5 (Tsuang et 
al., 2013). This ‘close-in’ strategy has led to the identification of individuals who are 
much closer to the point to illness onset than those identified solely on the basis of a 
family history of schizophrenia. Studies of UHR youth therefore offer the opportunity 
to identify factors that may directly trigger the onset of psychosis. Furthermore, the 
results of these studies may be more generalisable than those obtained in genetic 
high-risk studies, which possibly relate only to a familial form of illness. However, a 
substantial proportion of UHR youth are treated with antipsychotics and other 
psychotropic medications (Woods et al., 2013), which are known to affect both brain 
structure and function. Thus, characterising premorbid neuroanatomical and 
neurocognitive abnormalities in UHR samples is confounded by treatment effects.  
From a clinical perspective, UHR youth already present with high levels of 
impairment and disability, to the extent that they are sufficiently distressed as to 
seek help for their symptoms. There is also evidence that even those who do not 
convert to psychosis continue to show poorer functioning (Addington et al., 2011a), 
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implying that the UHR state itself can be regarded as a negative outcome. 
Furthermore, the extent to which treatments such as antipsychotic medications and 
CBT can avert transition to psychosis is currently unclear (Stafford et al., 2013). Thus, 
the identification of individuals at elevated risk for psychosis at an earlier stage of 
illness (that is, prior to the emergence of features consistent with the prodromal 
phase) may help to reduce the negative outcomes associated with UHR status.   
1.2.3 Individuals with schizotypal personality disorder  
Background and rationale  
Schizotypal personality disorder (SPD) is a disorder within the schizophrenia 
spectrum that is characterised by attenuated forms of many of the traits and 
symptoms that define schizophrenia. Whilst SPD symptoms can be distressing and 
pervasive, unlike those of schizophrenia, they do not typically confer the need for 
long-term care (Chemerinski et al., 2013). The disorder originated from the 
observation that relatives of patients with schizophrenia are often characterised by 
schizophrenia-like traits, leading to the development of the term ‘schizotype’ to 
describe the inherited schizophrenia phenotype (Rado, 1953; Meehl, 1962). SPD was 
subsequently included in DSM III and in the current DSM version requires the 
presence of at least five of the following traits: (i) ideas of reference, (ii) odd beliefs 
or magical thinking, (iii) unusual perceptual experiences, (iv) odd thinking and 
speech, (v) suspiciousness or paranoid ideation, (vi) inappropriate or constricted 
affect, (vii) odd behaviour or appearance, (viii) the absence of close friends, and (ix) 
excessive social anxiety associated with paranoia (American Psychiatric Association, 
2013). Several scales have been developed to measure schizotypal traits in the 
general population; the most widely employed being the Chapman scales (Chapman 
et al., 1995), which assess perceptual aberration, magical ideation, physical 
anhedonia, and social anhedonia, and the Schizotypal Personality Questionnaire 
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(Raine, 1991), which maps more closely to the DSM criteria. The prevalence of SPD in 
the general population ranges from 0.6% to 4.6% (Raine, 2006), and, as in 
schizophrenia, rates are higher among males (Pulay et al., 2009). In line with original 
conceptions of schizotypy, family and adoption studies concur in showing that SPD is 
more prevalent among relatives of individuals with schizophrenia than healthy 
controls (Siever & Davis, 2004), and that relatives also show higher scores on scales 
assessing social-interpersonal schizotypal symptoms (Tarbox & Pogue-Geile, 2011).  
Characteristics of individuals with SPD 
Individuals with SPD appear to present some, but not all, of the neurobiological 
features associated with schizophrenia. Psychophysiological abnormalities, including, 
reduced P50 suppression, abnormal startle blink reflex, reduced P300 event-related 
brain potentials, and impaired smooth-pursuit eye movements have been observed 
among individuals with SPD and members of the general population with schizotypal 
traits (i.e., individuals who obtain high scores on schizotypy measures but who do not 
meet SPD criteria) (Siever & Davis, 2004; Raine, 2006). Compared to healthy controls, 
individuals with SPD also show poorer performance on measures of working 
memory, verbal memory, and executive functioning (Siever & Davis, 2004; Seeber & 
Cadenhead, 2005; Raine, 2006), although IQ appears to be relatively intact. Similarly, 
whilst structural brain abnormalities encompassing the superior temporal gyrus, 
corpus callosum, and thalamus have been found among individuals with SPD (Dickey 
et al., 2002; Hazlett et al., 2012), grey matter reductions in the frontal regions and 
medial temporal lobe have not. Finally, there is evidence that individuals with SPD 
also display higher rates of dyskinetic movement abnormalities than healthy controls 
(Walker et al., 1999; Mittal et al., 2007). Such findings may be indicative of abnormal 
function of the dopamine system, a suggestion which is partially supported by 
neurochemical imaging studies of individuals with SPD (Siever & Davis, 2004).  
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Prediction of schizophrenia outcome 
Few studies have followed individuals with SPD longitudinally to determine 
psychosis transition rates in this population. One early study found that 40% of 
inpatients with SPD developed schizophrenia within a 15-year follow-up (Fenton & 
McGlashan, 1989), where lower IQ, poorer work functioning, and transient delusion 
symptoms at baseline were associated with increased risk of transition to psychosis. 
More recently, transition rates of 25% and 48% were reported among psychiatric 
patients with SPD receiving integrated and standard treatment, respectively 
(Nordentoft et al., 2006). The extent to which the results obtained in these clinical 
samples can be generalised to individuals with SPD in the general population is 
unclear. However, a similar transition rate (36% over 2.5 years) was reported for the 
subgroup of participants in the North American Prodrome Longitudinal Study who 
met SPD criteria only (Woods et al., 2009), comprising both help-seeking youth and 
individuals recruited from the community. Lower transition rates have been reported 
among university students with schizotypal features: Over a ten year follow-up 
period, youth who obtained high scores on the Chapman perceptual aberration and 
magical ideation scales showed elevated rates of psychosis compared to the control 
group (5% vs. 1%), although high scores on the non-conformity and physical 
anhedonia scales were not associated with greater risk (Chapman et al., 1994).  
Strengths and limitations 
The study of individuals with SPD who present attenuated features of schizophrenia 
has provided additional important insights into the aetiology of the disorder. 
However, by definition, these individuals present symptoms of sufficient severity to 
meet criteria for a schizophrenia spectrum disorder, which in some instances may 
warrant hospitalisation and treatment with antipsychotic medications. Whilst there 
is evidence that pharmacological agents can lead to improvements in symptoms and 
47 
 
cognitive function in SPD populations (Raine, 2006), identifying high-risk youth at an 
earlier stage of illness may prevent the need for such treatments. As a related issue, 
some studies of individuals with SPD have examined hospitalised patients whilst 
other studies have used advertisements to recruit non help-seeking members of the 
general population who meet SPD criteria at interview, this makes it difficult to 
compare findings across studies. An alternative approach has been to study youth 
with schizotypal traits (i.e., those who obtain high scores on measures of schizotypy) 
who do not meet full SPD criteria, although it is not clear that such individuals are 
indeed at greater risk of developing schizophrenia.  
1.2.4 Individuals presenting psychotic-like experiences  
Background and rationale  
Schizophrenia has traditionally been viewed as categorical entity, characterised by 
features which are distinct from the experiences of healthy individuals. However, 
evidence emerging over the past decade has indicated that psychosis exists on a 
continuum of severity, with members of the general population exhibiting symptoms 
that are similar, albeit less severe, than those presented by individuals with 
schizophrenia (van Os et al., 2000; van Os, 2009; van Os & Linscott, 2012). These 
subclinical psychotic symptoms, or psychotic-like experiences (PLEs), show 
aetiological continuity with schizophrenia (van Os et al., 2009) and are thought to be 
an expression of the underlying distribution of schizophrenia liability in the 
population (van Os, 2009).  
PLEs are common in the general population, with a median prevalence rate of 
around 7% (Linscott & van Os, 2012). However, estimates vary depending on the 
type of assessment method employed. Interview-based methods, such as the 
Composite International Diagnostic Interview [CIDI (Kessler & Ustun, 2004)] and the 
Schedule for Affective Disorders and Schizophrenia for School-Aged Children             
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[K-SADS (Kaufman et al., 1997)], are considered the gold standard. Self-report 
questionnaire measures offer the opportunity to screen large samples (Konings et al., 
2006; Laurens et al., 2007; Kelleher et al., 2011), but are associated with much higher 
levels of PLE endorsement. However, these measures have been found to show 
adequate predictive validity with PLEs assessed at interview (Konings et al., 2006; 
Kelleher et al., 2011). Auditory hallucinations are prevalent among younger children 
(median prevalence ~17%), but appear to be less common in adolescent samples 
(median prevalence ~8%) (Kelleher et al., 2012a). Indeed, longitudinal studies 
indicate that the majority of PLEs experienced during childhood and early 
adolescence are transient in nature (De Loore et al., 2011; Dominguez et al., 2011; 
Thapar et al., 2012; Downs et al., 2013). 
Characteristics of individuals presenting PLEs 
The high prevalence of PLEs in child and adolescent populations has generated much 
interest regarding the clinical significance of these experiences. Children and 
adolescents who report PLEs are characterised by higher levels of emotional 
symptoms and behavioural problems than those who do not (Laurens et al., 2007; 
Scott et al., 2009; Armando et al., 2010; Polanczyk et al., 2010; Barragan et al., 2011; 
Kelleher et al., 2012b), and are more likely to display self-harm and suicidal 
behaviours (Nishida et al., 2010; Polanczyk et al., 2010; Kelleher et al., 2013b). 
Longitudinal studies show that adolescents who experience persisting PLEs, as 
opposed to those whose PLEs remit, are at greater risk of developing internalising 
and externalising psychopathology (De Loore et al., 2011; Mackie et al., 2011; Downs 
et al., 2013). There is also evidence that children reporting PLEs are characterised by 
some of the neurocognitive features observed among adults with established 
schizophrenia. For example, children who report PLEs have been found to show 
poorer linguistic abilities, deficits in processing speed, and attentional impairments 
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compared to healthy youth (Kim et al., 2012; Hameed et al., 2013; Kelleher et al., 
2013a). Additionally, a recent neuroimaging study observed increased grey matter 
volume in the angular gyrus, orbitofrontal gyrus, and the superior and middle 
temporal gyri, as well as decreased grey matter volume in the inferior temporal gyrus 
in children reporting PLEs relative to their healthy peers (Jacobson et al., 2010).  
Prediction of schizophrenia outcome  
Data from the prospective, longitudinal investigation of a Dunedin birth cohort 
provided the first robust evidence that individuals reporting PLEs are at increased 
risk for psychotic disorders (Poulton et al., 2000). Children reporting ‘weak’ PLEs at 
interview (i.e., who responded ‘yes, likely’ on at least one PLE item among five) were 
five times more likely to meet criteria for schizophreniform disorder at age 26 years 
than children who did not report PLEs. Moreover, children reporting ‘strong’ PLEs 
(i.e., who responded ‘yes, likely’ on at least two PLE items or ‘yes, definitely’ on at 
least one item) experienced a 16-fold increase in risk. Importantly, PLEs were not 
found to predict mania or depression, suggesting some degree of specificity. A recent 
follow-up of the Dunedin cohort at age 38 years observed that the risk of developing 
schizophrenia was seven times higher among those who reported strong PLEs in 
childhood (Fisher et al., 2013a); whilst PLEs also increased the risk for post-
traumatic stress disorder by three-fold, they were not associated with increased risk 
for other psychiatric disorders.  
Similar findings have been obtained in other cohorts, although only one has used 
hospital admission (as opposed to research diagnostic criteria) to assess outcome 
(Werbeloff et al., 2012). This longitudinal study examined young adults (aged 25-34 
years at study commencement) over a mean follow-up period of 24 years, and found 
that the risk of later hospitalisation for non-affective psychotic disorders was 
approximately four times higher among those who reported at least one PLE at 
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interview compared to individuals who did not report PLEs. Risks were further 
increased among those who were also characterised by poor social functioning or 
anxiety disorder.  
Pooling data from six cohort studies, a recent meta-analysis calculated that the 
annual risk of developing a psychotic disorder is 3.5 times higher among individuals 
reporting PLEs compared to those who do not (Kaymaz et al., 2012). This meta-
analysis also found evidence of a dose-response relationship between PLEs and 
psychotic disorders (i.e., more severe/persistent PLEs associated with greater risk), 
and although PLEs also increased the risk for non-psychotic disorders, these 
associations were weaker.  
Strengths and limitations 
The study of individuals presenting PLEs has several advantages over more 
established high-risk strategies. PLEs can be assessed with ease using self-report 
questionnaires, allowing that the association with relatively rare risk factors can be 
examined in large population-based cohorts. Additionally, although PLEs are 
associated with high levels of comorbid psychopathology and distress, they do not 
typically confer a need for care. Thus, studies of individuals with PLEs are not 
confounded by help-seeking behaviour or treatment with antipsychotic medication. 
However, PLEs are experienced by a far higher proportion of the general population 
than clinical psychosis, and in the vast majority of instances these experiences are 
transient and benign. Further research is needed to determine the mechanisms by 




1.2.5 Summary of established high-risk approaches 
Table 1 summarises established strategies for identifying individuals at elevated risk 
for schizophrenia with particular emphasis on the strengths and limitations 
associated with each approach. Broadly speaking, these approaches have focused on 
two groups of individuals: those at elevated genetic-risk, as conferred by a family 
history of illness, and those at symptomatic-risk due to the presence of clinical 
features (i.e., UHR youth, individuals with SPD, and those reporting PLEs). Given that 
the majority of individuals with schizophrenia do not have an affected relative with 
the disorder, strategies based on the latter approach may have increased 
generalisability over the traditional genetic high-risk method. However, the degree of 
distress and illness severity among individuals at UHR and those with SPD limits the 
extent to which premorbid features can be examined in these populations.  
It is important to note that the distinction between these two broad approaches 
(i.e., genetic- vs. symptomatic-risk definitions) may be somewhat arbitrary. Firstly, 
the groups identified using these methods are by no means mutually exclusive. 
Indeed, one of the UHR criteria is the presence of a family history of illness in 
combination with a decline in function; thus, a subset of those meeting UHR criteria 
are also at genetic high-risk for schizophrenia. Similarly, relatives of individuals with 
schizophrenia are more likely to meet SPD criteria than members of the general 
population, which is not surprising given the origins of the term ‘schizotype’. 
Secondly, the clinical and neurobiological features that characterise individuals at 
genetic-risk and those at symptomatic-risk are not necessarily the product of 
different mechanisms. Characteristics of genetic high-risk individuals may be driven 
by environmental exposures rather than genetically-mediated effects, whilst 
individuals at symptomatic-risk may possess any number of the genetic variants 
which have been associated with increased risk for schizophrenia.  
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Table 1. Summary of existing strategies for identifying individuals at elevated risk for schizophrenia 
Group Identification Strengths Limitations 
Family history of 
schizophrenia 
Relatives (typically offspring or siblings) 
of patients with psychosis or members of 
the general population recruited via 
advertisements  
(i) Individuals can be identified in early life 
and followed longitudinally, (ii) provides the 
opportunity to identify psychosis 
vulnerability factors that may potentially be 
genetically-mediated 
(i) The majority of individuals with 
schizophrenia do not have an affected relative, 
thus, findings may not generalise, (ii) many 
studies include individuals who have passed 
the peak age of illness onset (~30 years)  
Ultra high-risk 
(UHR) 
Help-seeking adolescents and young 
adults who present with clinical 
characteristics consistent with the 
prodromal phase of illness 
(i) Close-in strategy identifies individuals 
who are more proximal to disease onset, (ii) 
findings from studies of UHR youth may be 
more generalisable than those of family 
history (genetic) high-risk studies 
(i) Help-seeking population: UHR youth are 
already characterised high levels of disability 
and impairment, (ii) studies examining brain 
structure and cognitive function may be 
confounded by medication use 
Schizotypal 
personality 
disorder (SPD)  
Psychiatric service users or members of 
the general population recruited via 
advertisements who meet SPD criteria at 
interview or obtain high scores on 
schizotypy measures 
(i) Not typically help-seeking (although 
sometimes includes treated samples), (ii) 
findings from studies of individuals with SPD 
may be more generalisable than those of 
family history (genetic) high-risk studies 
(i) Individuals with SPD present symptoms of 
sufficient severity to warrant a schizophrenia 
spectrum disorder diagnosis, (ii) considerable 




Members of the general population who 
report psychotic-like experiences as 
assessed at interview or using self-report 
questionnaires  
(i) Non help-seeking population, not 
confounded by medication use (ii) 
epidemiological approach, associations can 
be examined in general population samples 
(i) High prevalence of PLEs indicates this 
approach may be too broad and that the 
majority of individuals identified will not go 




1.3 Clinical staging model of schizophrenia  
The study of individuals at elevated risk for psychosis has demonstrated that many of 
the clinical and neurobiological features that characterise individuals with 
schizophrenia are present to some degree before illness onset. Such findings are 
consistent with the clinical staging model of schizophrenia (McGorry et al., 2006; 
Yung & McGorry, 2007; Wood et al., 2011), which offers a framework by which to 
better characterise the disorder. Clinical staging, a method commonly implemented 
in other medical disciplines, attempts to define the extent to which the illness has 
progressed and thus where an individual lies on the continuum of severity. The 
strategy is based on two main assumptions, (i) individuals in the early stages of 
illness will show less severe symptoms and should respond better to treatment, and 
(ii) in accordance with risk-benefit principles, treatments offered at an early stage 
should be benign and more effective.  
Drawing on the findings of several decades of high-risk research, the model 
outlines a series of stages that precede psychosis onset, each corresponding to the 
extent, progression, and impact of the illness. According to the model (Table 2), the 
early stages of psychosis are characterised by relatively mild or non-specific 
symptoms (e.g., depression and anxiety, neurocognitive deficits, or PLEs with mild 
functional impairment). For some individuals, these symptoms worsen, new 
symptoms develop, and progressive neuroanatomical and neurocognitive changes 
occur which eventually manifests as psychosis (Wood et al., 2011). Whilst chronic 
illness may follow, an important feature of the model is that not all individuals will 
progress to psychosis. It is hoped that the staging model will help to elucidate the 
disease process and ultimately lead to more successful intervention strategies. The 
approach may also help to distinguish between biological processes that contribute 
to disease onset and those that represent epiphenomena (McGorry et al., 2006).   
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Table 2. Clinical staging model of schizophrenia, adapted from McGorry et al. (2006) and Wood et al. (2011) 
Stage  Description  Example populations Proposed interventions 
Stage 0 
 
Increased risk of psychotic or severe mood disorder, no 
current symptoms  
First-degree adolescent relatives 
of individuals with schizophrenia 
Improved mental health literacy, family 
education, substance use education, brief 
cognitive skills training 
Stage 1a Mild or non-specific symptoms (neurocognitive deficits, 
PLEs with mild functional decline, mood or anxiety 
symptoms resulting in distress and/or help-seeking) with 
mild functional change or decline 
Referrals from youth mental 
health services, primary care, or 
school counsellors 
Formal mental health literacy, family 
psychoeducation, formal CBT, active substance 
abuse reduction 
Stage 1b Ultra high-risk (moderate but subthreshold symptoms) 
with/without mild to moderate neurocognitive changes, 
comorbid substance abuse, and functional decline 
Help-seeking youth meeting 
CAARMS criteria 
Family psychoeducation, formal CBT, active 
substance abuse reduction, atypical antipsychotic 
agents, antidepressants, or mood stabilisers 
Stage 2 Full threshold disorder with moderate-to-severe 
symptoms, neurocognitive deficits, and functional decline 
Individuals meeting psychosis 
criteria as defined by the 
CAARMS  
Family psychoeducation, formal CBT, active 
substance abuse reduction, atypical antipsychotic 
agents, antidepressants or mood stabilisers, and 
vocational training 
Stage 3 Incomplete remission or recurrence/relapse Individuals with a recurrence of 
Stage 2 psychosis 
As for Stage 2, with additional emphasis on 
medical and psychosocial strategies to achieve 
full remission 
Stage 4 Severe, persistent, and unremitting illness  Patients with established 
schizophrenia and functional 
impairment 
As for Stage 3, with additional emphasis on 
relapse prevention strategies and identifying 
early warning signs  
Note. CAARMS: Comprehensive Assessment of At-Risk Mental States (Yung et al., 2005); CBT: cognitive behavioural therapy.
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1.4 Children presenting multiple antecedents of schizophrenia  
1.4.1 A novel high-risk strategy 
Rationale 
Researchers at the Institute of Psychiatry sought to develop a novel method for 
identifying putatively high-risk children in the general population who present 
multiple antecedents of schizophrenia (Laurens et al., 2007; Laurens et al., 2011). 
This strategy was designed to enable the identification of high-risk youth at an earlier 
stage of illness than the UHR approach in the hope that this would maximise 
opportunities for early intervention. A further aim was to develop a high-risk 
strategy that would support research efforts to identify causal processes contributing 
to schizophrenia. It was anticipated that the identification of high-risk children from 
community samples would minimise the role of confounding factors that influence 
the study of UHR youth (e.g., help-seeking behaviour and medication use) and 
address the generalisability issues associated with genetic high-risk studies. 
Antecedents of schizophrenia 
Prospective longitudinal studies of population cohorts and genetic high-risk studies 
have identified a number of factors that may be considered childhood antecedents of 
schizophrenia (i.e., factors that characterise children who later develop the disorder 
which may be early expressions of illness). These include: delays and abnormalities 
in speech development, motor dysfunction, social withdrawal and emotional 
problems, behavioural difficulties, intellectual and cognitive impairments, and 
psychotic-like experiences (Niemi et al., 2003; Welham et al., 2009a; Matheson et al., 
2011). As these antecedents are typically non-specific (i.e., conferring risk for a range 
of mental health problems in adulthood), and the effect sizes associated with each 
individual antecedent are typically small, it was reasoned that identifying children 
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who present multiple replicated antecedents, rather than any single risk factor (e.g. 
PLEs), would provide a more specific and sensitive means of identifying putatively at-
risk children. Given the low prevalence of schizophrenia in the general population, it 
was anticipated that large numbers of children would need to be screened in order to 
identify those presenting multiple antecedents. The selection of antecedents was 
therefore restricted to those that could be easily assessed via questionnaire.   
Questionnaires were subsequently developed to identify children aged 9-12 years 
presenting a triad of antecedents of schizophrenia (ASz), defined as (i) a speech 
and/or motor developmental delay or abnormality, (ii) a social, emotional, and/or 
behavioural problem, and (iii) a psychotic-like experience. Longitudinal studies have 
provided robust evidence that these factors represent early antecedents of 
schizophrenia (see Table 3 for examples). Birth cohort studies indicate that children 
who later develop schizophrenia display markers of abnormal neurodevelopment; 
specifically, these individuals show delays in attaining speech and motor milestones, 
poorer expressive and receptive language skills, and motor coordination problems in 
early life (Jones et al., 1994; Bearden et al., 2000; Rosso et al., 2000; Isohanni et al., 
2001; Cannon et al., 2002; Sørensen et al., 2010; Welham et al., 2010; McNeil et al., 
2011). There is also consistent evidence from population-based cohort studies and 
high-risk studies that those who later develop schizophrenia are characterised by 
social withdrawal and emotional problems in childhood (Jones et al., 1994; Crow et 
al., 1995; Bearden et al., 2000; Cannon et al., 2002; Kim-Cohen et al., 2003; Schiffman 
et al., 2004) as well as externalising symptoms and behavioural difficulties 
(Amminger et al., 1999; Bearden et al., 2000; Cannon et al., 2002; Carter et al., 2002; 
Kim-Cohen et al., 2003; Welham et al., 2009b). Finally, children reporting PLEs are at 
increased risk for later development of schizophrenia and related disorders (Poulton 
et al., 2000; Welham et al., 2009b; Fisher et al., 2013a; Zammit et al., 2013).  
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Table 3. Examples of longitudinal studies identifying childhood antecedents of schizophrenia 
Study Sample Risk factor Method  Relationship to schizophrenia outcome 
Speech and motor delays and abnormalities 
Jones et al.  
(1994)                         
British 1946 Birth 
Cohort (N=4,746) 
Speech problems Clinical observations at ages 
2, 6, 7, 11, and 15 years 
Speech problems (any age) more common in those who 
developed schizophrenia than controls (OR=2.8) 
  Milestone delays Health visitors records 
completed at age 2 years 
Schizophrenia cases were less likely to have learnt to talk 
or sit, stand, or walk unaided than controls (OR=4.8) 









Examination by a speech 
pathologist at age 7 years 
Abnormal speech rating significantly predicted 
schizophrenia (OR=12.7)  
 Poor expressive 
language 
Auditory-vocal association 
test at age 7 years 
Individuals who later developed schizophrenia showed 
poorer expressive language skills than controls (OR=0.7)  
Rosso et al.  
(2000)   




Assessment of motor skills at 
age 7 years 
Schizophrenia cases more likely to have motor 
coordination problems than controls (OR=2.4) 




1966 Birth Cohort 
(N=9,901) 
Motor milestone 
delays      
                                                                   
Caregiver report and 
examination by a research 
clinician at age 1 year 
Age at which child learned to stand and walk unaided 
were both significantly associated with schizophrenia at 
follow-up (risk increased with later age) 









Standardised language tests 
at ages 3, 5, 7, and 9 years 
Those who later developed schizophreniform disorder 
showed poorer receptive language skills than controls 
 Motor milestone 
delays 
Maternal self-report at age 3 
years 
Schizophreniform disorder cases did not start to walk 
until significantly later in childhood than controls 
Note. N: number of participants contributing to specific analysis; controls: individuals without schizophrenia/psychotic disorder; OR: odds ratio.   
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Table 3. (continued) 
Study Sample Risk factor Method Relationship to schizophrenia outcome 










(structured diary) during 
first year of life 
Schizophrenia cases were later to attain developmental 
milestones (head lifting, sitting unsupported, crawling, 
and walking unsupported) than controls  
Welham et al.  









Standardised vocabulary test 
at age 5 years 
 
In males, but not females, individuals who developed non-
affective psychosis had poorer vocabulary at age 5 than 
controls  
 







Motor milestones assessed at 
multiple time-points   
Delayed motor milestone attainment associated with risk 
of schizophrenia-spectrum disorder (OR=4.5) 
Social, emotional, and behavioural problems 
Jones et al.  
(1994) 
 
British 1946 Birth 
Cohort (N=4,746) 
Social anxiety and 
withdrawal 
Child self-report personality 
inventory at age 13 years 
Linear association between social anxiety and risk for 
schizophrenia  
   Teacher ratings at age 15 
years   
         
Schizophrenia cases appeared more anxious in school 
than controls 
Amminger et al. 
(1999) 




Caregiver interview at age 9 
years 
Individuals who developed schizophrenia had higher 
levels of behavioural problems than controls 








maladjustment                
                       
Teacher ratings of social 
adjustment at age 7 and 11 
years 
Schizophrenia cases characterised as more anxious and 
hostile at age 7 (males) and more withdrawn and 
depressed at age 11 (females) than controls 




Table 3. (continued) 
Study Sample Risk factor Method  Relationship to schizophrenia outcome 
Bearden et al. 
(2000)  
 




Clinician assessment at age 8 
months, and 4 and 7 years 
Social maladjustment at age 7 years more common 
among schizophrenia cases than controls (OR=2.5) 
  Behavioural 
deviance 
Clinician assessment at ages 
4 and 7 years 
Schizophrenia cases more likely to show deviant 
behaviour at age 4 (OR=1.7) and 7 (OR=1.7) than controls  







Rutter Internalising Scales 1 
at 5, 7, 9, and 11 years 
Schizophreniform disorder cases obtained higher ratings 
on internalising scale at age 5-11 years than controls 
  Externalising 
problems 
Rutter Externalising Scales 1 
at 5, 7, 9, and 11 years 
Schizophreniform disorder cases obtained higher ratings 
on externalising scale at age 5-11 years than controls 
Carter et al.  
(2002)    
    
Copenhagen High-
Risk Project (N=311) 
Behavioural 
problems 
Teacher rated classroom 
behaviours at age 15 years 
Cases with schizophrenia had higher scores on disruptive 
behaviour scale than controls 
Kim-Cohen et al. 
(2003) 






Psychiatric diagnoses at ages 
11 and 15 years  
Anxiety (OR=2.5) and depression (OR=7.4) more common 
in schizophreniform disorder cases than controls 
 Externalising 
disorders 
Psychiatric diagnoses at ages 
11 and 15 years 
Schizophreniform disorder cases more likely to have had 
ODD/CD (OR=2.8) and ADHD (OR=4.5) than controls 
Schiffman et al. 
(2004) 
Danish High-Risk 
Cohort (N=265)  
Social deficits  
 
Ratings of video recordings 
obtained at age 11-13 years 
Schizophrenia cases had lower scores on a sociability 
scale than controls 
Welham et al.  
(2009b)  
 




Maternal reports on CBCL 2 at 
ages 5 and 14 years 
Non-affective psychosis predicted by high aggression 
scale scores at both 5 and 14 years in males (OR=6.8) 
Note. N: number of participants contributing to specific analysis; controls: individuals without schizophrenia/psychotic disorder; OR: odds ratio. 1 Rutter Child 
Scales (Rutter et al., 1970) completed by parent and teacher; 2 Child Behaviour Checklist (Achenbach, 1991).   
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Table 3. (continued) 
Study Sample Risk factor Method  Relationship to schizophrenia outcome 
Psychotic-like experiences (PLEs) 
Poulton et al.  
(2000)  
 




Clinical interview (DISC 3) 
completed at age 11 years 
Schizophreniform disorder cases more likely to report 
‘strong’ PLEs (OR=16.4) than controls 
Welham et al.  
(2009b)  
 




YSR 4 Thought problems 
subscale age 14 years 
Non-affective psychosis associated with auditory 
hallucinations in males (OR=5.1) and females (OR=2.3) 
Fisher et al.  
(2013a)  
 




Clinical interview (DISC 3) 
completed at age 11 years 
Children reporting PLEs at greater risk of developing 
schizophrenia (RR=7.2) than children who did not 










Interview at age 12 years 
 
Psychotic disorder at age 18 associated with definite PLEs 
at age 12 (OR=12.7) 
 
Note. N: number of participants contributing to specific analysis; controls: individuals without schizophrenia/psychotic disorder; OR: odds ratio; RR: risk ratio.  
3 Diagnostic Interview Schedule for Children (Costello et al., 1982); 4 Youth Self-Report (Achenbach, 1991).   
61 
 
1.4.2 Community-based screening approach 
Screening questionnaires 
A novel community-based screening method was developed to identify children 
presenting the triad of antecedents. Chapter 3 provides full details of the procedure 
and the measures included in the screening questionnaire. In brief, questionnaires 
including items assessing the triad of antecedents were completed by children aged 
9-12 years at school and by their caregivers at home. Delays or abnormalities in 
speech and/or motor development were assessed via caregiver-report using 
quantitative and qualitative questions, which demarcated gross deviations in 
milestone attainment and professional and parental concerns regarding speech or 
motor development. Social, emotional, and behavioural problems were defined as a 
score in the clinical range (approximating the top tenth percentile on UK population 
norms) on at least one of the four Strengths and Difficulties Questionnaire [SDQ 
(Goodman, 2001)] psychopathology scales, including, child-reported emotional 
symptoms, or caregiver-reported conduct problems, hyperactivity-inattention, or 
peer relationship problems. The presence of a psychotic-like experience was defined 
as at least one child-reported ‘certainly-true’ response on a nine-item PLE measure 
(Laurens et al., 2007; Laurens et al., 2011).   
Prevalence of the antecedent triad 
An initial pilot study examining data from 264 children and their primary caregivers 
demonstrated that the community screening approach provided a cost-effective and 
feasible method of identifying children presenting the triad of antecedents (Laurens 
et al., 2007). A subsequent publication reported school-based questionnaire 
screening data from 1,347 children in primary schools across Greater London 
(Laurens et al., 2011). Of these, 26% were reported to have experienced any speech 
and/or motor delay or abnormality, 32% presented with abnormal scores on at least 
62 
 
one of the four SDQ psychopathology scales (emotional symptoms: 12%; conduct 
problems: 11%; hyperactivity-inattention: 10%; peer relationship problems: 14%), 
and 63% reported at least one certainly-true PLE (Laurens et al., 2011). The 
percentage of children reporting each individual PLE ranged from 9% to 34%; the 
most commonly reported experiences being auditory hallucinations (34%), paranoid 
thoughts (30%), and visual hallucinations (27%). In total, 10% of children met ASz 
criteria and 24% presented with none of the antecedents. The majority of ASz 
children (69%) reported that the PLEs they experienced were either distressing or 
associated with impairment.  
Demographic correlates 
In accordance with the finding that males are at greater risk for schizophrenia 
(Tandon et al., 2009), the ASz triad was more common among boys than girls (13% 
vs. 6%) (Laurens et al., 2011). Relative to white British children, those of African-
Caribbean, black African, and ‘other’ ethnicity were significantly more likely to 
present the ASz triad (Laurens et al., 2008; Laurens et al., 2011); although migrant 
status was not associated with any of the antecedent components. The higher 
prevalence of the ASz triad among African-Caribbean and black African children is 
consistent with the elevated rates of psychosis observed among these groups in the 
UK (Kirkbride et al., 2012), which may reflect differences in the distribution of socio-
environmental risk factors across ethnic groups.  
1.4.3 Characteristics of ASz children 
Whilst only longitudinal follow-up can determine the specificity and sensitivity of the 
triad in predicting later schizophrenia, preliminary investigations comparing ASz 
children to their typically-developing (TD) peers (who do not present with any of the 
antecedents or a family history of illness) indicate that ASz children display several 
features that characterise adults with established illness.  
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Neurocognitive function  
Impairments in neurocognitive function, equating to a moderate effect size (d=0.52), 
have been observed among ASz children aged 9-12 years (Cullen et al., 2010). In this 
study, ASz children obtained lower scores than the TD group on all 16 neurocognitive 
subtests examined. Significant group differences were observed for four domains: 
general intelligence, verbal memory, working memory, and executive function – 
inhibition (Figure 2), with the largest impairments observed in working memory. 
These neurocognitive impairments are less pronounced than those reported in 
individuals with schizophrenia (Mesholam-Gately et al., 2009), but are of a similar 
magnitude to those observed in young adult relatives (Agnew-Blais & Seidman, 
2013), youth at UHR (Fusar-Poli et al., 2012b; Giuliano et al., 2012), individuals with 
SPD (Siever & Davis, 2004; Seeber & Cadenhead, 2005; Raine, 2006), and children 
reporting PLEs (Kim et al., 2012; Hameed et al., 2013; Kelleher et al., 2013a). 
 
Figure 2. Neurocognitive performance in ASz children relative to TD children 
























ASz (n=28) TD (n=28) 
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Event-related processing  
An event-related processing (ERP) study also provided evidence that ASz children 
are characterised by abnormalities of brain function similar to those observed in 
patients with schizophrenia (Laurens et al., 2010). Twenty-two ASz and 26 TD 
children completed a Go/No-Go ERP paradigm indexing error-related negativity 
(ERN), which describes the peak in brain activity that follows the detection of an 
erroneous response. Like adults with schizophrenia and their unaffected relatives 
(Bates et al., 2004; Simmonite et al., 2012), ASz children were found to show reduced 
amplitude of the ERN component compared to the TD group. This reduction in 
amplitude is thought to reflect functional abnormality of the anterior cingulate 
cortex, which, as noted in preceding sections, is a region in which reduced grey 
matter volume has been observed among individuals with a family history of illness 
(Fusar-Poli et al., in press).     
A subsequent ERP study examined performance on an auditory oddball task in 22 
ASz and 24 TD children matched on demographic variables, pubertal status, and IQ 
(Bruggemann et al., 2013). This task was used to investigate mismatch negativity 
(MMN), an ERP component that is observed when the brain detects a change in 
auditory stimuli (i.e., a discrepancy between an incoming stimulus and the memory of 
previously presented stimuli). Relative to the TD group, ASz children were found to 
show increased MMN amplitude at the frontal sites. Interestingly, individuals with 
schizophrenia have been found to show a decrease in MMN amplitude relative to 
healthy controls (Turetsky et al., 2007). The pattern of abnormality that was found to 
characterise ASz children is therefore different to that which is typically observed 
among individuals with schizophrenia, and may demonstrate important stage effects 




Figure 3. Significant clusters of relatively increased and decreased grey matter and 
white matter volume in ASz children relative to TD children 
Note. Figure adapted from (Cullen et al., 2013). Relatively decreased (yellow) and increased (red) 
grey matter volume, as well as relatively increased white matter volume (green) in ASz children 
(n=20) compared to the TD group (n=20) (p<0.05, corrected for multiple comparisons). 
 
Whole brain structure  
Voxel-based morphometry techniques have demonstrated that ASz children show 
differences in grey matter (GM) and white matter (WM) volume compared to TD 
children (Cullen et al., 2013). GM volume was significantly decreased in the right 
middle temporal gyrus in ASz children and significantly increased in the left superior-
middle temporal gyri (Figure 3). Additionally, ASz children showed increased WM 
volume in a cluster encompassing the left inferior parietal lobe, occipital lobe, and 
superior temporal gyrus. These structural brain abnormalities comprise a subset of 
the regions affected in first-episode psychosis patients and UHR youth (Fusar-Poli et 
al., 2012c; Shepherd et al., 2012). A similar pattern of abnormalities was also 
observed in study of children reporting PLEs at interview (Jacobson et al., 2010).  
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Involuntary dyskinetic movements  
ASz children have also been found to show higher levels of involuntary dyskinetic 
movements compared to their TD peers (Macmanus et al., 2012), thought to be an 
indication of abnormal striatal dopamine regulation. Using an established procedure 
(Walker et al., 1994), blind ratings of videotapes were used to assess involuntary 
dyskinetic movements in 21 ASz and 31 TD children. ASz children were found to 
present with significantly more movement abnormalities in the facial regions (e.g., 
tics, grimacing, blinking, tongue thrusts) and upper body (e.g., shoulder/hip torsion, 
writhing and extensions of the fingers or wrist). These abnormalities are similar to 
those that have been observed among children who later develop schizophrenia 
(Walker et al., 1994; Rosso et al., 2000) and adolescents with SPD (Mittal et al., 2007).  
Facial emotional processing 
ASz children have also been found to show moderate impairments in their ability to 
recognise facial emotions compared to TD children (Dickson et al., in press-a), with 
the largest impairments found for sad and angry facial emotions. Additionally, 
relative to the TD group (n=34), ASz children (n=34) more commonly misattributed 
neutral expressions to other facial emotions and mislabelled neutral emotions as sad. 
These impairments are similar to those observed in individuals with schizophrenia 
(Kohler et al., 2010) as well as those found in UHR youth (Thompson et al., 2011b) 
and first-degree relatives of individuals with schizophrenia (Lavoie et al., 2013). 
Social withdrawal 
Finally, a study of 38 ASz children, 49 TD children, and 34 children with a family 
history of schizophrenia (Matheson et al., 2013b) investigated social withdrawal 
using parent-reported scores on the Child Behaviour Checklist (Achenbach & 
Rescorla, 2001). ASz children were characterised by higher scores on the social 
withdrawal scale relative to their typically-developing peers, equating to a moderate-
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to-large effect size (d=0.74). Children with a family history of schizophrenia were 
also found to present with higher levels of social withdrawal relative to TD children; 
however, the effect size observed in the family history group (d=0.44) was smaller in 
magnitude than that observed among ASz children. These findings are consistent 
with studies showing that social withdrawal characterises children who go on to 
develop schizophrenia in later life (Tarbox & Pogue-Geile, 2008).  
1.5 Summary  
Strategies to identify individuals at elevated risk for schizophrenia have focused on 
individuals with a family history of illness, UHR youth, individuals with SPD, and 
those reporting PLEs. Evidence suggests that these groups are characterised by many 
of the neurobiological abnormalities and social cognitive impairments observed 
among individuals with established illness, although these abnormalities are typically 
smaller in magnitude. Such studies have enabled the characterisation of the 
premorbid stages of schizophrenia which may ultimately lead to more effective 
interventions being delivered during the early stages of psychosis to reduce the risk 
of illness progression. Limitations associated with established strategies for 
identifying high-risk individuals have motivated the development of a novel 
approach which focuses on children aged 9-12 years who present multiple 
antecedents of schizophrenia. Research has demonstrated that these children can be 
identified using a cost-effective school-screening procedure. Whilst only longitudinal 
follow-up will confirm the extent to which ASz children are at elevated risk for 
schizophrenia, preliminary investigations show that these children share several 




CHAPTER 2 Systematic review of stress and HPA axis function in 
individuals at elevated risk for schizophrenia 
2.1 Introduction  
As proposed by the neural diathesis-stress model of schizophrenia (Walker & Diforio, 
1997; Walker et al., 2008), psychosocial stress exposure may elicit abnormality 
within the HPA axis that contributes to the onset of psychosis among individuals with 
an underlying vulnerability for the disorder. Several lines of evidence support this 
model. Firstly, there is evidence that exposure to psychosocial stressors (e.g., major 
life events, childhood trauma, and milder daily hassles) contributes to the 
development and maintenance of psychosis (Myin-Germeys & van Os, 2007; Phillips 
et al., 2007; Varese et al., 2012) and that individuals with psychosis show greater 
emotional reactivity to potentially stressful experiences than healthy individuals 
(Myin-Germeys et al., 2001). Secondly, abnormal HPA axis function, as indexed by 
elevated diurnal cortisol levels and/or a blunted cortisol awakening response (CAR), 
has been observed in individuals with first-episode psychosis (Borges et al., 2013) 
and has also been associated with neurocognitive deficits in this population (Aas et 
al., 2011b). Finally, patients with first-episode psychosis have also been found to 
show enlarged pituitary volumes (Borges et al., 2013; Nordholm et al., 2013). Whilst 
these studies provide evidence that psychosis is characterised by increased exposure 
and reactivity to psychosocial stressors and HPA axis dysfunction, the extent to 
which these features precede illness onset is currently unclear. 
Two recent systematic reviews have investigated whether individuals at elevated 
risk for schizophrenia are also characterised by increased stress susceptibility and 
HPA axis dysfunction (Aiello et al., 2012; Nordholm et al., 2013). The first reported 
that individuals with a family history of illness and UHR youth are characterised by 
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increased emotional reactivity to stress and enlarged pituitary volume relative to 
controls (Aiello et al., 2012), but that only UHR youth showed elevated cortisol levels. 
This review did not compute standardised effect sizes to allow comparisons across 
high-risk groups and did not include at-risk individuals with SPD or those reporting 
PLEs. Moreover, studies examining psychosocial stress exposure (as opposed to 
stress reactivity) were not included. The second review, which focused specifically on 
pituitary volume abnormalities, reported that UHR youth and individuals with SPD 
were characterised by increased pituitary volume relative to controls (Nordholm et 
al., 2013); standardised effect sizes demonstrated that the observed differences were 
small in magnitude. This review did not include studies examining individuals with a 
family history of illness or those reporting PLEs. Thus, it is currently unclear as to 
whether all high-risk groups are characterised by increased exposure and reactivity 
to psychosocial stressors and HPA axis abnormalities, and whether effect sizes are 
similar across high-risk groups. The following chapter comprises a systematic review 
of studies examining experiences of psychosocial stress, cortisol levels, and pituitary 
volume among relatives of patients with schizophrenia, UHR youth, individuals with 
SPD, and those reporting PLEs. The specific aims were as follows: 
1. Review studies examining (i) exposure and reactivity to psychosocial 
stressors, (ii) cortisol levels, and (iii) pituitary volume in order to determine 
the magnitude of differences between high-risk and healthy individuals.  
2.  Evaluate the extent to which experiences of psychosocial stress (exposure 
and reactivity) and HPA axis abnormalities in high-risk individuals are 
associated with psychopathology and illness progression. 
3. Discuss methodological considerations pertinent to the work presented in 




2.2.1 Data sources and search terms 
Systematic literature searches were conducted within PubMed, PsycINFO, and 
EMBASE during September 2013. The following search terms were employed: 
“stress; hassle; life event; trauma; stressor; abuse; maltreatment; adversity; 
victimisation; neglect; cortisol; or pituitary” in combination with “relatives; offspring; 
sibling; family history; genetic risk; at risk mental state; ultra high risk; clinical high 
risk; prodrome; or high risk” and “schizophrenia or psychosis” or “schizotypal 
personality disorder; schizotypy; psychotic experiences; psychotic-like experiences; 
subclinical psychotic symptoms; subclinical psychosis; or non-clinical psychosis”. 
Searches were conducted in two waves; the first wave included psychosocial stress 
terms in combination with the high-risk search terms, and the second wave included 
cortisol and pituitary in combination with high-risk key words. Reference lists of 
review articles were manually searched to identify additional studies.  
2.2.2 Inclusion criteria 
The search was restricted to published studies only; conference abstracts and 
dissertations were excluded, as were studies not written in English. As the aim of the 
review was to determine whether individuals at elevated risk for psychosis are (i) 
more likely to encounter psychosocial stressors, (ii) show increased reactivity to 
psychosocial stressors, and (iii) are characterised by biological markers of HPA axis 
dysfunction relative to healthy controls, prospective studies examining the extent to 
which these factors precede the satisfaction of at-risk criteria (i.e., where the at-risk 
status may have evolved as a consequence of these features) were excluded. 
Similarly, retrospective studies examining the relationship between risk status and 
prior exposure to psychosocial stressors were not included if there was a clear 
passage of time between exposure occurrence and the onset of at-risk symptoms 
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(e.g., studies examining childhood trauma in adult populations). Association studies 
that used multivariate models to predict PLEs (i.e., where the univariate relationship 
between PLEs and experiences of psychosocial stress/HPA axis dysfunction could not 
be ascertained) were also not eligible for inclusion.  
The review therefore included cross-sectional studies examining the association 
between high-risk status and experiences of psychosocial stress (exposure and/or 
reactivity), cortisol levels, or pituitary volume, or prospective studies of high-risk 
individuals which assessed these outcomes at follow-up. The review included studies 
examining cortisol responses elicited by psychosocial stressor tasks (i.e., 
experimental tasks designed to induce an increase in cortisol levels). As it was 
beyond the scope of this review to examine cortisol secretion following 
pharmacological challenge, studies measuring responses to metabolic stressors (e.g., 
dexamethasone) were only included if baseline or placebo condition data were 
reported, thereby providing a measure of basal cortisol levels. Studies that did not 
include a healthy control group were not examined in the systematic review; 
however, those that assessed the extent to which experiences of psychosocial stress 
or HPA axis function were associated with psychopathology or illness progression 
were described in sections focusing on these outcomes. When two studies were 
found to examine overlapping samples, the first (i.e., original) study was included in 
the systematic review. Study inclusion was determined by the candidate. Titles and 
abstracts were first reviewed to identify potentially relevant studies; full texts of 
these studies were then examined to determine those that met full inclusion criteria.  
2.2.3 Data extraction and analyses 
Search results were exported into an Endnote database in order to identify duplicate 
studies. The database was subsequently transferred to a Microsoft Excel spreadsheet 
where manual cleaning was performed to remove additional duplicates and studies 
72 
 
were examined for eligibility. The following data were then extracted from studies 
that met inclusion criteria: (i) sample characteristics (sample size of high-risk and 
healthy control groups, and mean ages for each group), (ii) outcome measures 
(assessment of exposure and/or reactivity to psychosocial stressors, cortisol 
sampling protocol, or pituitary volume analysis software), and (iii) data necessary to 
compute standardised mean differences (d) in psychosocial stressor exposure, 
psychosocial stress reactivity, cortisol levels, or pituitary volume among high-risk 
individuals relative to healthy controls. Standardised mean differences were 
computed from means and standard deviations or derived from odds ratios using 
established methods (Lipsey & Wilson, 2001). Effect sizes of 0.20, 0.50, and 0.80 
corresponded to ‘small’, ‘medium’, and ‘large’ effects, respectively (Cohen, 1992). The 
diversity of measures employed across studies prevented the ability to perform a 




2.3 Search results 
Figure 4 summarises the search results and the reasons for study exclusion. Database 
searches yielded 7114 published studies in total. Two further studies were identified 
through manual searching. After removing duplicates, 6099 unique studies were 
identified. Of these, 5911 studies were excluded after reviewing the abstract; a 
further 150 were excluded after the full text was reviewed. The systematic review 
examining differences between high-risk individuals and healthy controls included 
38 studies in total (Schuldberg et al., 1996; Neumann & Walker, 1999; Weinstein et 
al., 1999; Miller et al., 2001; Myin-Germeys et al., 2001; Walker et al., 2001; Marcelis 
et al., 2004; Mitropoulou et al., 2004; Garner et al., 2005; De Loore et al., 2007; Mittal 
et al., 2007; Spelman et al., 2007; Brunelin et al., 2008; Kelleher et al., 2008; Mondelli 
et al., 2008; Takahashi et al., 2009; Zong et al., 2010; Büschlen et al., 2011; Collip et 
al., 2011; Pruessner et al., 2011; Soliman et al., 2011; Tessner et al., 2011; Yıldırım et 
al., 2011; Habets et al., 2012; Mizrahi et al., 2012; Palmier-Claus et al., 2012; Phillips 
et al., 2012; Sugranyes et al., 2012; Yang et al., 2012; Addington et al., 2013; Devylder 
et al., 2013; Kelleher et al., 2013c; Mittal et al., 2013; Pruessner et al., 2013a; Romo-
Nava et al., 2013; Sahin et al., 2013; Tikka et al., 2013; Walker et al., 2013). Of these, 
15 examined exposure or reactivity to psychosocial stressors, 17 examined basal 
cortisol levels or cortisol responses during psychosocial stressor tasks, and 6 
examined pituitary volume. These studies included data from 2432 high-risk 
individuals and 3742 healthy controls. Nine additional studies (Mason et al., 2004; 
Myin-Germeys et al., 2005a; Thompson et al., 2007; Thompson et al., 2009; Bechdolf 
et al., 2010; Walker et al., 2010; Takahashi et al., 2011; Corcoran et al., 2012; 
Thompson et al., in press) which did not meet inclusion criteria but which examined 
the extent to which psychosocial stress or HPA axis function was associated with 




Figure 4. Systematic review search strategy 
Psychosocial stress = 6686 
PubMed = 4772 
PsycINFO = 323 
EMBASE = 1591 
Database search = 7114 
Cortisol and pituitary = 428 
PubMed = 194 
PsycINFO = 97 
EMBASE = 137 
Duplicates excluded = 1017 
Potential reviews = 6099 
Excluded abstract read = 5911 
Not stress or HPA axis = 5193 
Not high-risk = 249 
Review or editorial = 384 
Single case study = 48 
Not English language = 37 
Manual searching = 2 
Full text read = 188 
Excluded full text read = 150 
Not stress or HPA axis = 32 
Not high-risk = 19 
Study design = 55 
No control group = 37 
Overlapping sample = 7 
Included studies = 38 
75 
 
2.4 Psychosocial stress  
2.4.1 Psychosocial stress in high-risk individuals compared to healthy controls 
Studies examining experiences of psychosocial stress among high-risk individuals 
and healthy controls are presented in Table 4 (ordered chronologically), with effect 
sizes (d) computed to indicate the magnitude of group differences.  
Individuals with a family history of illness 
Only two studies of individuals with a family history of psychosis met inclusion 
criteria. Miller and colleagues examined exposure to life events in a sample of high-
risk youth (age range: 16-25 years) who were selected on the basis of having at least 
two first- or second-degree relatives with schizophrenia (Miller et al., 2001). In this 
study, no difference was observed in the number of major or minor life events 
experienced by high-risk youth relative to healthy controls. The second study (Myin-
Germeys et al., 2001) assessed emotional reactivity to psychosocial stress using the 
Experience Sampling Method (ESM), a structured diary technique which assesses 
exposure to stressful experiences and current mood in the context of daily life (Myin-
Germeys & van Os, 2007). Participants are prompted by a digital wristwatch at 
random intervals throughout the day to describe stressful experiences (event-
related, activity-related, thought-related, and social stress) and provide ratings of 
current mood and symptoms. The study of adult first-degree relatives of individuals 
with psychosis (age range: 18-55 years) employing the ESM technique found no 
differences in the number of stressful experiences reported by relatives and healthy 
controls (Myin-Germeys et al., 2001). However, relatives showed greater decreases in 
positive affect in response to stressful experiences compared to healthy controls, and, 
to a lesser extent, greater increases in negative affect. Changes in positive and 
negative affect among relatives compared to controls were moderate-to-large and 
small-to-moderate in magnitude, respectively.  
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Youth at ultra high risk for psychosis  
Seven studies were identified which examined experiences of psychosocial stress 
among UHR youth (age range: 12-35 years). Three studies assessed exposure to 
trauma prior to age 18 years (abuse, neglect, and bullying), but were included as the 
age range of participants overlapped with the exposure period (Addington et al., 
2013; Sahin et al., 2013; Tikka et al., 2013). All three studies reported that UHR youth 
were characterised by higher levels of trauma than healthy controls, with moderate-
to-large effect sizes. In contrast, two studies reported that UHR youth experienced 
fewer recent life events than healthy controls (Phillips et al., 2012; Devylder et al., 
2013). Group differences were larger and only statistically significant in the former 
study (Phillips et al., 2012); however, UHR youth in this study were more distressed 
by these events than healthy controls. Similarly, this study also observed no 
differences in the number of recent hassles experienced by UHR youth and healthy 
controls (Phillips et al., 2012), yet UHR youth rated the hassles they experienced as 
significantly more intense. The ESM technique has also been employed in a recent 
study of UHR youth (Palmier-Claus et al., 2012). Relative to healthy controls, the UHR 
group experienced significantly greater social stress, equating to a large effect size, 
and showed a greater increase in negative affect than controls following exposure to 
each type of stressor. However, effect sizes could not be computed for negative affect; 
thus, it is not clear whether the magnitude of difference is equivalent to that 
observed in the study of individuals with a family history of psychosis (described in 
the previous section). Youth at UHR have also been reported to experience higher 
levels of perceived stress than healthy controls (Palmier-Claus et al., 2012; Phillips et 
al., 2012) and greater levels of impaired stress tolerance (Devylder et al., 2013), with 
large effect sizes reported for both measures. However, another study found that 
UHR youth and healthy controls did not differ on levels of chronic stress related to 
work and social relationships (Pruessner et al., 2011).  
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Individuals with schizotypal personality disorder 
Two studies were identified that assessed psychosocial stress in university/college 
students (age range: 18-25 years) characterised by high scores on measures of 
schizotypal traits. The first reported that among youth with schizotypal features, 
those with anhedonic traits, but not those with perceptual aberrations and magical 
ideas, experienced a higher frequency of daily hassles than healthy controls 
(Schuldberg et al., 1996), equating to a large effect size. However, youth with 
anhedonic traits rated the hassles they experienced as being less intense than those 
experienced by healthy controls. Furthermore, although both groups differed from 
the control group on their ability to cope with stressful events, no consistent pattern 
emerged (i.e., youth with schizotypal traits showed both poorer and better coping 
abilities). The more recent of these studies found that relative to healthy controls, 
youth with schizotypal traits experienced a higher number of stressful life events and 
were more distressed by these experiences (Zong et al., 2010), with moderate-to-
large effect sizes observed for both outcomes. Only one study examining youth with a 
diagnosis of SPD met criteria for inclusion. Adolescents with SPD (age range: 12-18 
years) experienced a significantly greater number of life events during the past year 
than their healthy peers, with a larger magnitude of differences observed for 
undesirable life events (Tessner et al., 2011). Furthermore, although youth with SPD 
did not report a higher number of daily hassles than healthy controls, they were more 
distressed by these experiences, with moderate-to-large differences observed.  
Two studies using data from a large, nationally-representative sample in the 
United States (Afifi et al., 2011; Afifi et al., 2012) did not meet criteria for inclusion in 
the systematic review, but provide further evidence that SPD is associated with 
psychosocial stress. The first of these studies (Afifi et al., 2011) reported that SPD 
was significantly associated with all types of childhood trauma (physical, sexual, and 
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emotional abuse, and neglect). Subsequently, it was found that SPD was associated 
with physical punishment (i.e., being pushed, grabbed, shoved, slapped, or hit by 
parents or other caregivers), even in the absence of childhood maltreatment (Afifi et 
al., 2012). 
Youth reporting psychotic-like experiences 
Three studies of individuals reporting PLEs were found to meet inclusion criteria; all 
three examined the association between PLEs and traumatic experiences in 
childhood. A cross-sectional study found that children reporting PLEs (age range: 12-
15 years) were more likely to have experienced physical abuse and to have witnessed 
domestic violence than their healthy peers (Kelleher et al., 2008), both exposures 
were associated with large effect sizes. Additionally, two large prospective studies 
were identified that examined the extent to which adolescents reporting PLEs (age 
range: 13-16 years) were at greater risk of experiencing trauma at follow-up, after 
controlling for trauma exposure at baseline. De Loore and colleagues found that 
adolescents who reported PLEs at baseline were more likely to experience negative 
life events during a two-year follow-up compared to adolescents who had not 
reported PLEs (De Loore et al., 2007); however, adolescents reporting PLEs were not 
at significantly greater risk of unwanted sexual experiences or bullying. It was not 
possible to compute effect sizes for these exposures. More recently, it was observed 
that adolescents reporting PLEs at baseline were at significantly greater risk of 
experiencing physical assault and bullying during a three-month follow-up than 
adolescents who did not report PLEs (Kelleher et al., 2013c), with both outcomes 
associated with large effect sizes. Additionally, PLEs remained significantly 
associated with physical assault during a 12-month follow-up, but the association 
with bullying reduced to trend level.    
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Table 4. Studies examining psychosocial stress in high-risk individuals relative to healthy controls 
Study Sample Age (mean) Measure Findings d 
Individuals with a family history of psychosis (FHx) 






Schedule of Recent Experiences 1 
(number of life events ever) 
No sig difference in the number of life 
events in FHx vs. HC 
Insufficient data to 
compute  






ESM: event-, activity-, thought-, and 
social-related stressful experiences 
and emotional reactivity (PA and NA) 
No sig difference in stress exposure; 
FHx greater decreases in PA and 
increases in NA than HC 
Stress (range): -0.17 – 0.53 
PA (range): -0.73 – -1.31 
NA (range): 0.29 – 0.58  
Youth at ultra high-risk (UHR) 






Trier Inventory for the Assessment of 
Chronic Stress 2 (chronic stress 
related to work and relationships) 
No sig difference in chronic stress 
between UHR and HC  
Insufficient data to 
compute 






ESM (described above); Perceived 
Stress Scale 3   
UHR sig higher ESM social stress, 
greater increases in NA, and higher 
levels of perceived stress than HC 
Social stress: 0.83 
Perceived stress scale: 1.23 






Life Events Interview Schedule 4  
(past month); Kanner hassles scale 5 
(past month); Perceived Stress Scale 3 
UHR sig fewer life events but greater 
life event distress, greater intensity of 
hassles, and higher levels of perceived 
stress than HC 
Life event exposure: -0.74 * 
Life event distress: 0.77 
Hassles intensity: 0.83 
Perceived stress scale: 1.13 
Note. HC: Healthy controls; NR: not reported; sig: significant; ESM: Experience Sampling Method; PA: positive affect; NA: negative affect; d: standardised effect 
size derived from means. * Computed from age-adjusted means. 1 (Paykel et al., 1971); 2 (Schulz & Schlotz, 1999); 3 (Cohen et al., 1983); 4 (Ventura et al., 
unpublished); 5 (Kanner et al., 1981). 
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Table 4. (continued) 
Study Sample Age (mean) Measure Findings d 






Childhood Trauma and Abuse Scale 6 
(physical abuse, psychological abuse, 
sexual abuse, and neglect) 
UHR sig more likely to experience all 
types of abuse and neglect than HC 
Range: 0.43 – 0.69 






Coddington’s Life Events Record 7 
(past 3 months); SOPS ‘impaired 
stress tolerance’ item 
No sig difference in the number of life 
events; UHR sig higher scores than HC 
on impaired stress tolerance item  
Life events: -0.29 
Impaired stress tolerance 
item: 1.48 






Childhood Trauma Questionnaire 8 
(physical abuse, psychological abuse, 
sexual abuse, and neglect) 
UHR sig higher scores than HC on all 
trauma scales except sexual abuse  
Total score: 0.74 






Trauma and Distress Scale 9 (sexual, 
physical, and emotional abuse and 
physical and emotional neglect) 
UHR sig higher total trauma scores 
than HC and sig higher scores on each 
trauma scale  
Total score: 1.54 
Adolescents with schizotypal personality disorder/schizotypal traits (SPD/ST) 







Kanner hassles scale 5 (past month); 
Stress Questionnaire 10 (appraisal, 
coping, and emotions relating to 
events during past fortnight) 
ST-a sig greater number of hassles 
than HC but lower intensity. ST-p and 
ST-a groups showed some differences 
to HC on coping strategies  
ST-a vs. HC 
Hassles frequency: 0.86 
Hassles intensity: -0.48 
Note. HC: Healthy controls; sig: significant; SOPS: Scale of Prodromal Symptoms (Miller et al., 2003); ST-p: schizotypal traits with perceptual aberrations and 
magical ideas; ST-a: schizotypal traits with anhedonia; d: standardised effect size derived from means. 6 (Janssen et al., 2004); 7 (Coddington, 1972); 8 (Bernstein 
& Fink, 1998); 9 (Patterson et al., 2002); 10 (Folkman & Lazarus, 1988). 
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Table 4. (continued) 
Study Sample Age (mean) Measure Findings d 






Coping Flexibility Questionnaire 11 
(life event exposure and distress) 
ST sig higher number of life events 
than HC and greater distress 
Total No. life events: 0.98 
Life event distress: 1.01 






Psychiatric Epidemiological Research 
Interview 12 (life events during past 
year) and Daily Stress Inventory 13 
(hassles current day) 
SPD sig higher number of total (and 
undesirable) life events than HC; no 
difference in number of hassles but 
greater distress relating to hassles   
Total life events: 0.54 
Undesirable events: 0.83 
Hassles distress: 0.70 
Children reporting psychotic-like experiences (PLEs) 





provided a  
Single questions assessing bullying, 
sexual trauma, and exposure to 
negative life events  
PLE group sig more likely to 
experience negative life events than 
HC but not bullying or sexual trauma 
Insufficient data to 
compute 





provided b  
K-SADS interview (physical and 
sexual abuse, domestic violence, and 
bullying) 
PLE group sig more likely to 
experience physical abuse and 
witness domestic violence than HC 
Physical abuse: 0.98 * 
Domestic violence: 1.27 * 





provided c  
Single questions assessing physical 
assault and bullying 
PLE group sig more likely to 
experience physical assault and 
bullying at follow-up than HC 
Physical assault: 1.09 ** 
Bullying: 0.92 ** 
Note. HC: Healthy controls; sig: significant; K-SADS: Kiddie Schedule for Affective Disorders and Schizophrenia for School Aged Children: Present and Lifetime 
Version (Kaufman et al., 1997); d: standardised effect size derived from means. * Computed from odds ratios adjusted for sex and socioeconomic status;                 
** computed from crude odds ratios. a Total sample mean = 15.1 years; b total sample range = 12–15 years; c total sample range = 13–16 years. 11 (Cheng, 2001); 
12 (Dohrenwend, 1998); 13 (Brantley et al., 1987). 
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2.4.2 Associations between psychosocial stress and current psychopathology 
Several studies have investigated the relationship between psychosocial stress and 
current psychopathology among high-risk individuals. These studies potentially offer 
the opportunity to determine whether psychosocial stress is more strongly 
associated with psychopathology among high-risk individuals compared to controls 
(as might be hypothesised based on the diathesis-stress model), although some 
studies have only examined associations across the total sample (i.e., combining high-
risk and healthy individuals). A study of youth with a family history of schizophrenia 
(age range: 16-25 years) observed that major life events (e.g., the death of a loved 
one), but not minor events (e.g., moving within the same city), predicted psychotic 
symptoms in the total sample of high-risk youth and healthy controls (Miller et al., 
2001). Similarly, a study of adolescents with SPD, other personality disorders, and 
healthy youth (age range: 12-18 years), reported that prodromal symptoms were 
correlated with both the number of recent life events and the number of daily hassles 
when data were collapsed across diagnostic groups (Tessner et al., 2011).  
Other studies have investigated the relationship between experiences of 
psychosocial stress and psychopathology in high-risk individuals only. Three such 
studies examined UHR youth (age range: 12-35 years). The first of these studies 
reported that the number of life events and daily hassles experienced during the past 
month were not associated with psychotic symptoms, depression, or anxiety 
(Thompson et al., 2007), although daily hassles were positively associated with 
global psychopathology. In two further studies, the degree of trauma exposure was 
associated with depression and anxiety symptoms (Thompson et al., 2009; Addington 
et al., 2013); in the former study, this was only true for white and not ethnic minority 
UHR youth, although trauma scores were correlated with positive symptoms across 
the entire UHR group. Another study of UHR youth (age range not provided) reported 
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that subjective feelings of chronic stress were associated with more severe positive 
and depressive symptoms (Pruessner et al., 2011). Finally, using the ESM technique, a 
study of adult first-degree relatives of patients with psychosis (age range: 18-55 
years) observed that stressful events were associated with an increase in psychotic 
experiences (Myin-Germeys et al., 2005a) whilst a study of UHR youth (age range: 18-
35 years) reported that these events were correlated with increased intensity of 
delusions and hallucinations (Palmier-Claus et al., 2012). 
2.4.3 Longitudinal studies relating psychosocial stress to outcome  
Longitudinal studies of high-risk individuals have examined the extent to which 
experiences of psychosocial stress are associated with symptom progression and 
transition to psychosis. In a study of adolescents with SPD (age range: 12-18 years), 
the number of daily stressors and undesirable life events experienced predicted an 
increase in positive prodromal symptoms across the total sample (i.e., adolescents 
with SPD, other personality disorders, and no personality disorders) at a one-year 
follow-up (Tessner et al., 2011). However, there were no significant associations 
when diagnostic groups were examined separately. In contrast, in a study which 
examined UHR youth (age range: 12-30 years) separately, the number of life events 
reported at baseline was not related to positive or negative prodromal symptoms 
during a four-year follow-up (Devylder et al., 2013), although impaired stress 
tolerance was strongly associated with later symptoms. Furthermore, in a study of 
individuals at UHR (age range: 13-28 years), exposure to stressful life events was not 
associated with transition to psychosis during a one-year follow-up (Mason et al., 
2004). Consistent findings have been obtained in two studies examining trauma 
exposure in UHR youth (age range: 15-30 years); the first assessed a wide range of 
interpersonal (e.g., sexual or physical assault) and non-interpersonal trauma 
exposures (e.g., being involved in an accident or natural disaster) occurring at any 
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age (Bechdolf et al., 2010), whilst the second study examined exposure to 
maltreatment during childhood (Thompson et al., in press). Both studies reported 
that whilst total trauma scores were not related to outcome, sexual trauma was 
specifically associated with transition to psychosis at follow-up.  
2.4.4 Summary of psychosocial stress findings 
There is evidence that, like individuals with schizophrenia, those at elevated risk for 
the disorder due to clinical characteristics (i.e., UHR youth, individuals with SPD, and 
those reporting PLEs) are exposed to higher levels of psychosocial stress than 
healthy controls. However, it is not clear whether this is also true of individuals at 
elevated risk due to a family history of psychosis. However, both UHR youth and 
individuals with a family history of psychosis have been shown to exhibit greater 
emotional reactivity to stressful experiences than healthy controls. Across all 
samples, childhood trauma, distress relating to daily hassles, and perceived stress 
have been consistently shown to distinguish between high-risk individuals and 
healthy controls and are associated with the largest effect sizes. The evidence for 
major life events is less compelling, and the role of physical punishment requires 
further investigation. Whilst the temporal relationship between psychosocial stress 
exposure and psychosis vulnerability is unclear, prospective studies show that 
adolescents reporting PLEs are at greater risk of experiencing negative life events, 
physical assault, and bullying (concurrently and in the future). Exposure and 
reactivity to psychosocial stress has also been associated with psychotic symptoms 
among UHR youth, individuals with a family history of illness, and adolescents with 
SPD, and with depression and anxiety among UHR youth. Finally, longitudinal studies 
of high-risk individuals indicate that psychosocial stress is associated with an 
increase in psychotic symptoms over time and that sexual trauma specifically 
increases the risk for later transition to psychosis.  
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2.5 Cortisol  
2.5.1 Cortisol in high-risk individuals compared to healthy controls 
Studies comparing basal cortisol levels and cortisol responses elicited during 
psychosocial stressor tasks in individuals at elevated risk for schizophrenia and 
healthy controls are presented in Table 5 (ordered chronologically). Effect sizes 
comparing high-risk individuals and healthy controls on these measures are 
presented for comparison. 
Individuals with a family history of illness 
The systematic review identified six studies examining cortisol levels in relatives of 
patients with psychosis and healthy controls. All six studies examined adult first-
degree relatives (age range: 18-55 years); two assessed cortisol responses to a 
metabolic stressor but were eligible for inclusion because they reported cortisol 
levels at baseline (Brunelin et al., 2008) or during the placebo condition (Marcelis et 
al., 2004); effect sizes were therefore computed from these data. Taken collectively, 
studies of individuals with a family history of illness have yielded inconsistent 
findings, which may be due to the different methodologies employed. Marcelis and 
colleagues measured fasting plasma cortisol levels at multiple time-points 
throughout the morning and observed higher cortisol levels in relatives compared to 
healthy controls; however, differences were small in magnitude and not statistically 
significant at any time-point (Marcelis et al., 2004). Three subsequent studies 
examining fasting plasma levels of cortisol at a single time-point in the morning 
(08:00 to 09:00 am) reported lower cortisol levels in relatives compared to healthy 
controls (Spelman et al., 2007; Brunelin et al., 2008; Yang et al., 2012); however, only 
one of these studies observed differences that approached statistical significance 
(Yang et al., 2012). In contrast, a study measuring serum cortisol levels in a non-
fasting blood sample also obtained in the morning (08:00 am) reported significantly 
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higher cortisol levels among individuals with a family history of schizophrenia 
compared to controls (Yıldırım et al., 2011), although effect sizes were small. 
Similarly, a study using the ESM technique reported that relatives were characterised 
by moderately elevated salivary cortisol over multiple sampling events throughout 
the day compared to healthy controls (Collip et al., 2011).  
Youth at ultra high-risk for psychosis 
Two studies were identified that examined basal salivary cortisol levels in UHR youth 
(age range: 12-35 years), both of which observed higher cortisol levels among at-risk 
youth relative to healthy controls (Sugranyes et al., 2012; Walker et al., 2013). 
Despite the large effect size, however, the smaller of these studies only observed 
significant differences when UHR youth who were not receiving antipsychotic 
medication were compared to healthy controls (Sugranyes et al., 2012). Studies 
examining cortisol responses during psychosocial stressor tasks (i.e., experimental 
procedures designed to elicit an increase in cortisol) have yielded inconsistent 
findings. A small study of UHR youth (age range: 18-35 years) observed differences in 
the pattern of salivary cortisol secretion exhibited by at-risk youth and healthy 
controls during the Montreal Imaging Stress Task, assessing mental arithmetic ability 
(Mizrahi et al., 2012). Specifically, whilst healthy controls showed a decrease in 
salivary cortisol during the task, UHR youth showed no change. However, it is not 
clear whether the change in cortisol secretion during the task was significantly 
different between UHR youth and healthy controls (the study compared individuals 
with established schizophrenia, UHR youth, healthy controls, and only a significant 
main effect of group was reported), and insufficient data was provided to allow 
computation of effect sizes. In contrast, Pruessner and colleagues reported that UHR 
youth (age range: 16-27 years) completing the Trier Social Stressor Test, comprising 
both a mental arithmetic test and a public speaking task, showed lower levels of 
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salivary cortisol in the period prior to task commencement and lower levels of 
cortisol during the task compared to healthy controls (Pruessner et al., 2013a). 
Moreover, compared to the healthy control group, UHR youth showed a blunted 
cortisol response (i.e., a smaller increase in cortisol) within the first 10 minutes of the 
task. The divergent pattern of findings observed in these studies may relate to 
differences in the experimental procedures employed. In the former study (Mizrahi et 
al., 2012), participants performed the psychosocial stressor task while completed a 
positron emission tomography (PET) scan (a procedure which may in itself induce 
stress), whilst participants in the latter study (Pruessner et al., 2013a) completed the 
task under normal conditions.  
Individuals with schizotypal personality disorder 
Studies conducted by Walker and colleagues have shown that individuals with SPD 
are characterised by elevated cortisol levels. Neumann and Walker examined salivary 
cortisol samples obtained at multiple time-points throughout the day among adults 
with SPD (age range not reported; mean age: 41.0 years) and reported higher cortisol 
levels among these individuals compared to healthy controls at two of the time-
points (15:00 and 16:00 pm), equating to moderate effect sizes (Neumann & Walker, 
1999). However, mean cortisol levels across the day (averaged over time-points) 
were not significantly elevated. Subsequent studies by this group have used a similar 
cortisol sampling protocol (i.e., cortisol values averaged over multiple time-points 
throughout the day) but have examined adolescents meeting SPD criteria (age range: 
12-18 years). The first of these studies reported that adolescents with SPD were 
characterised by elevated salivary cortisol relative to those with no personality 
disorder, equating to a moderate effect size (Weinstein et al., 1999). A subsequent 
study reported that the pattern and magnitude of differences was maintained at a 
two-year follow-up (Walker et al., 2001). A further study examining a larger sample 
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also observed elevated salivary cortisol in adolescents with SPD compared to those 
with no personality disorder (Mittal et al., 2007), albeit with a far smaller magnitude 
of difference. Consistent with these findings, a study assessing fasting plasma cortisol 
levels at multiple time-points throughout the day reported significantly elevated 
cortisol levels among adult psychiatric patients with SPD (age range not provided; 
mean age: 36.0) compared to healthy controls (Mitropoulou et al., 2004). In contrast, 
a small study examining groups of university students with schizotypal traits who 
presented with perceptual aberrations or with anhedonia reported that neither 
group showed differences in the total amount of salivary cortisol secreted during the 
Montreal Imaging Stress Task when compared to healthy controls (Soliman et al., 
2011). Furthermore, there were no group differences in the proportion of individuals 
who exhibited an increase in cortisol during the task. Thus, whilst there is consistent 
evidence that individuals meeting SPD criteria are characterised by elevated cortisol, 
it is unclear whether this is also true of individuals presenting schizotypal traits.    
Youth reporting psychotic-like experiences 
Little work has been done to determine whether individuals reporting PLEs are 
characterised by abnormal cortisol levels. However, one recent study examined 
university students (age range not reported; mean age: 18.8 years) who obtained 
high scores on a questionnaire assessing hallucinations (Mittal et al., 2013). 
Compared to young adults with low levels of PLEs (scores in the bottom 10th 
percentile), those with high levels of PLEs (scores in the top 10th percentile) were 
characterised by elevated salivary cortisol levels, which, despite the small effect size, 
was statistically significant after adjusting for sampling time of day.  
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Table 5. Studies examining cortisol in high-risk individuals relative to healthy controls 
Study Sample Age (mean) Measure Findings d 
Individuals with a family history of psychosis (FHx) 






Plasma cortisol levels (fasting) 
Multiple time-points (t=6): 10:00 am 
to 12:30 pm  
No sig differences between FHx and 
HC on plasma cortisol levels during 
placebo condition at any time-point 
Basal cortisol (range):          
0.22 – 0.36  






Plasma cortisol levels (fasting) 
Single time-point: 08:00 am 
FHx lower cortisol levels than HC 
although not sig different 
Basal cortisol: -0.32 






Plasma cortisol levels (fasting) 
Single time-point: 09:00 am 
FHx lower cortisol levels than HC 
although not sig different 
Basal cortisol: -0.58 






Salivary cortisol levels 
Multiple time-points: ESM technique 
FHx sig higher cortisol over sampling 
events (averaged) than HC 
Mean cortisol: 0.45 






Serum cortisol levels  
Single time-point: 08:00 am 
FHx sig higher cortisol levels than HC Basal cortisol: 0.29 






Plasma cortisol levels (fasting) 
Single time-point: 08:00 am 
Trend for lower cortisol levels in FHx 
relative to HC 
Basal cortisol: -0.45  
Youth at ultra high-risk (UHR) 






Salivary cortisol levels 
Multiple time-points: MIST 
UHR no change in cortisol levels 
during MIST; cortisol decreased in HC  
Insufficient data to 
compute 
Note. HC: Healthy controls; sig: significant; ESM: Experience Sampling Method; MIST: Montreal Imaging Stress Task (Dedovic et al., 2005); d: standardised effect 
size derived from means; t: time-points. 
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Table 5. (continued) 
Study Sample Age (mean) Measure Findings d 
Sugranyes et al. 
(2012) 




Salivary cortisol levels 
Single time-point: 11:30 am 
Trend for  higher cortisol in total UHR 
compared to HC, sig for med-free UHR 
Basal cortisol all UHR: 0.70 
Medication-free UHR: 0.98 






Salivary cortisol levels 
Multiple time-points: TSST 
UHR sig lower cortisol during TSST  
and blunted response relative to HC 
Total cortisol secreted 
during TSST: -0.66 






Salivary cortisol levels 
Multiple time-points (t=3): 10:00 am 
to 12:00 pm (values averaged) 
UHR sig higher mean cortisol 
(averaged) than HC after adjusting for 
age, sampling time, and tobacco use 
Mean cortisol: 0.24 * 







Salivary cortisol levels 
Multiple time-points (t=4): 13:00 pm 
to 16:00 pm  
SPD sig higher cortisol than HC at 
15.00 and 16.00 only, but not when 
values averaged over time-points 
Cortisol at 15:00 pm: 0.60 
Cortisol at 16:00 pm: 0.71 
Mean cortisol: 0.26 






Salivary cortisol levels 
Multiple time-points (t=4): 12:30 pm 
to 15:30 pm (values averaged) 
SPD sig higher mean cortisol 
(averaged) than HC after adjusting for 
age 
Mean cortisol: 0.59 ** 






Salivary cortisol levels 
Multiple time-points (t=4): times not 
provided (values averaged) 
SPD sig higher mean cortisol 
(averaged) than HC  
Mean cortisol: 0.60  
Note. HC: Healthy controls; sig: significant; TSST: Trier Social Stressor Test (Kirschbaum et al., 1993); d: standardised effect size derived from means; t: time-
points. a 21/33 UHR medication-free, b study is a longitudinal follow-up (1.5–2.0 yrs) of the Weinstein et al. (1999) sample, age at follow-up not provided.                
* Computed from one-way ANCOVA statistics adjusted for age, sampling time, and tobacco use; ** computed from one-way ANCOVA statistics adjusted for age. 
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Table 5. (continued) 
Study Sample Age (mean) Measure Findings d 






Plasma cortisol levels (fasting) 
Multiple time-points (t=7): 10:00 
am to 12:00 pm (AUC computed) 
SPD sig higher cortisol AUC values 
than HC during placebo (non-drug) 
condition 
AUC cortisol: 0.92 






Salivary cortisol levels 
Multiple time-points (t=4/5): 09:00 
am to 13:00 pm (values averaged) 
SPD sig higher mean cortisol 
(averaged) than HC after adjusting 
for medication and age 
Mean cortisol: 0.23  








Salivary cortisol levels 
Multiple time-points: MIST (AUC 
computed) 
No sig differences between ST 
groups and HC on cortisol AUC 
values (total or increase) 
Insufficient data to 
compute 
Youth reporting psychotic-like experiences 






Salivary cortisol levels 
Multiple time-points (t=3): 09:00 
am to 17:00 pm  
High PLE group sig higher mean 
cortisol (averaged) than low PLE 
group (adjusting for sampling time) 
Mean cortisol: 0.17  
Cortisol AUC: 0.14  
Note. HC: healthy controls; sig: significant; AUC: area under the curve; ST-p: schizotypal traits with perceptual aberrations; ST-a: schizotypal traits with 
anhedonia; MIST: Montreal Imaging Stress Task (Dedovic et al., 2005); d: standardised effect size derived from means; t: time-points. a Participants identified 
using the Launay–Slade Hallucination Scale - Revised (Bentall & Slade, 1985) assessing psychotic-like experiences; those scoring in the top and bottom 10th 




2.5.2 Associations between cortisol levels and current psychopathology  
Several studies have investigated the extent to which cortisol levels are associated 
with psychopathology among UHR youth (age range: 12-35 years). One study of UHR 
youth reported that plasma cortisol levels were significantly correlated with anxiety 
and depression symptoms but were unrelated to positive and negative psychotic 
symptoms (Thompson et al., 2007). Consistent with these findings, two recent 
studies of UHR youth, found that salivary cortisol levels were not associated with 
prodromal symptoms (Corcoran et al., 2012; Sugranyes et al., 2012), with one study 
observing that cortisol was positively correlated with anxiety symptoms (Corcoran et 
al., 2012). However, data from the largest study of UHR youth indicated that salivary 
cortisol was significantly correlated with positive and negative psychotic symptoms 
(Walker et al., 2013), although correlation coefficients were small (0.13 and 0.09, 
respectively). Examining data over the total sample of adolescents with SPD, other 
personality disorders, and no personality disorders (age range: 12-18 years), salivary 
cortisol levels were significantly associated with negative but not positive psychotic 
symptoms in the initial study of SPD youth (Weinstein et al., 1999), and in the follow-
up study, cortisol levels were associated with severity of SPD symptoms (Walker et 
al., 2001). Finally, using the ESM technique, a recent study reported that momentary 
increases in psychotic experiences were associated with increases in salivary cortisol 
among adult siblings of patients with psychosis (age range: 16-55 years) but not 
among controls (Collip et al., 2011).  
2.5.3 Longitudinal studies relating cortisol levels to outcome 
The few studies that have examined the extent to which cortisol is associated with 
symptom progression and diagnostic outcome have yielded inconsistent findings. A 
study of 29 UHR youth (age range: 14-30 years) reported significantly lower plasma 
cortisol levels among the five individuals who transitioned to psychosis within the 
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two-year follow-up period relative to youth who did not (Thompson et al., 2007). 
Similar findings were obtained in further study of UHR youth (age range: 14-30 
years), although the lower salivary cortisol levels among those who developed 
psychosis were not significantly different from UHR youth who did not (Sugranyes et 
al., 2012). In contrast, a large study of UHR youth (age range: 12-35 years) reported 
that those who transitioned to psychosis had higher levels of salivary cortisol relative 
to those whose symptoms remitted, but not when compared to UHR youth who 
remained symptomatic or whose symptoms progressed (Walker et al., 2013). 
Salivary cortisol was also examined in a longitudinal study of high-risk adolescents 
with SPD and/or prodromal symptoms (age range: 12-18 years); those who 
developed psychosis during the one-year follow-up showed an increase in cortisol 
over time (Walker et al., 2010).  
2.5.4 Summary of cortisol findings 
Elevated basal salivary cortisol has been observed consistently among adolescents 
and young adults who are at elevated risk for psychosis on account of their clinical 
features. However, both lower and higher cortisol levels have been observed among 
individuals with a family history of psychosis, although this may be due to different 
methodologies employed across studies (i.e., fasting plasma samples vs. repeated 
saliva sampling). Furthermore, the extent to which individuals at elevated risk for 
schizophrenia show abnormal cortisol responses during psychosocial stressor tasks 
is unclear. There is limited evidence to suggest that cortisol levels are associated with 
psychotic symptoms among high-risk individuals. It is also currently unclear as to 
whether high-risk youth who transition to psychosis are characterised by elevated or 
decreased cortisol. One important limitation with the existing literature is that no 
study has as yet investigated whether high-risk individuals are characterised by a 
blunted cortisol awakening response relative to healthy controls. 
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2.6 Pituitary gland volume 
2.6.1 Pituitary gland volume in high-risk individuals and healthy controls 
Studies examining pituitary gland volume in individuals at elevated risk for 
schizophrenia and healthy controls are described in Table 6 (ordered 
chronologically) with effect sizes computed for comparison.  
Individuals with a family history of illness 
Only two studies have examined pituitary volume among individuals with a family 
history of psychosis. The first of these reported that pituitary volume was 
significantly larger among first-degree adult relatives of patients with psychosis in 
comparison to healthy controls (Mondelli et al., 2008), equating to a moderate-to-
large effect size. Furthermore, the magnitude of difference between relatives and 
healthy controls was even larger among relatives of patients with familial 
schizophrenia (i.e., patients with first- or second-degree relatives with the disorder) 
compared to relatives of patients with non-familial schizophrenia. However, a 
subsequent study observed no differences in pituitary volume in adult siblings of 
individuals with psychosis and healthy controls (Habets et al., 2012). Whilst the 
studies did not differ in the ratio of males to females, relatives in the study by 
Mondelli and colleagues were often parents of patients and thus were typically older 
(mean age: 49.7 years) than those examined in the subsequent study (mean age: 28.3 
years), which may account for the difference in findings.  
Youth at ultra high-risk for psychosis 
Neither of the studies examining pituitary volume in UHR youth reported data for the 
total UHR group (Garner et al., 2005; Büschlen et al., 2011), but instead examined 
pituitary volumes in relation to outcome status (i.e., psychosis onset) and compared 
healthy controls to UHR youth who had transitioned to psychosis and UHR youth 
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who had not. However, for both studies, data for the total UHR groups were provided 
in a recent meta-analysis (Nordholm et al., 2013). In the larger of these studies 
(Garner et al., 2005), pituitary volumes in the total UHR sample (age range: 14-30 
years) were smaller relative to the healthy control group, but this difference was 
small in magnitude and not statistically significant. In contrast, Büschlen and 
colleagues observed larger pituitary volumes in the total UHR group compared to 
healthy controls (all participants aged 18 years or older), but while the effect was 
moderate in size, the difference did not reach statistical significance. Both study 
samples were similar in terms of sex, the proportion of medication-naive UHR youth 
within the sample, and subsequent transition rates; with the only difference being the 
inclusion of younger UHR youth (i.e., <18 years) in the study by Garner and 
colleagues, although mean ages were also similar across studies. Thus, the reason for 
the difference in findings is unclear. 
Individuals with schizotypal personality disorder 
Two studies were found to have examined pituitary volume in individuals with SPD. 
A study of young adults (age range not reported) observed that pituitary volumes 
were significantly larger among those with SPD relative to healthy controls 
(Takahashi et al., 2009), equating to a moderate effect size. In contrast, a recent study 
observed smaller pituitary volumes among individuals with SPD (age range: 18-55 
years) compared to healthy controls, although the effect was only significant in males 
(Romo-Nava et al., 2013). Differences in findings may relate to illness severity and 
medication use; in the study by Takahashi and colleagues, all individuals with SPD 
were recruited from psychiatric services and the majority (85%) were receiving 
antipsychotic medication at the time of scanning. In contrast, individuals with SPD in 
the study by Romo-Nava and colleagues were recruited from the community and all 
were medication-naive.  
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Table 6. Studies examining pituitary gland volume in high-risk individuals relative to healthy controls 
Study Sample Age (mean) Measure Findings d 
Individuals with a family history of psychosis (FHx) 






Manual tracing using ANALYZE 
software 
FHx sig larger pituitary volume than 
HC (adjusted for age, WBV, and sex) 
Pituitary volume: 0.70 






Semi-automated (manual tracing and 
automatic tissue classification) using  
GIANT software 
Pituitary gland volumes identical in 
FHx and HC (adjusted for ICV) 
Pituitary volume: 0.00 
Youth at ultra high-risk (UHR) 






Manual tracing using ANALYZE 
software 
No sig difference in pituitary volume 
in UHR vs. HC (adjusted for WBV) 
Pituitary volume: -0.11* 






Manual tracing using AMIRA 
software 
UHR larger pituitary volume than HC 
but not sig (adjusted for WBV) 
Pituitary volume: 0.45* 
Individuals with schizotypal personality disorder (SPD)  






Information not provided SPD sig larger pituitary volume than 
HC (adjusted for age and ICV) 
Pituitary volume: 0.47 






Manual tracing using 3DSlicer 
software 
SPD sig larger pituitary volume than 
HC in males only (adjusted for age, 
education, SES, and WBV) 
Pituitary volume (males 
only): -0.77 
Note. HC: Healthy controls; sig: significant; WBV: whole-brain volume; ICV: intracranial volume; SES: socioeconomic status; d: standardised effect size derived 
from means * Insufficient data provided, means and SD obtained from a meta-analysis (Nordholm et al., 2013) reporting raw data provided by the study authors.  
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2.6.2 Associations between pituitary volume and current psychopathology 
Whilst only three studies of high-risk individuals have examined the relationship 
between pituitary volume and psychopathology, consistent results have emerged 
indicating a lack of association. Pituitary volume was not significantly correlated with 
positive or negative symptoms in the clinically-derived sample of patients with SPD 
(Takahashi et al., 2009), or in the largest study of UHR youth published to date 
(Garner et al., 2005), which also observed no relationship between pituitary volume 
and symptoms of anxiety or depression. Consistent with these findings, among adult 
relatives of patients with schizophrenia, schizotypal symptoms were not significantly 
correlated with pituitary volume (Mondelli et al., 2008).  
2.6.3 Longitudinal studies relating pituitary volume to outcome 
In contrast to the inconsistent pattern of findings observed when all UHR youth were 
compared with healthy controls (i.e., both smaller and larger volumes reported 
among UHR youth relative to controls), both studies examining the relationship 
between pituitary volume and transition to psychosis among UHR youth have yielded 
similar results. Specifically, both studies observed that UHR youth who later 
developed psychosis (participants followed for a minimum of one year and up to 3.7 
years) had larger pituitary volumes at baseline than both UHR youth who did not 
develop psychosis and healthy controls (Garner et al., 2005; Büschlen et al., 2011). 
Furthermore, Garner and colleagues observed that larger pituitary volume was 
highly predictive of illness onset. The only study of individuals at elevated risk for 
schizophrenia to have examined changes in pituitary volume over time observed a 
significant increase in pituitary volume among patients with SPD during a three-year 
follow-up that was not present in the healthy control group (Takahashi et al., 2011). 
However, changes in pituitary volume were not significantly associated with 
symptom progression among individuals with SPD.  
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2.6.4  Summary of pituitary volume findings 
Studies comparing pituitary gland volume in individuals at elevated risk for 
schizophrenia with that of healthy controls have yielded conflicting findings. Whilst 
there is some evidence to suggest that individuals with SPD, and less consistently, 
relatives of individuals with schizophrenia, are characterised by abnormal pituitary 
volumes relative to healthy controls, both larger and smaller volumes have been 
reported. However, the only two studies of UHR youth published to date have 
reported similar findings. These studies indicate that whilst pituitary volumes across 
the total sample of UHR youth do not differ from healthy controls, those who later 
transition to psychosis show enlarged pituitary volumes compared to both UHR 
youth who do not transition and healthy controls. The few studies which have 
examined the relationship between pituitary volume and psychopathology have also 
yielded consistent negative findings, with no study of high-risk individuals having 
observed an association between pituitary volume and psychotic symptoms.   
2.7 Summary of findings across domains  
Table 7 presents a summary of the findings of the systematic review. As illustrated, 
there is evidence that youth at UHR and individuals with SPD are characterised by 
increased susceptibility to psychosocial stress (higher levels of exposure and greater 
reactivity to these exposures) and elevated cortisol levels. Whilst there have been 
fewer studies of individuals reporting PLEs, similar findings have been observed in 
this group. In contrast, there is no evidence that individuals with a family history of 
schizophrenia are more likely to experience psychosocial stress, although increased 
stress reactivity has been reported, and both higher and lower cortisol levels have 
been observed in this population. The extent to which high-risk individuals are 
characterised by abnormal pituitary volume is unclear, with enlarged volumes, 
volume reductions, and no volume differences all reported relative to controls.  
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Table 7. Summary of psychosocial stress, cortisol, and pituitary volume abnormalities across high-risk groups 
Domain  
Individuals with a family 
history of schizophrenia 
Youth at ultra high-risk for 
psychosis  







‒ ↑ ↑ ↑ 
Psychosocial stress 
reactivity        
 
↑ ↑ ↑ Not examined 
Cortisol levels  
 ↓  ↑ ↑ ↑ ↑ 
Pituitary volume ↑ ‒ ↓  ↑ Not examined 
Note. ↑ Increased in high-risk group relative to healthy controls; ↓ decreased in high-risk group relative to healthy controls; ‒ no difference between high-risk 
group and healthy controls.  Psychosocial stress reactivity: emotional reactivity to stressful events as assessed using the Experience Sampling Method or 
distress ratings relating to other psychosocial stress exposures (e.g., daily hassles and negative life events); cortisol levels: basal cortisol levels (as measured in 




2.8  Methodological considerations 
2.8.1 Limitations associated with previous studies of high-risk individuals 
Influence of different vulnerability profiles for schizophrenia  
The neural diathesis-stress model proposes that underlying biological vulnerability 
to psychosis influences the extent to which psychosocial stress increases the risk for 
subsequent illness (Walker & Diforio, 1997; Walker et al., 2008). However, it is not 
currently clear whether individuals with a putative genetic predisposition to develop 
schizophrenia (as conferred by a family history of illness) and those with clinical 
vulnerability factors are similarly affected by psychosocial stressors or whether they 
show the same HPA axis abnormalities. Whilst studies of UHR youth, adolescents 
with SPD, and youth presenting PLEs demonstrate that these individuals experience 
higher levels of exposure and reactivity to psychosocial stressors and show elevated 
cortisol levels relative to healthy controls, studies investigating these characteristics 
in individuals with a family history of psychosis have yielded inconsistent findings. 
Furthermore, the extent to which relatives of psychosis patients in some of these 
studies remain at elevated risk for schizophrenia is unclear, as many have passed 
through the typical age period of peak illness onset (~30 years). No study has yet 
compared experiences of psychosocial stress or HPA axis function in different groups 
of high-risk individuals; thus, further studies examining youth with different 
vulnerability profiles are needed. The current study will address these limitations by 
examining children at putatively elevated symptomatic-risk for schizophrenia who 
present multiple antecedents of the disorder, and those at genetic-risk due to a family 
history of illness. However, as noted previously, the distinction may be somewhat 
artificial (i.e., children at symptomatic-risk may also possess schizophrenia 
susceptibility genes, and any psychosocial stress or HPA axis abnormalities observed 
among children at elevated genetic-risk may be due to environmental factors).  
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Concurrent measures of stress and HPA axis function 
The HPA axis provides a potential mechanism by which psychosocial stress might 
influence the structure and function of the brain and thus lead to psychosis onset 
(Walker & Diforio, 1997; Walker et al., 2008). However, few studies have examined 
the association between experiences of psychosocial stress and HPA axis function 
among individuals at elevated risk for schizophrenia. Higher plasma cortisol levels 
were correlated with the number of daily hassles (but not with the number of recent 
life events) in a study of UHR youth (Thompson et al., 2007). Furthermore, a study 
employing the ESM technique demonstrated that stressful events and emotional 
reactivity to these events were associated with increases in salivary cortisol in 
relatives of psychosis patients but not healthy controls (Collip et al., 2011). Finally, 
three studies of UHR youth reported that salivary cortisol levels were positively 
associated with clinician-rated impaired stress tolerance (Corcoran et al., 2012; 
Sugranyes et al., 2012; Walker et al., 2013). Thus, whilst there is some evidence to 
suggest that the cortisol abnormalities observed among high-risk individuals are due 
to increased psychosocial stress exposure and/or increased reactivity to these 
stressors, further studies are needed to confirm this finding.  
In contrast, there is limited evidence to suggest that the pituitary volume 
abnormalities which have been observed among individuals at elevated risk for 
schizophrenia reflect stress-induced HPA axis hyperactivity. A study of UHR youth 
reported that plasma cortisol levels were not significantly correlated with pituitary 
volume (Thompson et al., 2007). Consistent with this finding, the only other study to 
have measured cortisol levels and pituitary volume concurrently observed no 
association between these measures among young adults with a family history of 
psychosis (Habets et al., 2012). Whilst no study of high-risk individuals has yet 
examined the relationship between pituitary volume and stress exposure, Habets and 
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colleagues also reported that pituitary volumes among patients with psychosis, and 
to a lesser extent, their adult siblings, were positively associated with emotional 
stress reactivity (Habets et al., 2012). Even within healthy populations, few studies 
have examined the relationship between pituitary volume and psychosocial stress 
exposure. However, studies of children with PTSD (Thomas & De Bellis, 2004) and 
adolescents with borderline personality disorder (Garner et al., 2007) have observed 
pituitary volume abnormalities among those exposed to childhood maltreatment. 
Thus, further studies employing concurrent measures of psychosocial stress and HPA 
axis function are needed. This thesis, which examines children at elevated risk for 
schizophrenia, will use measures of psychosocial stress, cortisol levels, and pituitary 
volume collected at the same assessment phase in order to determine the 
relationship these factors. 
Relationship to neurocognitive function 
Neurocognitive deficits are a core feature of schizophrenia (Kahn & Keefe, 2013) and 
have been consistently observed among individuals at elevated risk for the disorder 
(Siever & Davis, 2004; Fusar-Poli et al., 2012b; Agnew-Blais & Seidman, 2013). 
Impairments in memory and executive function are particularly pronounced among 
individuals with established illness (Reichenberg & Harvey, 2007), and several lines 
of evidence suggest that stress-induced HPA axis dysfunction may contribute to these 
deficits. Firstly, animal studies indicate that persistently-elevated glucocorticoid 
levels and behavioural stressors can cause damage to hippocampal cells and 
structural changes in the medial prefrontal cortex (Sapolsky, 2000; Corcoran et al., 
2003; Cerqueira et al., 2008). Secondly, among individuals with psychosis, elevated 
cortisol has been associated with memory and executive function deficits (Walder et 
al., 2000), and a greater blunting of the CAR has been found to correlate with poorer 
verbal memory (Aas et al., 2011b). Finally, studies of individuals with schizophrenia 
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have reported that childhood maltreatment is associated with greater impairments in 
memory and executive function (Lysaker et al., 2001; Shannon et al., 2011); although 
similar results have not been obtained other studies (Schenkel et al., 2005; Aas et al., 
2011b; Sideli et al., in press). To date, no study of individuals at elevated risk for 
schizophrenia has yet investigated whether the neurocognitive deficits that 
characterise these individuals are associated with experiences of psychosocial stress 
and HPA axis dysfunction. The current study will be the first to investigate the 
relationship between neurocognitive function and experiences of psychosocial stress 
and cortisol levels among children at elevated risk for schizophrenia. This study will 
also examine whether the same relationship exists among healthy children.  
2.8.2 Additional factors of relevance to the current study  
Several potentially confounding factors (discussed below) may obscure group 
differences in experiences of psychosocial stress and HPA axis function.  
Adolescence, puberty, and sex  
Adolescence is typically a time of marked developmental change characterised by 
increases in sex hormones and changes in affect and behaviour (Buchanan et al., 
1992). Evidence from cross-sectional and longitudinal studies indicates that there are 
both age- and puberty-related effects on cortisol levels which increase between 
childhood and adulthood (Gunnar & Vazquez, 2006). Furthermore, among 
adolescents, more advanced pubertal stages have been associated with a decreased 
CAR (Adam, 2006), and increasing age associated with a more blunted cortisol 
response to stress (Gunnar et al., 2009). Consistent with these findings, pituitary 
volume also increases during adolescence and is correlated with pubertal stage 
(Elster et al., 1990; Zipursky et al., 2011). In adolescent populations there also 
appears to be a sex difference in salivary cortisol levels during the morning 
(Netherton et al., 2004; Rosmalen et al., 2005), with girls showing higher levels than 
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boys. Additionally, female adolescents have larger pituitary volumes than males 
(Elster et al., 1990; MacMaster et al., 2007b), a pattern that has also been observed 
consistently in studies of adults with psychosis (Nordholm et al., 2013).  
Ethnicity and socioeconomic status 
There is also evidence to suggest that ethnicity and socioeconomic status may 
influence HPA axis function. A large study of adults reported that those of low 
socioeconomic status and black ethnicity had higher cortisol during the evening 
relative to individuals of high socioeconomic status and white ethnicity, respectively 
(Cohen et al., 2006). Similarly, young children from low socioeconomic backgrounds 
have been found to show elevated daytime cortisol compared to those of high 
socioeconomic status (Lupien et al., 2001). Additionally, a large study of adolescents 
reported a U-shaped association between socioeconomic status and morning cortisol 
levels, with those from high and low socioeconomic families showing a blunted CAR 
relative to adolescents from intermediate families (Marsman et al., 2012). Ethnic 
differences have also been observed in cortisol responses to psychosocial stress, 
specifically, individuals of black ethnicity have been reported to show a blunted 
cortisol response relative to white participants (Chong et al., 2008). It is possible that 
ethnic differences in basal cortisol levels and cortisol reactivity may reflect 
differences in psychosocial stress exposure. For example, a recent North American 
study reported that among UHR youth, those from ethnic minority groups (African-
American, Hispanic, and Asian) were more likely to have experienced trauma 
(particularly physical abuse) than white youth (Thompson et al., 2009). Similarly, a 
study of first-episode psychosis patients and healthy controls in the UK observed that 
individuals of black Caribbean ethnicity were more likely to have experienced long-
term parental separation than white British participants (Morgan et al., 2007).  
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Tobacco and substance use  
Long-term tobacco use may also affect HPA axis function. Smokers have been shown 
to exhibit a blunted cortisol response to psychosocial stress (Rohleder & Kirschbaum, 
2006) and an altered CAR relative to non-smokers (Clow et al., 2004; Fries et al., 
2009). Whilst acute cannabis administration has been associated with elevated 
cortisol (D'Souza et al., 2004), little work has been conducted to determine the effect 
of long-term cannabis use on the HPA axis. However, a large study of adolescents 
recently reported that cannabis users exhibited a blunted cortisol response to stress 
relative to non-users (van Leeuwen et al., 2011).  
2.9 Conclusions 
Consistent with a previous systematic review examining psychosocial stress and HPA 
axis function among high-risk individuals (Aiello et al., 2012), the current review 
indicates that both individuals with a family history of illness and UHR youth show 
increased reactivity to psychosocial stressors, and additionally demonstrates that 
this feature also characterises individuals with SPD. The current review also 
concludes that individuals at elevated risk for schizophrenia on account of their 
clinical features (i.e., UHR youth, individuals with SPD, and those reporting PLEs) are 
exposed to higher levels of psychosocial stressors (e.g., major life events, daily 
hassles, and trauma) relative to healthy controls. Further work is merited to establish 
whether exposures such as physical punishment are also more prevalent among 
high-risk individuals. Aiello and colleagues reported that UHR youth, but not 
individuals with a family history of illness, exhibit elevated cortisol levels during the 
day. The current review concurs with this conclusion, and also demonstrates that 
individuals with SPD and those reporting PLEs are similarly characterised by 
elevated cortisol relative to healthy controls. However, the extent to which high-risk 
individuals also exhibit a blunted CAR is not yet known. In contrast to previous 
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reviews (Aiello et al., 2012; Nordholm et al., 2013), the current review found no 
consistent evidence to indicate that that high-risk individuals are characterised by 
pituitary volume abnormalities. Whilst abnormal pituitary volumes have been 
observed in some studies of adult relatives of individuals with psychosis and 
individuals with SPD, other studies have reported no differences between high-risk 
individuals and controls. However, there is evidence that UHR youth who later 
transition to psychosis show increased pituitary volume relative to UHR youth who 
do not transition and healthy controls. The current review included several studies 
examining pituitary volume that were not included in previous reviews, which is 
likely to have contributed to the difference in findings. 
The studies examined in this review suggest that HPA axis abnormalities, 
potentially caused by exposure to psychosocial stress, are present prior to the onset 
of psychosis and may increase the risk of subsequent illness. Unfortunately, several 
characteristics of the high-risk samples examined to date limit the ability to draw this 
conclusion. Firstly, many of the studies of individuals with a family history of 
schizophrenia have included relatives who have passed through the typical age 
period of peak illness onset (~30 years); thus, the extent to which these individuals 
remain at elevated risk for the disorder is unclear. Secondly, UHR youth are by 
definition already sufficiently distressed as to seek treatment for their symptoms, 
and therefore, elevations in cortisol may be due to emerging psychosis rather than 
psychosocial stressor exposure. Finally, studies of youth with SPD, although not 
typically confounded by help-seeking behaviour, are limited by the fact that these 
individuals already present with symptoms of sufficient severity as to meet 
diagnostic criteria for a schizophrenia spectrum disorder. In addition to these 
limitations, no study has directly compared individuals with a family history of 
psychosis (with putatively genetically-mediated risk) those at symptomatic risk for 
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psychosis, and few have assessed psychosocial stress and HPA axis function 
concurrently. Furthermore, the extent to which neurocognitive function among high-
risk individuals is associated with experiences of psychosocial stress and HPA axis 
function has yet to be investigated. The work presented in Chapters 4, 5, 6, and 7 
aims to address some of these methodological limitations by: 
 Examining exposure and reactivity to psychosocial stressors, and biological 
markers of HPA axis function in children at elevated risk for schizophrenia, 
none of whom are yet seeking treatment for their symptoms. 
 Comparing children with different vulnerability profiles for schizophrenia, 
that is, children at symptomatic-risk who present multiple antecedents of 
the disorder, and those at genetic-risk due to a family history of illness.  
 Assessing both exposure to psychosocial stress and distress relating to these 
exposures in children at elevated risk for schizophrenia, and additionally 
exploring the association between risk status and physical punishment.  
 Examining the CAR and diurnal cortisol in high-risk children and the extent 
to which these measures relate to experiences of psychosocial stress.  
 Measuring pituitary volume in medication-naive high-risk children and 
examining the relationship with cortisol levels and psychosocial stress.  
 Exploring the extent to which neurocognitive function among children at 
elevated risk for schizophrenia is associated with experiences of 
psychosocial stress and cortisol levels.  
 Examining the role of additional factors (e.g., age, puberty, sex, 
socioeconomic status, ethnicity, and substance use) that may influence the 
relationship between risk status and psychosocial stress/HPA axis function.   
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CHAPTER 3 Study methodology 
3.1 Introduction 
This thesis examines experiences of psychosocial stress and HPA axis function among 
children recruited to the London Child Health and Development Study (CHADS; 
http://www.chads-project.org.uk), a longitudinal investigation of children at 
putatively elevated risk for psychosis because they present multiple antecedents of 
schizophrenia (ASz) or a family history of illness (FHx). The study also follows the 
development of a group of low-risk typically-developing (TD) children. The study was 
established in 2005 by researchers at the Institute of Psychiatry, including Dr Kristin 
Laurens (Principal Investigator) and Professors Sheilagh Hodgins, Barbara Maughan, 
Robin Murray, and Eric Taylor. The overall aim of the study was to develop a novel 
method of identifying children within the general population who are at elevated risk 
for developing schizophrenia. The work was primarily supported by funding received 
by Dr Kristin Laurens from the National Institute for Health Research (NIHR).  
Chapter aims 
This chapter describes the methodology of the CHADS project; the specific aims of 
this chapter are as follows:  
1. Provide a detailed description of the procedures used to recruit ASz, FHx, 
and TD children to the CHADS project.  
2.  Delineate the assessment phases of the study and compare the three groups 
on the extent to which they completed the measures examined in this thesis. 
3. Describe the measures used to assess sociodemographic characteristics and 
current psychopathology. 
4. Outline the analytic strategy employed in subsequent chapters.  
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3.2 Participant recruitment  
3.2.1 Recruitment of ASz and TD children   
ASz and TD children aged 9-12 years were recruited using a novel, cost-effective, 
community-screening method (Laurens et al., 2007; Laurens et al., 2011). The 
screening procedure was conducted in 73 primary schools in the Greater London 
area (predominately located in inner-city boroughs) using an ‘opt-out’ procedure. 
Specifically, after obtaining approval from the head of the school, children were 
provided with a letter for their caregiver that described the content of the screening 
questionnaire and the scheduled date of screening. Caregivers who did not wish their 
child to participate in the screening procedure (4%) were asked to indicate their 
refusal on a form to be returned to the school. Collaborating schools were sampled to 
reflect the range of socioeconomic disadvantage represented in London schools (as 
indexed by the percentage of children eligible to receive free school meals) and 
included both state and religious schools. Children completed screening 
questionnaires in class in the presence of a researcher who read the questions aloud 
and ensured that children responded independently. Each child was subsequently 
issued with a corresponding questionnaire for their primary caregiver who was 
asked to return the completed form via reply-paid mail. Screening questionnaires 
included items assessing the antecedent triad (see Appendices), defined as (i) a delay 
or abnormality in speech and/or motor function, (ii) a social, emotional, and/or 
behavioural problem, and (iii) a psychotic-like experience. The measures used to 
assess the antecedent triad are described in detail below. ASz children were those 
who presented with abnormalities in each of the three antecedent domains. The TD 
group comprised children who presented none of antecedents and who had no first-, 
second-, or third-degree relatives with a schizophrenia-spectrum disorder as 
confirmed using the Family Interview for Genetic Studies [FIGS (Maxwell, 1992)].  
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Delays and abnormalities in speech and/or motor function 
The caregiver questionnaire included nine items assessing delays or abnormalities in 
speech or motor development (Laurens et al., 2007). Three quantitative questions 
were used to ascertain the age at which speech and motor developmental milestones 
were attained (using a selection of age range options); delayed milestone attainment 
was defined according to the World Health Organisation population norms (age > 
95th percentile reported for milestone attainment). Five qualitative (yes/no) 
questions enquired as to whether there were any parental or professional concerns 
regarding speech or motor development, and one further qualitative question 
assessed whether the child had experienced any difficulties with coordination or 
unsteadiness. The presence of a speech and/or motor delay or abnormality was 
defined as at least one caregiver-reported problem among these nine items.  
Social, emotional, and behavioural problems 
The child and caregiver questionnaires included items from the Strengths and 
Difficulties Questionnaire [SDQ (Goodman, 2001)], a well-established measure of 
child psychopathology with demonstrated validity for identifying children with 
mental health problems. The measure shows moderate-to-high internal and test-
retest reliabilities for the parent- and self-report versions (Goodman, 2001; Goodman 
et al., 2003) and can be reliably completed by children as young as eight years (Muris 
et al., 2004). The SDQ includes four psychopathology scales: emotional problems, 
conduct problems, hyperactivity-inattention, and peer relationship problems. Each 
scale includes five items rated 0 ‘not true’, 1 ‘somewhat true’, or 2 ‘certainly true’, 
yielding a total score of 10 for each scale. The SDQ has been evaluated extensively in 
UK population samples and three normative bandings are provided: ‘normal’ (scores 
below the 80th percentile on UK population norms), ‘borderline’ (scores within the 
80th to 90th percentiles), and ‘abnormal’ (scores above the 90th percentile). A social, 
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emotional, and/or behavioural problem was defined as a score in the ‘abnormal’ 
range on at least one of the four psychopathology scales. Caregiver-report was used 
for all scales with the exception of the emotional problems scale based on evidence 
that child reports of internalising symptoms may be more accurate than parent 
reports (Edelbrock et al., 1986; Angold et al., 1987). 
Psychotic-like experiences (PLEs) 
The child questionnaire included nine PLE items (Table 8) assessing a range of 
hallucination- and delusion-like experiences (Laurens et al., 2007; Laurens et al., 
2012). Five items were adapted from the Diagnostic Interview Schedule for Children 
[DISC (Costello et al., 1982)], including, auditory hallucinations, thoughts read, ideas 
of reference, paranoid ideas, and ideas of somatic changes. These five items from the 
DISC were used in the Dunedin study and have previously been shown to distinguish 
between children who develop schizophreniform disorder by age 26 years and those 
who do not (Poulton et al., 2000). Four additional items were included to capture a 
broader range of experiences, including, visual hallucinations, passivity phenomena, 
telepathic experiences, and grandiosity. Each item was rated on a three-point scale: 0 
‘not true’, 1 ‘somewhat true’, or 2 ‘certainly true’. For the purposes of identifying 
children who present the triad of antecedents, the presence of a PLE was defined as 
at least one child-reported ‘certainly true’ experience. A recent study examining the 
psychometric properties of this measure in a general population sample of nearly 
8,000 children aged 9-12 years reported that the nine PLE items load onto a single 
latent psychotic-like construct that is distinct from, although correlated with, 
internalising and externalising symptom dimensions (Laurens et al., 2012). A similar 
seven-item screening questionnaire has been shown to exhibit adequate criterion 
validity for clinician-rated subclinical psychotic symptoms reported at interview in a 
sample of children aged 11-13 years (Kelleher et al., 2011). 
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Table 8. Psychotic-like experiences assessed in the screening questionnaire   
Symptom domain Item 
Thoughts read a “Some people believe that their thoughts can be read. Have other people ever read your thoughts?” 
Ideas of reference a “Have you ever believed that you were being sent special messages through the television?” 
Paranoid ideas a “Have you ever thought that you were being followed or spied upon?” 
Auditory hallucinations a “Have you ever heard voices that other people could not hear?” 
Somatic changes a “Have you ever felt as though your body had been changed in some way that you could not understand?” 
Passivity phenomenon “Have you ever felt that you were under the control of some special power?” 
Telepathic experiences “Have you ever known what another person was thinking even though that person wasn't speaking?” 
Grandiosity “Do you have any special powers that other people don't have?” 
Visual hallucinations “Have you ever seen something or someone that other people could not see?” 
Note. a Items adapted from the Diagnostic Interview Schedule for Children (Costello et al., 1982). Each item was scored as 0 ‘not true’, 1 ‘somewhat true’, or 2 





3.2.2 Recruitment of FHx children 
Two methods were used to identify children with a family history of schizophrenia. 
Firstly, the caregiver screening questionnaire included items to assess family mental 
health difficulties (i.e., caregivers were asked whether any family members had 
experienced mental health problems and to indicate the nature of these problems). 
Secondly, the medical records of mental health service users within the South London 
and Maudsley (SLaM) National Health Service (NHS) Foundation Trust were 
reviewed to identify patients with a diagnosis of schizophrenia or schizoaffective 
disorder who had a child relative aged between 9 and 12 years. Identified families 
were approached following liaison with the patient’s care worker. The presence of a 
family history of schizophrenia was subsequently confirmed using the FIGS (Maxwell, 
1992), a semi-structured interview completed with the caregiver which assesses 
mental health problems among family members. FHx children (identified either via 
community screening or via medical records) had at least one first- or second-degree 
relative with schizophrenia or schizoaffective disorder.  
3.2.3 Exclusion criteria  
The following exclusion criteria were applied to all groups:  
(i) Insufficient English language ability in the child or caregiver to complete 
assessments. 
(ii) The presence of a neurological condition in the child that affected 
developmental milestone attainment or current functioning (e.g., epilepsy 
or cerebral palsy). 
(iii) A diagnosis of autism or Asperger’s disorder in the child or a diagnosed 
learning disability (defined as an IQ score < 70).  
(iv) Child having previously experienced a psychotic episode or having ever 




















Figure 5. Recruitment pathway 
Note. ASz: all three antecedents; FHx: reported family history of schizophrenia or schizoaffective 
disorder; TD: none of the antecedents and no family history of schizophrenia/schizoaffective 
disorder. a Denominator = 1020 (family history items not included in the first wave of screening).  
b Eligibility criteria not met or recruitment not logistically feasible (e.g., invalid contact details).      
c Recruitment rates among potential ASz, TD, and FHx: 59%, 60%, and 58% respectively. 
Children completing screening 
questionnaires = 7545 
(95% of eligible children) 
 
Children with complete dyad screening 
data =1343 
(18% of screened children) 
Including: ASz = 128 (9.5%); FHx = 35 
(3.4%a); TD = 302 (22.5%) 
 
Caregiver provided consent to further 
contact = 744 
(55% of children with complete data) 
 
FHx cases identified via medical 
records = 36 
 
Declined further                 
contact = 599 
 
Invited to participate = 193 
(26% of initially consenting families) 
Group status: ASz = 64; FHx = 43; TD = 86 
 
 
Not invited to participate in the 
study = 587 b 
 
Recruited to study = 114 
(59% of invited families) c 
Group status: ASz = 38; FHx = 26; TD = 50  
 
 
Declined participation = 79 
Confirmed group status = 111 
ASz only = 33; FHx only = 26;             
ASz+FHx = 6; TD = 46 
 
 
Group criteria not met = 3 
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3.2.4 Recruitment rates 
Participant flow through the study is summarised in Figure 5. Complete screening 
data (i.e., child- and caregiver-report) were available for 1,343 children. Among these 
children, 9.5% presented all three antecedents, 3.4% were reported to have a family 
history of schizophrenia/schizoaffective disorder, and 22.5% presented none of the 
antecedents. These children were potentially eligible for the ASz, FHx, and TD groups, 
respectively. Half of the families supplying child- and caregiver-questionnaires (55%) 
agreed to be contacted regarding further research. Permission was obtained to 
contact a further 36 families who were identified via medical records (i.e., 36 SLaM 
service users with a diagnosis of schizophrenia agreed for their child relatives to be 
approached regarding the study). In total, 193 families (26% of those who indicated 
their willingness to receive information about the study) were subsequently invited 
to participate in a longitudinal study of child development; the remaining children 
either did not meet eligibility criteria or it was no longer logistically feasible to 
recruit these cases (e.g., contact details for the family had changed or the family had 
moved out of the area). Of those invited to participate, 114 (59%) were subsequently 
recruited to the study; participation rates for those who were potentially eligible for 
the ASz, FHx, and TD groups were 59%, 60%, and 58%, respectively. Following the 
initial assessment session to confirm group status (i.e., when all families completed 
the FIGS, and antecedent questionnaires were completed for potential FHx children 
identified via medical records), 33 children met ASz criteria only, 26 met FHx criteria 
only, 6 met both ASz and FHx criteria, and 46 met TD criteria.   
Independent samples t-tests and chi-squared tests were used to compare the 
characteristics of ASz and TD children who participated in the study and children 
who were potentially eligible for these groups but did not participate for one of the 
following reasons: (i) their caregivers provided questionnaire data but did not supply 
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contact information to receive an invitation for further research, (ii) their caregivers 
supplied contact information but no further contact with the family was established, 
or (iii) caregivers/children declined their invitation to participate further. Compared 
to TD children who did not participate in the study, TD participants did not differ on 
age, sex, or ethnicity (p>0.05). Furthermore, there were no significant group 
differences between TD participants and TD non-participants in the proportion of 
children who presented with scores in the ‘borderline’ range on each of the four SDQ 
psychopathology scales or the proportion of children reporting at least one 
‘somewhat true’ PLE. Among potential ASz cases, those who participated in the study 
did not differ to ASz non-participants on age, sex, ethnicity, or the prevalence of triad 
components (i.e., the proportion of children obtaining SDQ scores in the ‘abnormal’ 
range or the proportion of children reporting at least one ‘certainly true’ PLE), with 
the exception that ASz participants were less likely to score in the ‘abnormal’ range 
on the SDQ emotional symptoms scale than ASz non-participants (p=0.01).  
3.2.5 Cases meeting ASz and FHx criteria 
As described above, six children met both ASz and FHx criteria. Specifically, three 
children eligible for recruitment to the ASz group were subsequently confirmed to 
have a first- or second-degree relative with schizophrenia or schizoaffective disorder 
when the FIGS was completed with their caregiver. Similarly, three children who 
were recruited via medical records as relatives of individuals with schizophrenia 
were found to present the triad of antecedents when they completed the antecedent 
screening questionnaires. In order to most accurately reflect the ASz and FHx 
populations from which participants were sampled, these six ASz+FHx children were 
retained in both groups yielding total group sizes of 39 ASz children and 32 FHx 
children. Given the non-independent nature of the resultant ASz and FHx groups, all 
analyses reported in this thesis compare each at-risk group to the TD group only. 
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3.3 Procedure  
Children meeting ASz, FHx, and TD criteria were invited to participate in a 
longitudinal study of child development conducted at the Institute of Psychiatry, 
King’s College London. Ethical approval for each phase of the study was granted by 
the Joint SLaM and Institute of Psychiatry NHS Research Ethics Committee. 
Caregivers and children provided written informed consent and assent, respectively, 
for participation. 
3.4 Follow-up assessment phases 
Assessment phases were completed at approximately two-yearly intervals 
commencing at age 9-12 years (baseline) with follow-ups at 11-14 years (24-month) 
and 13-16 years (48-month). A range of biological and psychosocial assessments 
were completed by children and their caregivers at each assessment phase. This 
thesis primarily examines cross-sectional data on psychosocial stress, salivary 
cortisol, and pituitary volume collected at the 24-month follow-up assessment. 
Children who did not participate in the 24-month assessment phase, or who were 
unable to complete the measures examined in this thesis, were re-approached at the 
48-month follow-up phase. For example, some children were unable to complete an 
MRI scan at the 24-month assessment due to the presence of contraindicators (e.g., 
metal dental braces) but completed a scan two years later. Data obtained at the 48-
month assessment phase were included in this thesis for children who were still 
within the 24-month age range (i.e., 11-14 years) at the time of their 48-month 
assessment, and are herein referred to as 24-month assessment data.  
Of the 111 ASz, FHx, and TD children recruited to the CHADS project, 99 (89%) 
were followed-up approximately 24-months later and completed at least one of the 
three measures examined in this thesis. Specifically, 95 children (86%) completed 
psychosocial stress measures, 91 (82%) provided salivary cortisol data, and 79 
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(71%) completed a structural MRI scan which was used to examine pituitary volume. 
Table 9 indicates the follow-up rates by group; among ASz, FHx, and TD children, 
90%, 78%, and 96%, respectively, participated in the 24-month assessments. 
Statistical analyses confirmed that ASz and TD groups did not differ in the extent to 
which they participated in the 24-month assessment phase; however, compared to 
the TD group, proportionally fewer FHx children participated in this assessment 
phase (p=0.03). Similarly, when individual measures were examined (Table 9), there 
were no significant group differences in the proportion of ASz and TD children who 
provided psychosocial stress, salivary cortisol, or pituitary volume data (p>0.45). 
However, relative to the TD group, FHx children were significantly less likely to have 
provided salivary cortisol data (p=0.05). This difference likely reflects the fact that 
recruitment of FHx children via medical records did not commence until after school 
screening was underway: as such, some FHx children had not completed the 24-
month assessment phase at the time of analyses.  
Within-group analyses were conducted to compare children who participated in 
the 24-month assessment phase and children who did not on psychopathology 
measures completed at screening (Table 10). Analyses were performed on 
continuous psychopathology variables rather than dichotomous variables owing to 
the small group sizes. These analyses confirmed that, across all three groups, children 
who participated in the 24-month follow-up phase did not differ significantly from 
children who did not on any of the four SDQ psychopathology scales or on total PLE 
scores at screening. However, analyses conducted in the ASz and TD groups should 
be interpreted with caution owing to the extremely small group sizes. Within-group 
analyses also indicated that participants who provided psychosocial stress, salivary 
cortisol, and pituitary volume data did not differ from those who did not provide 
these data on psychopathology scores at screening (p>0.09, data not shown).  
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 ASz vs. TD FHx vs. TD 
Participated in the 24-month assessment phase; n (%) 35 (90) 25 (78) 44 (96) FE p=0.41 FE p=0.03 
Provided psychosocial stress data; n (%) 34 (87) 24 (75) 42 (91) FE p=0.73 FE p=0.06 
Provided salivary cortisol data; n (%) 33 (85) 22 (69) 40 (87) χ2=0.10 p=0.76 χ2=3.84 p=0.05 
Provided pituitary gland volume data; n (%) 30 (77) 22 (69) 32 (70) χ2=0.58 p=0.45 χ2=0.00 p=0.94 
Note. Groups are not mutually exclusive - six cases met both ASz and FHx criteria and are included in both groups. FE: Fisher’s exact.  
 


























SDQ Emotional symptoms; mean ± SE    6.3 ± 1.7 4.4 ± 0.4 p=0.29 3.0 ± 1.2 2.8 ± 0.5 p=0.86 3.5 ± 0.5 2.5 ± 0.3 p=0.50 
SDQ Conduct problems; mean ± SE     1.5 ± 0.6 2.9 ± 0.4 p=0.25 1.4 ± 0.7 2.8 ± 0.5 p=0.18 0.5 ± 0.5 1.0 ± 0.2 p=0.73 
SDQ Hyperactivity/inattention; mean ± SE     3.3 ± 0.5 6.1 ± 0.5 p=0.07 3.6 ± 0.9 4.0 ± 0.5 p=0.72 2.5 ± 0.5 2.1 ± 0.3 p=0.91 
SDQ Peer relationship problems; mean ± SE     4.3 ± 0.6 3.1 ± 0.4 p=0.38 1.4 ± 0.4 1.8 ± 0.3 p=0.76 2.0 ± 0.0 0.8 ± 0.2 p=0.14 
Psychotic-like experiences; mean ± SE     9.8 ± 2.1 8.0 ± 0.5 p=0.33 5.6 ± 1.7 4.4 ± 0.8 p=0.48 2.5 ± 0.5 1.7 ± 0.2 p=0.41 
Note. No FU: Not participated in the 24-month assessment phase; FU: participated in the 24-month assessment phase. Statistical analyses: Mann-Whitney U; 
analyses conducted in ASz and TD groups should be interpreted with caution due to extremely small group sizes.  
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3.5 Measures  
The primary measures examined in this thesis, namely, psychosocial stress, salivary 
cortisol, pituitary volume, and neurocognitive function, are described in their 
respective chapters. Details of the methods used to assess sociodemographic 
characteristics and current psychopathology are provided in the following section.   
3.5.1 Sociodemographic characteristics  
Ethnicity 
Participant ethnicity was determined using detailed information obtained from 
caregivers during the FIGS (Maxwell, 1992), a semi-structured interview designed to 
elicit information regarding mental health problems among first-, second-, and third-
degree relatives. At the start of each interview, caregivers completed a detailed 
family tree, and, for each family member, provided information on their ethnicity and 
country of birth. These data were used to assign an ethnic group to each participant; 
groups were subsequently collapsed into white British, white other, black (i.e., black 
African and black Caribbean), and other.  
Socioeconomic status 
Caregivers completed a semi-structured interview to provide information on 
employment status, current occupation (or previous occupation for those not 
currently employed), and employer establishment size. Data were then coded 
according the UK National Statistics Socio-economic Classification (Office for National 
Statistics, 2010), and used to derive three classes: (i) higher managerial, 
administrative, and professional occupations, (ii) intermediate occupations, and (iii) 
routine and manual occupations. Relevant data were obtained for all caregivers 
residing with the child. Where two household representatives were identified, the 
‘dominance’ approach was used to allocate a socioeconomic class to the family unit 




Internalising and externalising symptoms 
At the 24-month assessment phase, caregivers and children completed the Child 
Behaviour Checklist for school-aged children [CBCL (Achenbach & Rescorla, 2001)] 
and the accompanying Youth Self-Report (YSR), respectively. The CBCL/YSR is one of 
the most widely-used measures of childhood psychopathology; the measure has been 
evaluated extensively in child and adolescent populations and exhibits high reliability 
and validity (Achenbach & Rescorla, 2001). The CBCL and YSR incorporate a checklist 
of problems occurring during the past six months (CBCL: 113 items; YSR: 112 items); 
each item is scored on a three-point scale (0 ‘not true’, 1 ‘somewhat true or 
sometimes true’, or 2 ‘very true or often true’). The problem checklists assess eight 
empirically derived syndrome subscales. The current study examined caregiver- and 
child-reported scores on the internalising scale (sum of anxious-depressed, 
withdrawn-depressed, and somatic complaints subscales) and the externalising scale 
(sum of rule breaking and aggressive behaviour subscales).  
Psychotic-like experiences 
At the 24-month follow-up assessment, children re-completed the nine-item PLE 
measure included in the antecedent screening questionnaire (Laurens et al., 2007; 
Laurens et al., 2012) to provide ratings of current experiences. This measure 
(described in Section 3.2.1) included a range of hallucination- and delusion-like 
experiences, each rated on a three-point scale (0 ‘not true’, 1 ‘somewhat true’, or 2 
‘certainly true’). Scores on each item were summed to provide a total PLE score (total 
score range: 0-18).   
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3.6 Analysis strategy 
3.6.1 Examination of group differences  
As described previously, children meeting both ASz and FHx criteria were retained in 
both groups in order to most accurately reflect the ASz and FHx populations from 
which these participants were sampled. As these groups were not therefore mutually 
exclusive, the effect of ASz and FHx status on psychosocial stress, salivary cortisol,  
and pituitary volume was tested in independent analyses. Thus, ASz and FHx groups 
were each examined relative to the TD group but were not directly compared to each 
other.  
3.6.2 Regression analyses 
Linear regression analyses were used to examine the effect of risk status (ASz vs. TD 
and FHx vs. TD) on continuous outcome measures (number of life events, previous 
and current distress relating to negative life events, daily hassles frequency scores, 
daily hassles distress scores, cortisol awakening response, diurnal cortisol levels, and 
pituitary volume) and logistic regression analyses were employed for binary 
outcome measures (exposure to physical punishment). The distributions of all 
continuous outcome measures were examined prior to undertaking linear regression 
analyses using both visual inspection techniques (histograms) and statistical 
methods (skewness and kurtosis statistics) in order to check that these variables 
were approximately normally distributed.     
3.6.3 Effect size computations 
For all primary measures, standardised mean differences (d) were computed to 
indicate the magnitude of differences between each risk group (ASz and FHx) and the 
TD group. These effect sizes were computed to facilitate comparisons across the at-
risk groups (which were not directly compared to one another) and across measures 
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(i.e., psychosocial stress, salivary cortisol, and pituitary volume). Whilst d is usually 
calculated from means and standard deviations (i.e., the mean difference divided by 
the pooled standard deviation) established methods exist for deriving d from 
unstandardised regression coefficients (Lipsey & Wilson, 2001), allowing that the 
magnitude of group differences can be examined after adjusting for additional 
variables. Specifically, the unstandardised regression coefficient (B) for the variable 
‘group’ (where TD=0 and ASz/FHx=1) is equal to the difference between the two 
group means. Thus, as shown in the formulas below, B divided by the pooled 
standard deviation of the dependent variable produces an estimate of d. For binary 
measures, odds ratios were converted into d using the formula provided below 
(Lipsey & Wilson, 2001). As defined by Cohen (1992), for effect sizes derived from 
standardised mean differences, values of 0.20, 0.50, and 0.80 corresponded to ‘small’, 
‘medium’, and ‘large’ effects, respectively.  
 
 
Equation 1. Computation of d from unstandardised regression coefficients 
 
    
      
         
                                                              
 
         
   




Equation 2. Computation of d from odds ratios 
 
    





        





3.6.4 Stratified analyses 
As described in Chapter 2, an additional aim of this thesis was to examine the extent 
to which demographic factors (e.g., age, puberty, sex, socioeconomic status, ethnicity, 
and substance use) influence the relationship between risk status and psychosocial 
stress susceptibility/HPA axis function. All regression analyses were therefore 
adjusted for demographic factors that differed significantly between the groups or 
that were associated with the primary measures. Where adjustment for demographic 
factors led to a substantial change in the effect size associated with risk status ‒ as 
denoted by a change in d > 0.30 (which represents the numerical difference between 
‘small’, ‘medium’, and ‘large’ effects) ‒ stratified analyses were performed to further 
explore the effect of these variables. 
3.6.5  Correlation analyses 
Within-group correlation analyses were conducted to examine relationships between 
the primary measures (experiences of psychosocial stress, salivary cortisol, and 
pituitary volume) and current psychopathology. In Chapter 7, correlations between 
neurocognitive function and psychosocial stress and salivary cortisol were also 
preformed. Prior to undertaking analyses, all variables were examined to ensure that 
they were approximately normally distributed. Pearson’s ‘r’ correlation analyses 
were used for normally distributed variables and Spearman’s rho ‘ρ’ correlation 
analyses were employed for non-normally distributed variables. Correlation 
coefficients of 0.10, 0.30, and 0.50 constituted ‘small’, ‘medium’, and ‘large’ effect 




CHAPTER 4 Psychosocial stress in children at elevated risk for 
schizophrenia 
4.1 Introduction  
The diathesis-stress model of schizophrenia proposes that exposure to psychosocial 
stressors can trigger the onset of psychosis among individuals with an underlying 
vulnerability for the disorder (Rosenthal, 1970; Zubin & Spring, 1977). Indeed, 
retrospective studies of patients with schizophrenia and prospective population 
cohort studies indicate that psychosocial stressors (encompassing major life events, 
childhood trauma, and milder daily hassles) contribute to the development and 
maintenance of psychosis (Myin-Germeys & van Os, 2007; Phillips et al., 2007; Varese 
et al., 2012). Furthermore, stressful events have been found to elicit greater 
emotional reactivity in individuals with psychosis compared to healthy controls 
(Myin-Germeys et al., 2001). Whilst these studies implicate stress in the aetiology of 
schizophrenia, the study of individuals at elevated risk for the disorder provides the 
opportunity to directly test whether schizophrenia vulnerability is associated with 
increased susceptibility to psychosocial stress (i.e., increased exposure to 
psychosocial stressors and greater reactivity to these exposures).     
There is evidence that individuals identified as being at elevated risk for 
schizophrenia on account of their clinical presentation experience greater exposure 
to psychosocial stressors. Relative to healthy youth, higher levels of trauma have 
been observed among UHR youth and children reporting PLEs (Kelleher et al., 2008; 
Addington et al., 2013; Kelleher et al., 2013c; Sahin et al., 2013; Tikka et al., 2013), 
and adolescents with SPD and those reporting PLEs have been found to experience a 
greater number of recent life events (De Loore et al., 2007; Tessner et al., 2011). It is 
unclear whether this is also true of individuals at elevated risk due to a family history 
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of psychosis, and no study has yet compared individuals with different vulnerability 
profiles (i.e., symptomatic-risk vs. genetic-risk). However, both UHR youth (Palmier-
Claus et al., 2012) and adults with a family history of psychosis (Myin-Germeys et al., 
2001) have been found to show greater emotional reactivity to stressful experiences 
than healthy controls. Similarly, studies of adolescents with SPD (Tessner et al., 
2011) and UHR youth (Phillips et al., 2012) indicate that these youth are more 
distressed by daily hassles than their healthy peers. Whilst several of these studies 
have reported that psychosocial stress exposure is associated with psychotic 
symptoms and depression (Miller et al., 2001; Thompson et al., 2007; Tessner et al., 
2011), whether psychosocial stress is more strongly related to psychopathology 
among high-risk individuals compared to healthy controls has yet to be established.  
Chapter aims  
This chapter aimed to examine exposure to psychosocial stressors and reactivity to 
these exposures in children with different vulnerability profiles for schizophrenia: (i) 
children presenting multiple antecedents of schizophrenia (ASz), (ii) children with a 
family history of illness (FHx), and (iii) typically-developing (TD) children. A further 
aim was to determine whether the relationship between psychosocial stress and 
current psychopathology is associated with risk status.  
Hypotheses 
1a. ASz and FHx children will be exposed to higher levels of psychosocial 
stressors compared to the TD group.  
1b.  Relative to TD children, both ASz and FHx children will be more distressed 
by psychosocial stressors. 
1c. Experiences of psychosocial stress will be more strongly associated with 
current psychopathology among ASz and FHx children than in TD children. 
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4.2 Methods  
4.2.1 Participants and procedure 
Chapter 3 provides full details of the recruitment procedure. In brief, ASz and TD 
children were recruited using a novel, school-based, community-screening method 
(Laurens et al., 2007; Laurens et al., 2011). FHx children were identified either via the 
caregiver screening questionnaire, which included items assessing family mental 
health difficulties, or as relatives of individuals with schizophrenia or schizoaffective 
disorder who were identified via medical records. Children eligible for the ASz, FHx, 
and TD groups were invited to participate in a longitudinal study of child 
development. This chapter primarily examines psychosocial stress data collected at 
the 24-month assessment phase.  
4.2.2 Negative life events  
Participants completed an eight-item self-report measure which assessed exposure 
to a range of child-appropriate negative life events (Heubeck & O’Sullivan, 1998), 
including: (i) the death of someone close, (ii) parental separation or divorce, (iii) 
experiencing a fire or natural disaster, (iv) being involved in a serious car accident, 
(v) serious illness requiring hospitalisation, (vi) serious illness in the parent, (vii) 
being the victim of burglary, and (viii) being the victim of any crime. For each event, 
participants were asked whether it had ever happened to them (yes or no), how 
distressed they had felt at the time of the event, and how much the event distressed 
them currently. Both distress ratings were scored on a four-point scale (0 ‘not at all’, 
1 ‘a little’, 2 ‘somewhat’, and 3 ‘a lot’). The number of negative life events was 
summed to give a total score. Distress ratings for each item were summed and 
divided by the number of items endorsed to provide two average distress scores 
(previous and current).  
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4.2.3 Daily hassles  
Children completed a 37-item questionnaire, adapted from Heubeck and O’Sullivan 
(1998) assessing school-related daily hassles in four domains: scholastic (9 items: 
e.g., ‘I have to sit a test’ and ‘my homework is too hard’), home (4 items: e.g., ‘my 
parents want me to do better’ and ‘my parents are critical of my homework’), peer 
(16 items: e.g., ‘other children make fun of me, tease me, or pick on me’ and ‘I feel left 
out’), and teacher (8 items: e.g., ‘a teacher does not listen to me’ and ‘a teacher is 
unfair to me or other children’). For each item, participants indicated on a four-point 
scale how frequently the hassle had occurred during the past six months (0 ‘never’, 1 
‘rarely’, 2 ‘sometimes’, and 3 ‘often’), and how distressed this event made them feel (0 
‘not at all’, 1 ‘a little’, 2 ‘somewhat’, and 3 ‘a lot’). Frequency ratings for items included 
in each subscale were summed to give total frequency scores for each of the four 
domains (reflecting the number of hassles experienced and how often they occurred). 
A total daily hassles frequency score was computed by summing frequency scores on 
all 37 items. Average domain distress scores were created by summing distress 
ratings on contributing items and dividing this score by the number of endorsed 
items (reflecting the average distress per item); the same procedure was performed 
with all items to obtain an overall average daily hassle distress score. After excluding 
one item from the scholastic domain which was poorly correlated with the remaining 
items (‘I have trouble with reading, writing, or spelling’), Cronbach’s alpha 
coefficients were moderate-to-high (range: 0.71-0.89) for all domain frequency and 
distress scales except the home frequency scale (α=0.55) and the home distress scale 
(α=0.59), which likely reflects the few items contributing to the home domain. Both 
scales were retained in analyses but should be interpreted with caution. Internal 
consistencies for the total frequency and overall distress scales were high (0.88 and 




4.2.4 Physical punishment  
Exposure to physical punishment was assessed using the corporal punishment scale 
of the Alabama Parenting Questionnaire [APQ (Shelton et al., 1996)], completed by 
the child and their caregiver independently. The APQ is a widely-used measure of 
parenting practices which demonstrates high reliability and validity (Shelton et al., 
1996; Dadds et al., 2003). The corporal punishment scale includes three items: (i) 
spanking, (ii) slapping, and (iii) hitting with a belt, switch, or other object; children 
and their caregivers were asked to indicate how often each item typically occurred in 
their home on a five-point scale (1 ‘never’, 2 ‘almost never’, 3 ‘sometimes’, 4 ‘often’, 
and 5 ‘always’). Unlike the negative life event and daily hassles measures, the APQ 
was administered at both the baseline and 24-month assessment phases (rather than 
at the 24-month assessment only). Thus, in order to provide a more comprehensive 
index of exposure to physical punishment occurring during the time interval between 
initial identification of participants and the 24-month assessment phase, both 
baseline and 24-month assessment data were examined in this chapter. Internal 
consistencies for the child- and caregiver-report corporal punishment scales were 
moderate-to-high at the baseline assessment (α=0.85 and 0.65, respectively) and 24-
month assessment (α=0.90 and 0.72, respectively). A dichotomous summary variable 
for physical punishment incorporating reports from both informants and both 
assessment phases was created, defined as a child- or caregiver-reported score of 
three or more on at least one of the three items at the baseline and/or 24-month 
assessment. To assess more severe forms of physical punishment, a further 
dichotomous variable was derived, defined as a child- or caregiver-reported score of 
three or more on the ‘hitting with a belt, switch, or other object’ item at the baseline 
and/or 24-month assessment.  
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4.2.5 Current psychopathology  
Psychopathology measures were described in Chapter 3. In brief, participants and 
their caregivers completed the Child Behaviour Checklist [CBCL (Achenbach & 
Rescorla, 2001)] and the corresponding Youth Self-Report (YSR), respectively. The 
current study examines scores on the internalising and externalising scales of the 
CBCL/YSR. Children also re-completed the nine-item PLE measure (Laurens et al., 
2012) assessing delusion- and hallucination-like experiences. Scores on each item 
were summed to provide a total PLE score (range: 0-18). 
4.2.6 Statistical analyses  
Independent samples t-tests, Mann-Whitney U tests, chi-squared tests, and Fisher’s 
exact tests were used to examine group differences on demographic variables, APQ 
physical punishment scale scores, and current psychopathology. Independent 
samples t-tests, one way ANOVA’s, correlation analyses, and chi-squared tests were 
used to explore associations between demographic variables and negative life events, 
daily hassles, and physical punishment in the total sample.  
The effect of risk status on negative life event and daily hassles variables was 
examined using linear regression analyses. All daily hassles scales (frequency and 
distress) were approximately normally distributed, as was the number of negative 
life events (skewness and kurtosis values ≤ 1.00). However, the two negative life 
event distress scales (distress at the time of the event and current distress) showed 
minor departures from normality (skewness: 0.13 and 1.11; kurtosis: -1.36 and 0.57, 
respectively). Non-parametric analyses were performed on these two variables using 
quantile (median) regression in Stata version 12 which yielded an identical pattern of 
results to those obtained in linear regression analyses. Thus, in order to maintain 
consistency in the analytic method and software package employed, and to provide 
estimates of effect size which cannot be derived from the quantile regression 
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coefficients, parametric linear regression analyses were employed for all variables. In 
addition, logistic regression was used to determine the effect of risk status on 
physical punishment. In each regression analysis, the predictive effect of each risk 
group was tested independently (i.e., ASz and FHx children were examined relative to 
TD children but were not directly compared to each other due to several children 
meeting inclusion criteria for both groups). All regression analyses were 
subsequently adjusted for demographic factors that differed significantly between 
the groups or that were associated with psychosocial stress measures in preliminary 
analyses. Unstandardised regression coefficients from both unadjusted and adjusted 
analyses were used to derive standardised mean differences (d) as indices of effect 
size (Lipsey & Wilson, 2001). Odds ratios from logistic regression analyses were also 
converted into standardised effect sizes (Lipsey & Wilson, 2001). As described in 
Chapter 3, where adjustment for demographic factors led to a substantial change in 
the effect size associated with risk status (change in d > 0.30), stratified analyses 
were performed to further explore the effect of these variables.  
Within-group correlation analyses were conducted to examine relationships 
between psychosocial stress variables and current psychopathology. Pearson’s ‘r’ 
correlation analyses were used for normally distributed variables (daily hassles 
scales, number of negative life events, and YSR scores) and Spearman’s rho ‘ρ’ 
correlation analyses for non-normally distributed variables (negative life event 
distress scales, APQ physical punishment scale scores, and CBCL and PLE scores). To 
limit the number of statistical tests conducted (and hence prevent inflation of type 1 
error rate), only total scores on the daily hassles frequency and distress scales (as 
opposed to the four domain scores) were examined in the correlation analyses. All 
final analyses were conducted using the Statistical Package for the Social Sciences 
(SPSS) version 20.  
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 ASz vs. TD FHx vs. TD 
Age (years); mean ± SE 12.9 ± 0.2 13.2 ± 0.2 13.1 ± 0.2 t=1.00 p=0.32 t=-0.57 p=0.57 
Time lapse: screening to stress assessment (years); mean ± SE 2.6 ± 0.1 2.6 ± 0.2 2.8 ± 0.1 t=0.86 p=0.39 t=0.77 p=0.44 
Sex (male); n (%) 24 (71) 11 (46) 20 (48) χ2=4.07 p=0.04 χ2=0.02 p=0.89 
Ethnicity; n (%)       FE=8.72 p=0.03 χ2=17.30 p=0.001 
White British 7 (21) 3 (13) 19 (45)     
White other 8 (23) 2 (8) 12 (29)     
Black  5 (15) 9 (37) 5 (12)     
Other 14 (41) 10 (42) 6 (14)     
Socioeconomic status; n (%) a        FE=15.29 p<0.001 FE=14.22 p<0.001 
Higher managerial, administrative, and professional 14 (41) 12 (50) 35 (83)     
Intermediate  12 (35) 3 (13) 6 (14)     
Routine and manual  8 (24) 9 (37) 1 (3)     




4.3 Results  
4.3.1 Sample characteristics 
In total, 95 children completed assessments of psychosocial stress; 29 children met 
ASz criteria only, 19 met FHx criteria only, 5 met both ASz and FHx criteria, and 42 
met TD criteria. The five ASz+FHx cases were included in both the ASz and FHx 
groups, yielding data for 34 ASz and 24 FHx children in total. As described previously, 
ASz and FHx groups were examined relative to the TD group only and not directly to 
each other. Sample characteristics are presented by group in Table 11. There were no 
significant group differences (ASz vs. TD or FHx vs. TD) in age or lapse of time 
between screening and assessment (p>0.30). ASz children were significantly more 
likely to be male compared to the TD group (p=0.04). When ASz and FHx groups were 
compared to the TD group, they each differed significantly on ethnicity (p<0.05) and 
socioeconomic status (p≤0.001).  
4.3.2 Factors associated with experiences of psychosocial stress 
Preliminary analyses were conducted to identify sociodemographic correlates of 
psychosocial stress. Age was negatively correlated with previous (ρ=-0.25, p=0.01) 
and current distress (ρ=-0.21, p=0.04) relating to negative life events. Additionally, 
ethnicity was significantly associated with home hassles frequency (F[3, 91]=5.35, 
p=0.002) and distress scores (F[3, 91]=2.80, p=0.05), and with physical punishment 
(χ2=20.03, p<0.001). Specifically, children of black and ‘other’ ethnicity had higher 
scores on the home hassles frequency and distress scales and were more likely to 
experience physical punishment relative to white British and other white children. 
Socioeconomic status was also significantly associated with physical punishment 
(χ2=24.10, p<0.001); children in the ‘intermediate’ and ‘routine and manual’ classes 
were more likely to experience physical punishment than those in the ‘higher 
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4.3.3 Group differences in negative life events  
Across the total sample, 73 children (77%) reported that they had experienced at 
least one negative life event; the most commonly-reported event being the death of 
someone close. Visual inspection of these data (Figure 6), indicated that the 
prevalence of each life event was higher among ASz and FHx children compared to 
the TD group with the exception that being involved a serious car accident was more 
common in the TD group than in the ASz group, and that TD children were more 
likely than both ASz and FHx children to have been the victim of burglary.  
The mean number of negative life events experienced by the ASz, FHx, and TD 
groups was 1.74, 1.96, and 1.10, respectively (Table 12). Linear regression analyses 
indicated that FHx children reported a significantly higher number of negative life 
events than TD children, equating to a moderate effect size (d=0.66, p=0.01). This 
effect was not substantially changed after adjustment for demographic factors. Post-
hoc tests confirmed that among FHx children, those with a first-degree relative with 
schizophrenia (n=8), and those with second-degree relative with the disorder (n=16), 
did not differ on the mean number of life events experienced (2.00 vs. 1.93, 
respectively; t=-0.09, p=0.93). In unadjusted analyses, FHx and TD children did not 
differ significantly on either of the negative life event distress scales (previous or 
current). After adjustment for demographic factors, the effect of FHx status on 
current distress was increased in magnitude and achieved statistical significance 
(d=0.70, p=0.04); stratified analyses were not employed as the magnitude of change 
in the effect size was just less than 0.30. The ASz group also reported a significantly 
greater number of negative life events relative to the TD group (d=0.55, p=0.02); this 
effect was largely unchanged after adjustment for demographic factors although 
estimates were less precise (d=0.48, p=0.09). ASz and TD children did not differ on 
the degree of distress experienced either at the time of the event or currently.  
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Table 12. Linear regression analyses examining the effect of risk status on negative life event exposure and distress 








ASz vs. TD FHx vs. TD 
 d B (95% CI) p d B (95% CI) p 
Number of negative life 
events; mean ± SE 
1.74 ± 0.20 1.96 ± 0.31 1.10 ± 0.19 Unadjusted 0.55 0.64 (0.10 – 1.18) 0.02 0.66 0.86 (0.19 – 1.54) 0.01 
   Adjusted 0.48 0.57 (-0.09 – 1.22) 0.09 0.77 0.99 (0.14 – 1.84) 0.02 
Distress at the time of the 
event; mean ± SE 
1.44 ± 0.17 1.51 ± 0.23 1.26 ± 0.18 Unadjusted 0.16 0.18 (-0.33 – 0.69) 0.49 0.22 0.25 (-0.34 – 0.85) 0.39 
   Adjusted* -0.03 -0.04 (-0.63 – 0.55) 0.90 0.42 0.48 (-0.25 – 1.21) 0.19 
Current distress relating 
to event; mean ± SE 
0.88 ± 0.15 0.91 ± 0.19 0.58 ± 0.11 Unadjusted 0.37 0.30 (-0.07 – 0.66) 0.12 0.41 0.33 (-0.08 – 0.75) 0.12 
   Adjusted* 0.16 0.13 (-0.31 – 0.57) 0.56 0.70 0.54 (0.04 – 1.05) 0.04 
Note. Five ASz+FHx cases are included in both groups; d: standardised effect size; B: unstandardised regression coefficient. a Linear regression analyses without 
adjustment for potential confounders (unadjusted) and adjusted for sex, ethnicity, and socioeconomic status (adjusted), with age included as an additional 
covariate (adjusted*).  
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4.3.4 Group differences in daily hassles  
Mean daily hassles frequency scores, reflecting the number of daily hassles 
experienced during the past six months and how often they were experienced, are 
presented by group in Table 13. Linear regression analyses were conducted to 
examine the effect of risk status on domain frequency scores. Relative to the TD 
group, ASz children were exposed to a higher frequency of peer-related (d=0.84, 
p=0.001) and teacher-related hassles (d=0.90, p<0.001). The effect of ASz status on 
hassles frequency scores in these domains remained moderate-to-large and 
statistically significant after adjustment for sex, ethnicity, and socioeconomic status 
(peer: d=1.02, p=0.001; teacher: d=0.73, p=0.008). In contrast, FHx children reported 
that they were more frequently exposed to home-related daily hassles than TD 
children (d=0.53, p=0.05). The effect size was reduced after adjusting for 
demographic factors (d=0.24, p=0.42), again, stratified analyses were not employed 
as the magnitude of change in the effect size was just less than 0.30. 
Mean daily hassles distress scores for each domain are presented by group in 
Table 14; these scores reflect the average level of distress experienced per item. 
Linear regression analyses indicated that relative to the TD group, ASz children 
reported significantly greater distress regarding daily hassles across all four domains 
(p<0.03), these differences were moderate in magnitude (d range: 0.53–0.63). 
Adjustment for sex, ethnicity, and socioeconomic status, led to a moderate change in 
these effect sizes (magnitude of change in d<0.30 for all effects) and subsequently a 
significant effect of ASz status was observed for the scholastic-related, peer-related, 
and teacher-related distress scales (d range: 0.72–0.91, p<0.05). In contrast, relative 
to TD children, the FHx group reported that they were more distressed by hassles in 
the home domain only (d=0.53, p=0.05); a slight reduction in effect was observed 
after adjustment for demographic factors (d=0.42, p=0.21).  
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Table 13. Linear regression analyses examining the effect of risk status on frequency of daily hassles 







 Model a 
ASz vs. TD FHx vs. TD 
 d B (95% CI)   p   d B (95% CI) p 
Scholastic hassles  
frequency; mean ± SE 
12.09 ± 0.58 12.04 ± 0.84 11.00 ± 0.59 Unadjusted 0.30 1.09 (-0.59 – 2.76) 0.20 0.27 1.04 (-0.98 – 3.06) 0.31 
   Adjusted 0.42 1.49 (-0.46 – 3.44) 0.13 0.23 0.85 (-1.50 – 3.19) 0.47 
Home hassles  
frequency; mean ± SE 
4.76 ± 0.41 4.92 ± 0.43 3.76 ± 0.35 Unadjusted 0.44 1.00 (-0.07 – 2.07) 0.07 0.53 1.16 (0.02 – 2.29) 0.05 
   Adjusted 0.17 0.41 (-0.77 – 1.58) 0.49 0.24 0.53 (-0.78 – 1.85) 0.42 
Peer hassles 
frequency; mean ± SE 
14.94 ± 1.21 10.88 ± 1.37 9.31 ± 1.02 Unadjusted 0.84 5.63 (2.51 – 8.76) 0.001 0.24 1.57 (-1.82 – 4.96) 0.36 
   Adjusted 1.02 6.60 (2.81 – 10.40) 0.001 0.47 3.00 (-1.22 – 7.23) 0.16 
Teacher hassles 
frequency; mean ± SE 
10.29 ± 0.77 8.29 ± 0.83 6.86 ± 0.52 Unadjusted 0.90 3.44 (1.65 – 5.23) <0.001 0.40 1.44 (-0.41 – 3.28) 0.13 
   Adjusted 0.73 2.88 (0.78 – 4.98) 0.008 0.30 1.09 (-1.20 – 3.37) 0.35 
Note. Five ASz+FHx cases are included in both groups. d: standardised effect size; B: unstandardised regression coefficient. a Linear regression analyses without 




Table 14. Linear regression analyses examining the effect of risk status on distress relating to daily hassles 








ASz vs. TD FHx vs. TD 
 d B (95% CI) p d B (95% CI) p 
Scholastic hassles     
distress; mean ± SE 
1.43 ± 0.08 1.17 ± 0.12 1.07 ± 0.10 Unadjusted 0.63 0.37 (0.10 – 0.64) 0.008 0.16 0.10 (-0.22 – 0.42) 0.54 
   Adjusted 0.91 0.50 (0.21 – 0.79) 0.001 -0.01 -0.01 (-0.41 – 0.39) 0.97 
Home hassles           
distress; mean ± SE 
1.10 ± 0.10 1.11 ± 0.14 0.76 ± 0.10 Unadjusted 0.53 0.34 (0.04 – 0.64) 0.03 0.53 0.35 (0.00 – 0.69) 0.05 
   Adjusted 0.33 0.21 (-0.14 – 0.56) 0.23 0.42 0.28 (-0.16 – 0.72) 0.21 
Peer hassles      
distress; mean ± SE 
1.15 ± 0.12 0.80 ± 0.14 0.81 ± 0.09 Unadjusted 0.56 0.34 (0.06 – 0.63) 0.02 0.00 -0.00 (-0.32 – 0.32) 0.99 
   Adjusted 0.85 0.50 (0.17 – 0.82) 0.003 0.13 0.08 (-0.32 – 0.48) 0.70 
Teacher hassles 
distress; mean ± SE 
1.23 ± 0.10 0.84 ± 0.13 0.91 ± 0.09 Unadjusted 0.58 0.33 (0.06 – 0.59) 0.02 -0.12 -0.07 (-0.38 – 0.24) 0.64 
   Adjusted 0.72 0.40 (0.09 – 0.70) 0.01 -0.19 -0.11 (-0.51 – 0.28) 0.57 
Note. Five ASz+FHx cases are included in both groups. d: standardised effect size; B: unstandardised regression coefficient. a Linear regression analyses without 
adjustment for potential confounders (unadjusted) and adjusted for sex, ethnicity, and socioeconomic status (adjusted). 
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4.3.5 Group differences in physical punishment  
Mean scores on the APQ physical punishment scales (child- and caregiver-report) are 
presented by group in Table 15. Relative to the TD group, both ASz and FHx children 
obtained significantly higher scores on the child-report physical punishment scales at 
both the baseline and 24-month assessment (p≤0.001), in addition, ASz children were 
characterised by significantly higher scores on the caregiver-report physical 
punishment scale at the 24-month assessment (p=0.01).  
Dichotomous measures of physical punishment were created using the 
procedures described previously in order to incorporate information from both 
informants (i.e., child and caregiver) and both assessment phases (i.e., baseline and 
24-month). As shown in Table 16, the prevalence of physical punishment among ASz, 
FHx, and TD children was 47%, 54%, and 24%, respectively. Severe physical 
punishment (i.e., hitting with a belt or other object) was experienced by 9 (27%) ASz 
children and 9 (38%) FHx children; however, none of the TD group had experienced 
these more severe forms of punishment. Thus, logistic regression analyses examining 
the effect of risk status on physical punishment were subsequently performed only 
on the more leniently defined variable. Relative to the TD group, the odds of being 
exposed to physical punishment were 2.84 times higher among ASz children 
(p=0.04), equating to a large effect size (d=1.57). Adjustment for sex, ethnicity, and 
socioeconomic status, led to a substantial reduction in the effect size associated with 
ASz status, such that no statistically significant effect of ASz status was observed 
(d=0.61, p=0.89). Similarly, unadjusted logistic regression analyses indicated that 
FHx children were 3.78 times more likely to experience physical punishment than TD 
children (d=2.09, p=0.02). Again, adjustment for demographic factors substantially 
reduced the effect size associated with FHx status (d=0.70, p=0.77).  
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 ASz vs. TD FHx vs. TD 
Baseline APQ physical punishment score (child-report); mean ± SE 6.03 ± 0.64 5.64 ± 0.68 3.56 ± 0.18 U=325.5 p<0.001 U=242.0 p=0.001 
Baseline APQ physical punishment score (caregiver-report); mean ± SE 4.44 ± 0.29 4.48 ± 0.34 3.93 ± 0.20 t=-1.49 p=0.14 t=-1.48 p=0.14 
24-month APQ physical punishment score (child-report); mean ± SE 4.53 ± 0.43 5.00 ± 0.58 3.26 ± 0.13 U=523.0 p=0.01 U=295.0 p=0.001 
24-month APQ physical punishment score (caregiver-report); mean ± SE 4.26 ± 0.24 4.39 ± 0.40 3.76 ± 0.20 U=536.0 p=0.04 U=382.5 p=0.11 
Note. Five ASz+FHx cases are included in both groups. APQ: Alabama Parenting Questionnaire. Missing data: baseline – child (n=9); baseline – caregiver (n=2);      
24-month – child (n=1); 24-month – caregiver (n=1). 
 
Table 16. Logistic regression analyses examining the effect of risk status on exposure to physical punishment 








ASz vs. TD FHx vs. TD 
 d OR (95% CI) p d OR (95% CI) p 
Physical punishment      
(ever experienced); n (%) 
16 (47) 13 (54) 10 (24) Unadjusted 1.57 2.84 (1.07 – 7.57) 0.04 2.09 3.78 (1.30 – 11.05) 0.02 
   Adjusted 0.61 1.11 (0.27 – 4.54) 0.89 0.70 1.28 (0.25 – 6.44) 0.77 
Note. Five ASz+FHx cases are included in both groups. d: standardised effect size; OR: odds ratio.  a Logistic regression analyses without adjustment for potential 
confounders (unadjusted) and adjusted for sex, ethnicity, and socioeconomic status (adjusted). 
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Ethnicity and socioeconomic status were associated with physical punishment in 
preliminary analyses, and their inclusion in the regression models attenuated the 
effect of both ASz and FHx status; stratified analyses were therefore performed to 
explore the influence of these variables (Table 17). Ethnicity groups were combined 
to derive two summary groups: ‘white’ (‘white British’ and ‘white other’) and ‘other’ 
(‘black’ and ‘other’). A similar procedure was performed for the socioeconomic 
classes whereby the ‘higher managerial, administrative, and professional’ group was 
retained and the ‘intermediate’ and ‘routine and manual’ groups were combined, 
yielding a ‘higher’ and ‘lower’ group. Stratified analyses indicated that the effect of 
risk status was indeed influenced by ethnicity and socioeconomic status. Specifically, 
ASz and FHx children were more likely to experience physical punishment than TD 
children when ‘white’ children were examined (effects were moderate-to-large but 
did not achieve statistical significance), but this pattern was not present among 
children of ‘other’ ethnicity. Similarly, among children of ‘higher’ socioeconomic 
status, physical punishment was more common among ASz and FHx children than in 
TD children (equating to moderate-to-large, although not statistically significant, 
effects), yet in the ‘lower’ socioeconomic group the reverse pattern was observed.  
Table 17. Stratified analyses examining risk status and physical punishment 








 ASz vs. TD FHx vs. TD 
Ethnicity           
White  4 (27) 2 (40) 3 (10) d=0.67 p=0.19 d=1.01 p=0.13 
Other 12 (63) 11 (58) 7 (64) d=-0.01 p=1.00 d=-0.13 p=1.00 
SES           
Higher 4 (29) 4 (33) 4 (11) d=0.62 p=0.20 d=0.75 p=0.18 
Lower 12 (60) 9 (75) 6 (86) d=-0.76 p=0.36 d=-0.38 p=1.00 
Note. Five ASz+FHx cases included in both groups.* Fisher’s exact. SES: socioeconomic status; 
d: standardised effect size. 
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 ASz vs. TD FHx vs. TD 
YSR Internalising scale (child-report); mean ± SE 12.30 ± 1.39 10.04 ± 1.39 9.38 ± 1.11 t=-1.66 p=0.10 t=-0.36 p=0.72 
YSR Externalising scale (child-report); mean ± SE 11.55 ± 1.12 9.04 ± 1.39 6.24 ± 0.73 t=-4.11 p<0.001 t=-1.97 p=0.05 
CBCL Internalising scale (caregiver-report); mean ± SE 11.47 ± 1.43 8.04 ± 2.17 6.40 ± 0.80 U=445.0 p=0.005 U=460.0 p=0.56 
CBCL Externalising scale (caregiver-report); mean ± SE 12.26 ± 1.90 9.92 ± 2.39 4.74 ± 0.85 U=386.0 p=0.001 U=401.5 p=0.17 
Psychotic-like experiences (child-report); mean ± SE  2.15 ± 0.46 1.92 ± 0.53 0.85 ± 0.21 U=506.5 p=0.03 U=389.0 p=0.12 




4.3.6 Psychosocial stress and current psychopathology 
Psychopathology data are presented in Table 18. Relative to the TD group, ASz 
children obtained significantly higher scores on the CBCL internalising and 
externalising scales, the YSR externalising scale, and the PLE questionnaire (p<0.03), 
whilst FHx children were characterised by higher YSR externalising scores (p=0.05). 
Parametric (‘r’) and non-parametric (‘ρ’) correlation analyses were conducted to 
examine associations between psychosocial stress measures and current 
psychopathology (Table 19). In the ASz group only, moderate correlations were 
observed between the total number of negative life events and PLEs (ρ=0.50, 
p=0.003). Total daily hassles frequency scores were positively correlated with PLEs 
across all three groups; strong correlations were observed among ASz (ρ=0.53, 
p=0.001) and FHx children (ρ=0.55, p=0.006), but a moderate correlation only was 
observed in the TD group (ρ=0.33, p=0.04). Among FHx children, total daily hassles 
frequency scores were also positively correlated with child-reported internalising 
(ρ=0.49, p=0.02) and externalising symptoms (ρ=0.48, p=0.02). Similarly, in the TD 
group, positive correlations were observed between total daily hassles frequency 
scores and child-reported internalising (r=0.63, p<0.001) and externalising 
symptoms (r=0.57, p<0.001), and total daily hassles distress scores were associated 
with child-reported internalising symptoms (r=0.67, p<0.001) and PLEs (ρ=0.41, 
p=0.002). Among FHx children, child-reported (ρ=0.48, p=0.03) and caregiver-
reported (ρ=0.42, p=0.04) physical punishment scores at baseline were positively 
correlated with YSR internalising symptoms whilst child-reported physical 
punishment scale scores at the 24-month follow-up were positively correlated with 
PLEs (ρ=0.49, p=0.02). In addition, caregiver-reported physical punishment scale 
scores at the 24-month follow-up were associated with CBCL externalising symptoms 
in the TD group (ρ=0.46, p=0.002).  
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Table 19. Correlations between psychosocial stress measures and current psychopathology 
Note. * p<0.05; ** p<0.01; YSR-I: Youth Self-Report – Internalising scale; YSR-E: Youth Self-Report – Externalising scale; CBCL-I: Child Behaviour Checklist – 
Internalising scale; CBCL-E: Child Behaviour Checklist – Externalising scale; PLE: psychotic-like experiences; APQ: Alabama Parenting Questionnaire. Missing 








   YSR-I YSR-E CBCL-I CBCL-E PLE  YSR-I YSR-E CBCL-I CBCL-E PLE YSR-I YSR-E CBCL-I CBCL-E PLE 
Negative life events                
Total number 0.12 0.26 -0.32 -0.07    0.50** 0.23 0.15 0.00   -0.12 0.31 0.05   -0.03 0.02 0.06  -0.10 
Previous distress  0.03  -0.08 -0.06 -0.17    0.17 0.40 0.09   -0.12   -0.23 0.07 0.03    0.05   -0.10 0.10  -0.24 
Current distress  0.10 0.11 -0.06 -0.28    0.23 0.39 0.12 0.10   -0.21 0.08 0.08    0.08   -0.11 0.12  -0.20 
Daily hassles                
Total frequency score 0.28 0.26 -0.26 -0.14    0.53**   0.50*  0.47* 0.36 0.27   0.55**   0.63**  0.57**  -0.22   -0.05  0.33* 
Average distress score  0.12 0.00   0.09 -0.13    0.26 0.07   -0.01 0.05 0.13 0.01   0.67**    0.24  -0.02   -0.04    0.41** 
APQ physical punishment                
Baseline – child 0.07  -0.09   0.23  0.21    0.01 0.12 0.28  0.48* 0.33  -0.05 0.25    0.26 0.13 0.06  -0.02 
Baseline – caregiver  -0.17 0.21  0.09  0.26   -0.09   -0.04 0.20  0.43* 0.26 0.04   -0.04    0.14 0.09 0.13  -0.09 
24-month – child 0.16 0.28 -0.21 -0.08    0.22 0.23 0.33 0.10   -0.03  0.49* 0.17    0.03 0.06 0.02  -0.09 




The aim of this chapter was to examine experiences of psychosocial stress in children 
with different vulnerability profiles for schizophrenia: those who present multiple 
antecedents of the disorder, and those with a family history of illness. Relative to TD 
children, both FHx and ASz children were more frequently exposed to major negative 
life events and milder daily hassles respectively, and reported greater distress 
resulting from these experiences. Physical punishment was also more common 
among ASz and FHx children compared to TD children, and stratified analyses 
indicated that ethnicity and socioeconomic status may influence this relationship. 
Correlation analyses demonstrated that the association between psychosocial stress 
and current psychopathology was associated with risk status.   
4.4.1 Comparison with previous research  
Negative life events 
Relative to the TD group, FHx and ASz children were exposed to a greater number of 
negative life events. There was no substantial change in the magnitude of either effect 
after adjusting for demographic factors, although the effect of ASz status just missed 
statistical significance in adjusted analyses (likely to reflect a loss in statistical 
power). Studies examining life events in older samples of high-risk adolescents and 
young adults have yielded inconsistent findings. Miller and colleagues observed no 
difference in the number of major or minor life events reported by youth with a 
family history of schizophrenia and healthy controls (Miller et al., 2001). 
Furthermore, two recent studies reported that UHR youth (Phillips et al., 2012; 
Devylder et al., 2013) experienced fewer recent life events than healthy controls, 
although this was only statistically significant in the former study (Phillips et al., 
2012). In contrast, adolescents with SPD (Tessner et al., 2011) and children reporting 
PLEs (De Loore et al., 2007) have been found to experience a greater number of life 
147 
 
events than their healthy peers. The inconsistency across studies may relate to 
differences in the age of participants and/or life event measures employed. Measures 
used in previous studies also assessed positive events, which may have masked any 
group differences in negative life events. Indeed, larger effect sizes were observed in 
the study of adolescents with SPD when undesirable life events were examined in 
isolation (Tessner et al., 2011). In addition, despite the fact that all previous studies 
(with the exception of Miller and colleagues) examined recent life events only, the 
mean number of events reported by participants in these studies was far higher than 
in the current study. This may reflect the younger age of the current sample (i.e., life 
events being less common in childhood than in later life), or it may be that previous 
studies examined more frequently-occurring events that are less severe. FHx children 
also reported that they were currently more distressed by negative life events than 
TD children, although this was not also observed among ASz children. Youth at UHR 
have also been found to be more distressed by negative life events than healthy 
controls (Phillips et al., 2012).  
Daily hassles  
ASz children were more frequently exposed to peer- and teacher-related daily 
hassles than TD children, and were more distressed by hassles across all domains; 
findings remained broadly consistent after adjustment for demographic factors. In 
contrast, FHx children obtained higher scores on the home hassles frequency and 
distress scales only; these effects were somewhat attenuated after adjustment for 
demographic factors. Two previous studies, one of youth at UHR (Phillips et al., 2012) 
and the other of adolescents with SPD (Tessner et al., 2011), did not observe a higher 
frequency of daily hassles in high-risk youth relative to healthy controls. However, 
both studies reported that high-risk youth were more distressed by these 
experiences. Again, differences in findings are likely to relate to the measures 
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employed. Previous studies examined hassles occurring during the past month 
(Phillips et al., 2012), or during the previous and current day (Tessner et al., 2011), 
whereas the current study assessed hassles experienced over the past six months. 
Furthermore, in contrast to previous studies, the measure of daily hassles employed 
in the current study indexed not only the number of hassles experienced but also 
how often they occurred, which may be a more sensitive measure. 
Physical punishment 
Relative to the TD group, both ASz and FHx children were significantly more likely to 
experience physical punishment (odds ratios: 2.84 and 3.78, respectively). In both 
groups, the effect of risk status was substantially reduced after adjusting for 
demographic factors. This is the first study to examine physical punishment in high-
risk youth and healthy controls. However, a large epidemiological study found that 
individuals exposed to physical punishment were 2.46 times more likely to meet 
criteria for SPD (Afifi et al., 2012), and that physical punishment was more strongly 
associated with SPD than any other personality disorder. Additionally, the authors 
observed that the association between SPD and physical punishment was significant 
after adjustment for demographic factors, which may reflect the fact that, unlike the 
current study, indices of socioeconomic status were positively (and not negatively) 
associated with physical punishment. Physical punishment and childhood 
maltreatment are not separate entities but represent varying degrees of physical 
force which lie on a continuum of severity (Afifi et al., 2012). Thus, the current 
findings are consistent with previous studies showing that UHR youth are more likely 
to experience physical abuse than healthy controls (Addington et al., 2013; Sahin et 
al., 2013; Tikka et al., 2013). The results also converge with population-based cohort 
studies which show that childhood physical abuse is associated with having a parent 
with psychosis (Walsh et al., 2002; Fisher et al., in press).  
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Psychosocial stress and current psychopathology 
The relationship between psychosocial stress and current psychopathology was 
found differ across the risk groups. Whilst PLEs were strongly associated with the 
frequency of daily hassles among ASz and FHx children, only moderate correlations 
were observed in the TD group; furthermore, PLEs were correlated with the number 
of negative life events among ASz children only. Negative life events and daily hassles 
have been associated with psychotic symptoms in previous studies of youth with a 
family history of illness (Miller et al., 2001) and adolescents with SPD (Tessner et al., 
2011); however, correlations were examined across the total sample of high-risk 
youth and healthy controls. In contrast, daily hassles and life events experienced 
during the past month were not associated psychotic symptoms in a study of UHR 
youth (Thompson et al., 2007), which may reflect the shorter assessment period. 
Similar to previous studies in healthy children (Kliewer & Kung, 1998), significant 
correlations were observed between daily hassles and internalising and externalising 
symptoms in FHx and TD children. That this relationship was not also present in ASz 
children is consistent with a study reporting that daily hassles were not correlated 
with anxiety or depression among UHR youth (Thompson et al., 2007). Alternatively, 
this may reflect a ‘ceiling effect’ in measurement; it is possible that internalising and 
externalising symptoms among ASz children were sufficiently high so as to be 
unaffected by daily hassles. 
The current study also investigated whether the relationship between physical 
punishment and psychopathology differed by risk group. Among FHx children, 
physical punishment at baseline was positively associated with internalising 
symptoms at follow-up, whilst current physical punishment experiences were 
associated with PLEs. In contrast, physical punishment was not correlated with any 
symptom measure in the ASz group; although current physical punishment was 
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associated with externalising symptoms in the TD group. Whilst this appears to be 
the first study to have examined the relationship between physical punishment and 
psychotic symptoms, a large epidemiological study observed a weak association 
between harsh parenting during early childhood (which included mild forms of 
physical punishment) and PLEs at 12 years (Fisher et al., 2013b). Furthermore, the 
correlations between physical punishment and internalising and externalising 
symptoms observed among FHx and TD children are highly consistent with existing 
literature on outcomes of physical punishment in childhood (Gershoff, 2002).  
4.4.2 Potential mechanisms  
Risk for schizophrenia and psychosocial stress exposure 
In line with previous studies of youth at elevated risk for schizophrenia on account of 
their clinical presentation, ASz children were more frequently exposed to daily 
hassles than TD children. Consistent with the fact that eligibility for the ASz group at 
recruitment was partially determined on the basis of symptom presentation, ASz 
children continued to be characterised by higher scores on measures of internalising 
and externalising symptoms and PLEs at the 24-month follow-up (i.e., when 
psychosocial stress measures were completed). It is possible that these symptoms 
influence the way in which ASz children interact with their environment and increase 
the likelihood that they will encounter daily hassles in their lives. However, given the 
cross-sectional nature of these analyses, it is possible that ASz children were exposed 
to daily hassles prior to the onset of these symptoms. Indeed, psychosocial stress 
exposure may have triggered the emergence of PLEs in ASz children who may have 
been more susceptible to these experiences due to underlying biological vulnerability 
(as indexed by early neurodevelopmental abnormalities). Two recent population-
based cohort studies of adolescents suggest that the relationship between stress 
exposure and schizophrenia vulnerability may be bidirectional (De Loore et al., 2007; 
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Kelleher et al., 2013c). Both studies found that traumatic experiences were 
associated with increased risk of developing PLEs, but that adolescents who reported 
PLEs at baseline were also at greater risk of being exposed to traumatic events during 
the follow-up period.   
Relative to the TD group, FHx children reported a higher number of life events.  As 
life events could not have feasibly contributed to FHx risk status (with the exception 
of a parent being seriously ill, which was reported by only 17% of the FHx group) it 
appears that having a family history of schizophrenia is associated with increased 
risk of experiencing negative life events. It is possible that having a close family 
member who is unwell (e.g., a parent or sibling) may create an environment where 
some of these events are more likely to occur. That this pattern was not observed in a 
study of older youth with a family history of schizophrenia (Miller et al., 2001), may 
be due to the fact that participants in the current study have more contact with their 
unwell family members due to their younger age.   
Risk for schizophrenia and reactivity to psychosocial stress 
ASz children reported that they were more distressed by the daily hassles they had 
experienced than TD children; one potential explanation for this finding is that these 
minor, frequently-occurring events are more salient to ASz children. Studies 
indicating that the dopamine system plays a key role in mediating the attribution of 
salience to environmental stimuli have led to the proposal that psychosis is a 
disorder of aberrant salience (Kapur, 2003). Hallucinations are proposed to result 
from the aberrant assignment of salience caused by hyperactive dopamine 
transmission whilst delusions are a compensatory mechanism that enables the 
individual to make sense of these experiences. Further extensions of this theory 
propose that salience dysregulation exists on a continuum in the population, often co-
occurring with other features (e.g., mania and cognitive deficits), and that the need 
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for care arises if these symptoms reach a certain threshold (van Os, 2009). Thus, the 
heightened sensitivity to daily hassles among ASz children (who are already 
experiencing subclinical psychotic symptoms) may be due to underlying dopamine 
dysregulation which causes these events to be more salient.  
In contrast to the heightened reactivity to daily experiences that characterised 
ASz children, FHx children reported feeling greater distress in relation to major 
negative life events relative to the TD group. However, significant group differences 
were observed only for current levels of distress, not for distress experienced at the 
time of the event. Major life events are, of course, distressing by nature, but 
experiencing a reduction in distress over time is likely to be an adaptive coping 
response. Indeed, all three groups reported that they were more distressed at the 
time of the event than they were currently. Thus, the significantly higher current 
distress ratings in FHx children relative to TD children may imply that FHx children 
used less adaptive coping mechanisms, causing their distress to persist at higher 
levels over time. 
Role of ethnicity and socioeconomic status  
The effect of ASz and FHx status on physical punishment was substantially reduced 
after adjusting for ethnicity and socioeconomic status; stratified analyses were 
therefore conducted to explore the role of these factors. Although limited by the small 
group sizes, these analyses suggest that in environments where physical punishment 
occurs less frequently (i.e., in families of white ethnicity or high socioeconomic 
status), ASz and FHx children are more likely to experience physical punishment than 
their TD peers. However, in environments where physical punishment is more 
regularly employed (i.e., non-white ethnic groups and low socioeconomic families), 
ASz and FHx children are no more likely to experience physical punishment, and in 
fact the TD group showed higher levels of exposure. These findings tentatively 
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suggest that factors such as socioeconomic status and ethnicity may moderate the 
relationship between risk for schizophrenia and physical punishment.  
Relationship between psychosocial stress and psychopathology  
Scores on the physical punishment scale were correlated with internalising 
symptoms and PLEs among FHx children only. In contrast, physical punishment was 
associated with externalising problems in the TD group (an outcome that has been 
reported consistently in the literature), but was not related to any measure of 
psychopathology in ASz children. Recent findings from a large, prospective study of 
children in the general population demonstrated that the relationship between 
childhood exposure to harsh parenting and PLEs in adolescence was mediated by 
anxiety, depressive symptoms, external locus of control, and low self-esteem (Fisher 
et al., 2013b). Thus, these psychological processes may lead to the expression of PLEs 
among FHx children, who may be particularly susceptible to the effects of physical 
punishment. Alternatively, the more robust associations between physical 
punishment and psychopathology observed among FHx children may reflect the fact 
that they were exposed to more severe forms of physical punishment (i.e., hitting 
with a belt, switch, or other object), which were not experienced by TD children. 
However, ASz children also experienced these more severe forms of punishment, so 
this cannot fully account for the findings.  
4.4.3 Methodological considerations  
Methodological issues that influence the overall study are discussed in detail in the 
final chapter of this thesis. Issues specifically relevant to the data presented in this 
chapter are described here. In common with previous research conducted in child 
and adolescent samples (Kliewer & Kung, 1998; Barrett & Heubeck, 2000; Tessner et 
al., 2011); a potential limitation is the reliance solely on self-report to assess daily 
hassles and negative life events. While subjective ratings of distress elicited by stress 
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exposure are inherent, exposure to negative life events and at least some daily 
hassles are amenable to obtaining confirmatory reports from caregivers. However, 
previous studies have shown poor concordance between parent and child ratings of 
life events and traumatic experiences (Stover et al., 2010; Tessner et al., 2011). 
Furthermore, the pattern of group differences in physical punishment and the 
association between these experiences and psychopathology was broadly similar 
across both child- and caregiver-reports. A further limitation of the current study is 
that it is not possible to disentangle the temporal relationship between psychosocial 
stress exposure and risk status. This is particularly problematic when trying to 
elucidate the relationship between psychosocial stress and ASz group membership. 
However, longitudinal population cohort studies of adolescents indicate that this 
relationship is likely to be bidirectional.  
4.4.4 Conclusions  
Children at elevated risk for schizophrenia are more frequently exposed to 
psychosocial stressors than their typically-developing peers and exhibit greater 
distress in relation to these experiences. These findings are consistent with previous 
studies showing that youth at elevated risk for schizophrenia on account of their 
clinical presentation are also more likely to be exposed to psychosocial stressors, and 
with studies showing that UHR youth and individuals with a family history of 
psychosis exhibit greater reactivity to stress. There is also evidence to suggest that 
experiences of psychosocial stress are more strongly associated with psychotic 
symptoms among children at elevated risk for schizophrenia compared to healthy 
controls. Overall, these findings are consistent with the predictions of the diathesis-
stress model of schizophrenia. Chapters 5 and 6 will examine the extent to which 
susceptibility to psychosocial stress is associated with biological indices of HPA axis 
function among ASz and FHx children.  
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CHAPTER 5 Salivary cortisol in children at elevated risk for 
schizophrenia  
5.1 Introduction 
The HPA axis may play a key role in mediating the relationship between stress and 
psychosis (Walker & Diforio, 1997; Walker et al., 2008). Specifically, it is 
hypothesised that elevated cortisol levels (triggered by psychosocial stress exposure) 
contribute to the clinical features of psychosis by augmenting dopamine activity. 
Evidence to support this model has been obtained in studies examining cortisol levels 
in individuals with schizophrenia and healthy controls. Indeed, abnormal HPA axis 
function, as indexed by elevated diurnal cortisol levels and/or a blunted cortisol 
awakening response (CAR), has been observed among individuals who have recently 
experienced their first psychotic episode (Borges et al., 2013). These findings suggest 
that HPA axis abnormalities may be present during the early stages of illness. 
However, it is currently unclear as to whether HPA axis dysfunction emerges prior to 
the first psychotic episode or whether it is merely a consequence of the stress 
associated with illness onset. 
Elevated salivary cortisol has been observed consistently among youth at UHR 
(Sugranyes et al., 2012; Walker et al., 2013) and adolescents with SPD (Weinstein et 
al., 1999; Walker et al., 2001; Mittal et al., 2007) relative to healthy youth. However, 
both higher (Collip et al., 2011; Yıldırım et al., 2011) and lower (Yang et al., 2012) 
cortisol levels during the day have been reported in individuals with a family history 
of psychosis, perhaps due to differences across studies in the cortisol sampling 
methodologies employed. Whilst these studies provide some evidence to suggest that 
elevated cortisol levels precede the onset of psychosis, UHR youth are, by definition, 
already sufficiently distressed as to seek treatment for their symptoms. Thus, 
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elevations in cortisol might feasibly be due to distress relating to emerging illness, as 
opposed to external psychosocial stressors. Furthermore, a substantial number of 
UHR youth are treated with antipsychotics and other psychotropic medications 
(Woods et al., 2013), which are known to affect cortisol levels. Similarly, studies of 
youth with SPD are limited by the fact that these individuals already present with 
symptoms of sufficient severity as to meet diagnostic criteria for a schizophrenia 
spectrum disorder. Examining cortisol levels in non help-seeking youth who are at an 
earlier stage of illness will help to establish whether abnormal HPA axis function 
precedes the onset of psychosis. Furthermore, it is also not yet known whether 
individuals at elevated risk for schizophrenia are also characterised by the blunted 
CAR that has been observed among individuals with first-episode psychosis.  
Chapter aims 
The aim of this chapter was to determine whether children presenting multiple 
antecedents of schizophrenia (ASz) and those with a family history of illness (FHx) 
are characterised by abnormal cortisol levels (elevated diurnal cortisol and/or a 
blunted CAR) relative to typically-developing (TD) children. A further aim was to 
determine whether cortisol levels are associated with experiences of psychosocial 
stress and current psychopathology among ASz and FHx children.   
Hypotheses 
2a. ASz children and FHx children will show elevated diurnal cortisol levels and 
a blunted CAR relative to TD children.  
2b.  Cortisol levels will be associated with exposure to psychosocial stressors 
and distress related to these exposures in ASz and FHx children.  
2c.  Among ASz and FHx children, cortisol levels will be correlated with current 
symptoms of psychopathology.  
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5.2 Methods  
5.2.1 Participants and procedure 
Full details of the recruitment procedure are provided in Chapter 3. In brief, ASz and 
TD children were identified using a novel community-screening procedure (Laurens 
et al., 2007; Laurens et al., 2011). FHx children were identified either via the 
caregiver screening questionnaire, or as relatives of individuals with schizophrenia 
or schizoaffective disorder. Children eligible for the ASz, FHx, and TD groups were 
invited to participate in a longitudinal study of child development. This chapter 
examines salivary cortisol data obtained at the 24-month follow-up assessment.  
5.2.2 Salivary cortisol assessment  
Sampling protocol  
Participants were provided with a verbal explanation and written instructions for 
collecting saliva samples at home using a passive drool procedure (Salimetrics, 
Suffolk, UK) in which participants secreted saliva into 2ml cryovial storage tubes via 
a straw. Six saliva samples were collected throughout the day on two consecutive 
days: upon awakening (0 min), and at 15, 30, and 60 min after awakening, and at 
12:00 pm and 20:00 pm. Sample collections were scheduled for weekends or school 
holidays in order to avoid interference with the child’s school routine and maximise 
compliance. Participants were instructed to wake before 10:00 am and collect the 
first sample immediately upon awakening. Participants were also asked to avoid food 
consumption for 30 min prior to sample collection, and to refrain from strenuous 
exercise during the day. Participants recorded the actual times at which each sample 
was collected in a sampling diary as well as their activities prior to sampling and any 
food or drink consumed. Researchers ensured that sample collections were not 
scheduled on days when participants planned to engage in activities that might 
substantially affect cortisol levels (e.g., sports clubs, competitions, or sleepovers).  
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Processing and analysis 
Samples were stored in the participant’s home freezer until they were collected by 
the researcher and transported to the laboratory at the James Black Centre, Institute 
of Psychiatry. Samples were analysed using an established procedure described 
previously (Belvederi Murri et al., 2012). On arrival at the laboratory the samples 
were frozen at -20° C. Immediately before analysis, samples were thawed, and 
collection tubes were centrifuged for 15 min at 3000 rpm. Cortisol levels were 
determined using the Salimetrics High Sensitivity Salivary Cortisol ELISA KIT 
(Salimetrics, Suffolk, UK), following the recommended procedure. In brief, 25 µl of 
saliva and standards were assayed in duplicates by incubation on a microtitre plate 
coated with monoclonal antibodies against cortisol. Cortisol linked to horseradish 
peroxidase was added to compete with cortisol in the standards and unknowns for 
the antibody binding sites. After one hour of incubation, unbound components were 
washed away. Bound cortisol peroxidase was measured by reaction of the peroxidase 
enzyme on the substrate tetramethylbenzidine. The amount of cortisol peroxidase 
detected, as measured by the intensity of colour developed, was inversely 
proportional to the amount of cortisol present. Optical density was read at 450 nm 
with correction at 620 nm using a Beckman Coulter DTX 880 plate reader with 
Multimode Detection Software 2.0.0.12. Cortisol values were then calculated using 
SoftMax Pro 4.8 software, following a 4-parameter fit. All samples from the same 
participant were analysed in the same plate. The analytical sensitivity was set to 0.33 
nmol/L, equivalent to 0.012 µg/dL. Inter-assay and intra-assay precisions ranged 
from 8% to 11% and 6% to 10%, respectively; these values are highly consistent 
those reported in other studies of youth at elevated risk for psychosis (Collip et al., 
2011; Walker et al., 2013).   
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Computation of summary cortisol measures  
Cortisol data obtained at individual time-points were summarised using the two area 
under the curve (AUC) computations described by Pruessner et al. (2003): (i) AUC 
with respect to the increase in cortisol levels following awakening (AUCi-CAR), and 
(ii) AUC with respect to ground of cortisol levels during the day (AUCg-DAY). Both 
computations are based on the trapezium formula, described in detail below.  
AUCi-CAR values provide a measure of the CAR, that is, the increase in cortisol 
levels that typically occurs within the first 15-40 minutes after awakening (Pruessner 
et al., 1997). Cortisol values obtained from the awakening sample and the three post-
awakening samples (15, 30, and 60 min) were used to derive an AUCi-CAR value for 
each participant. Firstly, the AUC with respect to ground (AUCg) was computed, 
reflecting the total amount of cortisol secreted during the hour after awakening. 
Secondly, the AUC with respect to the increase (AUCi) in cortisol levels from the first 
sample was computed by subtracting the area between the ground and the first 
cortisol value from the AUCg value. The equations for computing AUCg and AUCi 
values are provided below. Figure 7 shows the composition of these curves; time 
intervals (t) for the AUCi-CAR were: t1=15 min, t2=15 min, and t3=30 min. 
 
Equation 3.  Area under the curve with respect to ground (AUCg) 
 
       
         
 
     
         
 
     
         
 
   
 
Equation 4. Area under the curve with respect to increase (AUCi) 
 




                  
Figure 7. Composition of the area under the curve with respect to ground (AUCg) and with respect to increase (AUCi) for the cortisol 
awakening response 
Note. m: cortisol values at each sampling point; t: time interval between consecutive samples; t1: 15 min; t2: 15 min; t3: 30 min. Figures adapted from 
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Figure 8. Composition of the area under the curve with respect 
to ground (AUCg) for cortisol during the day 
Note. m: cortisol values at each sampling point; t: time intervals between 
consecutive samples; t1: time between the awakening and 12:00 pm 
samples; t2: time between the 12:00 pm and 20:00 pm samples. Figure 
adapted from Pruessner et al. (2003).  
 
AUCg-DAY values, reflecting total cortisol levels during the day, were also 
computed using the formula provided above. To derive the AUC for cortisol during 
the day, it was necessary to compute time intervals (t) between consecutive sample 
measurements for each participant using the actual times at which the samples were 
collected. Thus, t1 corresponded to the time interval between the awakening sample 
and the actual time at which the 12:00 pm sample was collected (as determined by 
self-report), whilst t2 corresponded to the time interval between the actual times at 
which the 12:00 pm and 20:00 pm samples were collected. Figure 8 illustrates the 
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Spearman’s rank correlation analyses confirmed that cortisol values for each 
time-point were highly correlated across the two testing days (p<0.001 for each time-
point). Thus, data obtained on the first sampling day only were used for AUC 
computations, unless Day 1 data were missing or participants demonstrated better 
compliance with the measurement protocol on Day 2 (e.g., if participants reported 
waking after 10:00 am or engaging in physical activities on Day 1 but not Day 2).  
5.2.3 Psychosocial stress 
Psychosocial stress measures were described in detail in Chapter 4. In brief, self-
report measures were used to assess exposure and distress relating to a range of 
child-appropriate negative life events and school-related daily hassles (Heubeck & 
O’Sullivan, 1998). Physical punishment was assessed using the corporal punishment 
scale of the Alabama Parenting Questionnaire [APQ (Shelton et al., 1996)]. In order to 
assess physical punishment exposures occurring proximally to the salivary cortisol 
assessment, and to maintain consistency with the negative life event and daily 
hassles measures, this chapter examines child-reported physical punishment scale 
scores obtained at the 24-month follow-up. All psychosocial stress measures were 
completed within one month of collecting cortisol samples (mean lapse of time 
between questionnaire completion and cortisol assessments: ± 3.2 days). 
5.2.4 Current psychopathology 
Psychopathology measures were described in detail in Chapter 3. In brief, 
internalising and externalising symptoms were assessed via caregiver- and child-
report using the Child Behaviour Checklist [CBCL (Achenbach & Rescorla, 2001)] and 
Youth Self-Report (YSR), respectively. Participants also re-completed the 9-item PLE 
measure (Laurens et al., 2012), with scores on each item summed to provide a total 
PLE score (range: 0-18).  
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5.2.5 Growth and pubertal status  
Participant height and weight were collected by the researcher at the assessment 
session and used to compute Body Mass Index (BMI; kilograms/metres2). 
Participants completed the Pubertal Developmental Scale (Carskadon & Acebo, 
1993), a five-item self-report measure assessing three general domains of pubertal 
status: body growth, pubic hair, and skin changes; and two gender-specific domains: 
menstruation and breast growth (females), or voice changes and facial hair (males). 
Scores on each domain were averaged to create an overall score, with higher scores 
indicating more advanced pubertal development. Scores on three of these items were 
also summed (males: body hair growth, voice change, and facial hair; females: body 
hair, breast development, and menarche) and these scores were used to assign 
participants to one of the five Tanner stages (Tanner, 1962): pre-pubertal, early 
pubertal, mid-pubertal, late pubertal, and post-pubertal.  
5.2.6 Tobacco and cannabis use 
Tobacco and cannabis use were assessed using a self-report measure (McVie & 
Bradshaw, 2005) developed specifically for use in a large longitudinal study of 
adolescent substance use behaviours. To ascertain current tobacco use, participants 
were asked to chose one statement among five that best described their use (‘I have 
never tried a cigarette’, ‘I have tried smoking cigarettes, but I don’t smoke now’, ‘I 
smoke cigarettes, but less than once per week’, ‘I smoke cigarettes at least once a 
week’, and ‘I smoke cigarettes every day’). A further item asked participants to rate 
how often they had used cannabis (‘never’, ‘once’, ‘2-3 times’, and ‘4 or more times’).  
Using established scoring criteria (McVie & Bradshaw, 2005), regular tobacco use 
was defined as having smoked ‘at least once a week’ or ‘every day’ and regular 
cannabis use as having used cannabis on ‘at least four occasions’. 
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5.2.7 Statistical analyses  
Group differences on demographic variables, psychosocial stress measures, and 
current psychopathology were examined using independent samples t-tests, Mann-
Whitney U tests, chi-squared tests, and Fisher’s exact tests. Independent samples t-
tests, one-way ANOVAs, and correlation analyses were used to explore associations 
between cortisol AUC values and demographic variables.  
As AUCi-CAR and AUCg-DAY values were approximately normally distributed, 
linear regression analyses were conducted to examine the effect of risk status on 
cortisol AUC measures. As previously, the effect of each risk group was tested 
independently (i.e., ASz and FHx groups were examined relative to the TD group but 
were not directly compared). All regression analyses were subsequently adjusted for 
demographic factors that differed significantly between the groups or that were 
associated with AUC values in preliminary analyses. Unstandardised regression 
coefficients were used to derive standardised mean differences (d) as indices of effect 
size (Lipsey & Wilson, 2001) in both adjusted and unadjusted analyses. As described 
in Chapter 3, where adjustment for demographic factors led to a substantial change 
in the effect size associated with risk status (change in d > 0.30), stratified analyses 
were performed to further explore the effect of these variables.  
 Within-group correlation analyses were conducted to examine the extent to 
which cortisol AUC values were associated with psychosocial stress and current 
psychopathology. Pearson’s ‘r’ correlation analyses were used for normally 
distributed variables (daily hassles scales, number of negative life events, and YSR 
scores) and Spearman’s rho ‘ρ’ correlation analyses for non-normally distributed 
variables (negative life event distress scales, APQ physical punishment scale scores, 
and CBCL and PLE scores). All analyses were conducted using the Statistical Package 
for the Social Sciences (SPSS) version 20.  
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 ASz vs. TD FHx vs. TD 
Age (years); mean ± SE 12.8 ± 0.2 13.3 ± 0.3 13.1 ± 0.2 t=1.18 p=0.24 t=-0.50 p=0.62 
Time lapse: screening to cortisol (years); mean ± SE 2.6 ± 0.1 2.7 ± 0.2 2.8 ± 0.1 t=1.05 p=0.30 t=0.22 p=0.83 
Pubertal development scale score; mean ± SE a 2.4 ± 0.1 2.4 ± 0.1 2.3 ± 0.1 t=-0.07 p=0.94 t=-0.19 p=0.85 
BMI (kg/m2); mean ± SE 20.4 ± 0.6 19.7 ± 0.7 19.8 ± 0.5 t=-0.76 p=0.45  t=0.09 p=0.93  
Sex (male); n (%) 23 (70) 11 (50) 17 (43) χ2=5.40 p=0.02 χ2=0.32 p=0.60 
Tobacco use; n (%) 2 (6) 1 (5) 0 (0) FE p=0.20 FE p=0.36 
Ethnicity; n (%)       FE=7.69 p=0.05 FE=17.46 p<0.001 
White British 8 (24) 3 (14) 20 (50)     
White other 8 (24) 2 (9) 11 (27)     
Black  4 (12) 8 (36) 3 (8)     
Other 13 (40) 9 (41) 6 (15)     
Socioeconomic status; n (%) b        FE=13.44 p=0.001 FE=9.74 p=0.006 
Higher managerial, administrative, and professional 14 (43) 11 (50) 33 (82)     
Intermediate  12 (36) 5 (23) 6 (15)     
Routine and manual  7 (21) 6 (27) 1 (3)     
Time of awakening  8:36 ± 0:12 8:29 ± 0:13 8:34 ± 0:11 t =-0.11 p=0.79 t=0.27 p=0.91 
Note. Four ASz+FHx cases are included in both groups. BMI: Body Mass Index; FE: Fisher’s exact. a Mean scores in all groups equate to mid-pubertal stage.             
b Socioeconomic status based on caregiver occupation. Missing data: BMI (n=2). 
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5.3 Results  
5.3.1 Sample characteristics  
In total, 91 children completed the saliva collection protocol; 29 met ASz criteria 
only, 18 met FHx criteria only, 4 met both ASz and FHx criteria, and 40 met TD 
criteria. The four ASz+FHx cases were included in both the ASz and FHx groups, 
yielding data for 33 ASz and 22 FHx children in total. Demographic characteristics of 
the sample are presented by group in Table 20. There were no significant between-
group differences (i.e., ASz vs. TD or FHx vs. TD) in age, pubertal status, lapse of time 
between antecedent screening and salivary cortisol assessment, BMI, tobacco use, or 
time of awakening (p>0.20). None of the participants reported regular cannabis use. 
The FHx and TD groups did not differ in sex; however, ASz children were significantly 
more likely to be male compared to TD children (p=0.02). Relative to the TD group, 
both the ASz and FHx group were found to differ significantly on ethnicity (p≤0.05) 
and socioeconomic status (p≤0.006).  
5.3.2 Factors associated with salivary cortisol measures 
Preliminary analyses were conducted in the total sample to identify 
sociodemographic factors associated with salivary cortisol. Analyses indicated that 
cortisol AUCi-CAR and AUCg-DAY values were not significantly associated with age, 
sex, ethnicity, pubertal status, tobacco use, or time of awakening (p≥0.10). However, 
there was a significant main effect of socioeconomic status on AUCg-DAY values    
(F[2, 82]=6.31, p=0.003); post-hoc tests indicated that children classed in the highest 
socioeconomic category (i.e., whose caregivers were employed in higher managerial, 
administrative, or professional occupations) had significantly lower AUCg-DAY 
values relative to children in the intermediate socioeconomic category (p=0.001). 
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5.3.3 Group differences in the cortisol awakening response 
Figure 9 presents the mean cortisol values for the individual CAR time-points by 
group. Visual inspection of these data suggested that FHx children showed a smaller 
increase in cortisol during the first 15 minutes after awakening, and subsequently, a 
steeper decline in cortisol levels between 15 and 30 minutes compared to the TD 
group. In contrast, ASz children showed a similar pattern of post-awakening cortisol 
secretion to TD children. Mean AUCi-CAR values are presented in Table 21. Relative 
to the TD group, AUCi-CAR values were significantly lower in the FHx group (d=-0.73, 
p=0.01), reflecting a blunted CAR among FHx children. Post-hoc tests showed that 
magnitude of differences between FHx and TD children was twice as large among 
FHx children with a first-degree relative with schizophrenia (d=-1.09, p=0.005) 
compared to those with an affected second-degree relative (d=-0.50, p=0.14). 
Adjustment for demographic factors led to a substantial reduction in the effect of FHx 
status (d=-0.12, p=0.70). AUCi-CAR values did not differ between ASz and TD children 
(d=-0.19, p=0.42), with no change after adjustment for demographic factors. 
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Table 21. Linear regression analyses examining the effect of risk status on the cortisol awakening response 








ASz vs. TD FHx vs. TD 
 d B (95% CI) p d B (95% CI) p 
AUCi-CAR (nmol 
min/L); mean ± SE 
81.2 ± 39.0 -33.8 ± 52.5 121.6 ± 32.2 Unadjusted -0.19 -40.4 (-140.3 – 59.5) 0.42 -0.73 -155.3 (-272.2 – -38.4) 0.01 
   Adjusted -0.08 -16.1 (-135.2 – 102.9) 0.79 -0.12 -26.2 (-161.6 – 109.2) 0.70 
Note. Four ASz+FHx cases are included in both groups. d: standardised effect size; B: unstandardised regression coefficient. a Linear regression analyses without 
adjustment for potential confounders (unadjusted) and adjusted for sex, ethnicity, and socioeconomic status (adjusted).  
 
 
Table 22. Stratified analyses examining risk status and the cortisol awakening response 
Note. d: standardised effect size. * Independent samples t-tests. 














 ASz vs. TD FHx vs. TD  ASz vs. TD FHx vs. TD 
    d p d p     d p d p 
Male 56.7 ± 28.4 -38.5 ± 61.2  56.4 ± 26.5 0.00 1.00 -0.62 0.18 White    53.4 ± 68.9 136.5 ± 47.5 139.4 ± 38.7 -0.37 0.25 -0.01 0.98 
Female 143.7 ± 120.9 -28.5 ± 91.1 169.7 ± 50.6 -0.09 0.82 -0.77 0.05 Other  105.6 ± 42.5  -87.0 ± 62.1   60.3 ± 49.3 0.27 0.52 -0.67 0.12 
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Sex and ethnicity were significant predictors of AUCi-CAR values in multiple 
regression analyses and their inclusion in the model substantially reduced the effect 
of FHx status. Stratified analyses were therefore conducted to further examine the 
influence of these variables on the relationship between risk status and the CAR 
(Table 22). The pattern of lower AUCi-CAR values among FHx children relative to TD 
children was present in both males and females with moderate-to-large effect sizes 
(d=-0.62 and -0.77, respectively), although group differences only achieved statistical 
significance in females. In contrast, in both males and females, AUCi-CAR values did 
not differ between ASz and TD children (p>0.82). As previously, ethnicity groups 
were combined to derive two summary groups: ‘white’ (including ‘white British’ and 
‘white other’) and ‘other’ (including ‘black’ and ‘other’). Within the ‘other’ ethnicity 
group, FHx children continued to show lower AUCi-CAR values compared to the TD 
group, equating to a moderate effect size (d=-0.67, p=0.12). However, among children 
of ‘white’ ethnicity, FHx and TD children did not differ on AUCi-CAR values (d=-0.01, 
p=0.98). There were no differences between ASz and TD children on AUCi-CAR values 
when ‘white’ or ‘other’ groups were examined separately (p>0.25). 
5.3.4 Group differences in diurnal cortisol  
Mean cortisol values at awakening, 12:00 pm, and 20:00 pm are presented by group 
in Figure 10. When these data were inspected visually, all three groups appeared to 
exhibit an identical pattern of secretion throughout the day, with cortisol levels 
showing a sharp decrease between awakening and 12:00 pm, followed by a more 
gradual decline between midday and 20:00 pm. Mean AUCg-DAY values are 
presented by group in Table 23. Linear regression analyses indicated that there were 
no group differences in AUCg-DAY values when either ASz (d=0.21, p=0.38) or FHx 
groups (d=0.08, p=0.78) were compared to the TD group; results were unchanged 
after adjusting for demographic variables.  
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Table 23. Linear regression analyses examining the effect of risk status on diurnal cortisol  








ASz vs. TD FHx vs. TD 
 d B (95% CI) p d B (95% CI) p 
AUCg-DAY (nmol h/L); 
mean ± SE 
36.59 ± 3.14 34.47 ± 2.99 33.54 ± 1.79 Unadjusted 0.21 3.05 (-3.89 – 9.99) 0.38 0.08 0.92 (-5.71 – 7.56) 0.78 
   Adjusted 0.13 1.90 (-5.87 – 9.67) 0.63 -0.29 -3.24 (-10.87– 4.38) 0.40 
Note. Four ASz+FHx cases are included in both groups. d: standardised effect size; B: unstandardised regression coefficient. a Linear regression analyses without 
adjustment for potential confounders (unadjusted) and adjusted for sex, ethnicity, and socioeconomic status (adjusted).  
 

























ASz FHx TD 
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5.3.5 Cortisol and psychosocial stress  
Consistent with the data presented in Chapter 4, relative to the TD group, ASz and 
FHx children experienced a higher number of negative life events (p=0.007 and 
p=0.08, respectively) and obtained higher scores on the physical punishment scale 
p<0.005). ASz children also demonstrated higher scores on the total daily hassles 
frequency and distress scales (p≤0.001). Within-group correlation analyses were 
conducted to examine relationships between cortisol AUC values and psychosocial 
stress measures (Table 24). Across all three groups, AUCi-CAR values were not 
significantly associated with the total number of negative life events experienced 
(p≥0.30). However, among FHx children, AUCi-CAR values were positively correlated 
with the level of distress experienced in relation to negative life events at the time of 
the event (ρ=0.51, p=0.02) and with the level of distress experienced currently 
(ρ=0.52, p=0.02). In contrast, among TD children, AUCi-CAR values were negatively 
correlated with distress experienced at the time of the negative life event (ρ=-0.31, 
p=0.05). These variables were not significantly correlated among ASz children. AUCi-
CAR values were not associated with daily hassles or physical punishment, and none 
of the psychosocial stress measures were correlated with AUCg-DAY values (p≥0.10).  
 
Table 24. Correlations between cortisol and psychosocial stress 














Total No. negative life events 0.03 0.21 -0.03 0.09 0.04 0.27 
Life event previous distress -0.16 0.51* -0.31* 0.30 0.06 0.11 
Life event current distress -0.05 0.52* -0.27 -0.12 -0.05 0.20 
Daily hassles frequency scale 0.13 0.18 -0.12 0.10 0.00 0.18 
Daily hassles distress scale 0.16 0.17 0.00 -0.26 0.16 0.20 
Physical punishment  -0.03 -0.35 -0.11 -0.11 0.31 0.05 
Note. * p<0.05. 
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5.3.6 Cortisol and current psychopathology  
As previously (Chapter 4), ASz children were characterised by significantly higher 
scores on the CBCL internalising and externalising scales, the YSR externalising scale, 
and the PLE measure relative to the TD group (p<0.01). FHx children were not 
significantly different to the TD group on internalising or externalising symptoms 
(either CBCL or YSR), but obtained higher scores on the PLE measure (p=0.04). 
Within-group correlation analyses were conducted to examine associations between 
cortisol AUC values and current psychopathology (Table 25). Across all three groups, 
AUCi-CAR and AUCg-DAY values were not significantly correlated with internalising 
or externalising symptoms (either child- or caregiver-reported). AUCi-CAR values 
were moderately correlated with PLE scores in the FHx group, although this did not 
achieve statistical significance (ρ=0.37, p=0.10). Cortisol AUC values were not 
associated with PLEs in ASz children or in the TD group.  
 
Table 25. Correlations between cortisol and current psychopathology 














YSR Internalising scale 0.00 0.19 0.03 0.12 -0.11 0.16 
YSR Externalising scale -0.04 0.14 -0.17 -0.07 -0.22 0.23 
CBCL Internalising scale -0.15 -0.01 0.15 0.09 0.21 0.07 
CBCL Externalising scale -0.15 0.08 -0.08 0.06 0.21 0.26 
Psychotic-like experiences 0.12 -0.37 -0.03 0.17 -0.08 -0.26 





5.4 Discussion  
In the first study to examine the CAR in individuals at elevated risk for schizophrenia, 
children with a family history of illness, but not children presenting antecedents of 
schizophrenia, were characterised by a blunted CAR relative to their typically-
developing peers; an effect that appeared to be influenced by ethnicity. However, 
neither FHx nor ASz children were characterised by elevated diurnal cortisol levels 
relative to the TD group. The blunted CAR observed among FHx children was not 
explained by experiences of psychosocial stress; indeed, the CAR was positively 
correlated with distress relating to negative life events among FHx children but 
negatively correlated in the TD group. Neither the CAR nor cortisol levels during the 
day were associated with daily hassles or physical punishment. Furthermore, cortisol 
levels were not related to current psychopathology in any group.  
5.4.1 Comparison with previous research 
Cortisol awakening response 
The finding that FHx children were characterised by a blunted CAR relative to TD 
children converges with two recent studies which observed a blunted CAR in patients 
with first-episode psychosis compared to healthy controls (Mondelli et al., 2010a; 
Pruessner et al., 2013b). Adjustment for demographic factors indicated that sex and 
ethnicity may influence the relationship between risk status and the CAR; stratified 
analyses subsequently confirmed that the pattern of group differences was consistent 
across males and females but not across ethnic groups. In healthy adult and 
adolescent populations, lower cortisol levels upon awakening have been reported 
among individuals of black and Hispanic ethnicity relative to white participants 
(DeSantis et al., 2007; Hajat et al., 2010). Whilst these findings raise the possibility 
that the blunted CAR observed among FHx children might be due to the fact that 
these children were more likely to be of non-white ethnicity, this was not the case, in 
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fact, FHx status was still associated with a blunted CAR (with a moderate-to-large 
effect size) when the analysis was restricted to non-white participants. In contrast, 
there was no difference in the CAR when white FHx and white TD children were 
compared, which may reflect the small group sizes. Among the five FHx children who 
were of white ethnicity, only one had a first-degree relative with the disorder, whilst 
8 of the 17 non-white FHx children had an affected first-degree relative. Given that 
the effect of FHx status was twice as large among those with a first-degree relative 
with schizophrenia compared to those with a second-degree relative, this may have 
also contributed to the lack of group differences among children of white ethnicity. 
Diurnal cortisol 
In contrast, neither FHx nor ASz children were characterised by elevated diurnal 
cortisol levels relative to TD children, which contrasts with the elevated salivary 
cortisol levels reported among adult relatives of patients with psychosis (Collip et al., 
2011; Yıldırım et al., 2011), youth at UHR (Sugranyes et al., 2012; Walker et al., 
2013), adolescents with SPD (Walker et al., 2001; Mittal et al., 2007), and youth 
reporting PLEs (Mittal et al., 2013). This may be due to the participants being slightly 
younger (mean age: 13.1 years) than high-risk youth in previous studies (mean age 
range: 14.1-39.3 years). Longitudinal studies indicate that cortisol levels during the 
day increase during late childhood and through adolescence (Walker et al., 2001; 
Shirtcliff et al., 2012), thus, the elevation in diurnal cortisol levels observed in high-
risk youth relative to their healthy peers may not emerge until later in adolescence. 
Cortisol and psychosocial stress  
Cortisol levels were not correlated with the number of life events experienced or 
with the frequency of daily hassles in any group. A previous study of UHR youth also 
observed no relationship between the number of life events and cortisol, although 
cortisol levels were positively associated with the number of daily hassles 
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(Thompson et al., 2007). One possible explanation for the lack of association 
observed between cortisol levels and daily hassles in the current study is that the 
latter were not always assessed on the day of cortisol collection. For example, a large 
study of adults which obtained concurrent measures of salivary cortisol and daily 
hassles, reported that cortisol levels were significantly higher on days when 
participants experienced daily stressors compared to stress-free days (Stawski et al., 
2013). In contrast, among FHx and TD children, the CAR was correlated with distress 
relating to negative life events (although, as discussed below, the pattern of 
association was different across the two groups). The negative association between 
the CAR and distress relating to negative life events that was observed among TD 
children is consistent with previous studies which have reported that higher levels of 
subjective distress relating to chronic stressors are associated with lower morning 
cortisol levels (Miller et al., 2007).  
Cortisol and current psychopathology 
Cortisol levels were not significantly correlated with PLEs in ASz, FHx, or TD children. 
Studies of UHR youth have also observed that cortisol levels are not associated with 
psychotic or prodromal symptoms (Thompson et al., 2007; Corcoran et al., 2012; 
Sugranyes et al., 2012). In contrast, the largest study of UHR youth reported that 
salivary cortisol levels were significantly correlated with positive and negative 
psychotic symptoms (Walker et al., 2013). Furthermore, two studies examining 
adolescents with SPD, other personality disorders, and no personality disorders 
observed that salivary cortisol levels were associated with negative symptoms 
(Weinstein et al., 1999) and SPD symptoms (Walker et al., 2001). However, this may 
reflect the fact that correlations were performed across the total sample of healthy 
and at-risk youth (i.e., the fact that these groups differ on both cortisol levels and 
psychopathology may have contributed to the association).  
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The finding that cortisol levels were unrelated to internalising and externalising 
symptoms contrasts with previous studies of children and adolescents which have 
typically shown that elevated cortisol during the day is positively associated with 
depression (Lopez-Duran et al., 2009) and negatively correlated with externalising 
problems (Susman, 2006). Similarly, cortisol levels were found to be positively 
correlated with depression and anxiety symptoms in two previous studies of UHR 
youth (Thompson et al., 2007; Corcoran et al., 2012). However, not all studies of 
children and adolescents have observed this pattern, and it has been suggested that 
this may be due to studies not accounting for sex and symptom comorbidity 
(Marsman et al., 2008). Thus, the lack of significant associations in the current study 
may reflect the fact that correlations were examined across males and females and 
were not adjusted for the presence of other symptoms.  
5.4.2 Potential mechanisms 
Genetic influence on the CAR 
One possible explanation for the fact that FHx children, but not ASz children, were 
characterised by a blunted CAR relative to the TD group is that this reflects a 
genetically-mediated effect. For example, a study of individuals at increased risk of 
developing PTSD on account having parents with the disorder observed lower 
cortisol levels among offspring (a consistent finding among individuals with PTSD) 
even though they had not been exposed to trauma themselves (Yehuda et al., 2000). 
The fact that the effect of FHx status was twice as large among those with a first-
degree relative with schizophrenia than among those with a second-degree relative is 
consistent with this hypothesis (although, children with a first-degree relative are 
also likely to be living with their affected relative, which may in itself be more 
stressful). That FHx children were not also characterised by elevated diurnal cortisol 
levels may be due to the fact that the CAR is under more genetic control. Indeed, twin 
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studies in both adult and adolescent populations indicate that cortisol levels upon 
awakening and during the morning (Bartels et al., 2003) and the CAR (Wust et al., 
2000) are influenced by genetic factors, whilst cortisol levels later in the day are not. 
Of note, the fact that distress relating to negative life events was positively and 
not negatively correlated with the CAR among FHx children, suggests that the greater 
levels of distress experienced by FHx children relative to TD children cannot account 
for the blunted CAR observed among FHx children. Again, this is consistent with a 
previous study which observed that the CAR was positively correlated with the 
presence of childhood trauma among patients with first-episode psychosis (Mondelli 
et al., 2010a). Taken together, these lines of evidence indicate that the blunted CAR 
that has been described both in patients with psychosis (Mondelli et al., 2010a), and, 
in the current study, among children at elevated risk for the disorder, is not driven by 
the excess of psychosocial stressors but rather may reflect the expression of a genetic 
predisposition. 
Effect of psychosocial stress on cortisol levels 
The current study identified a dissociation between psychosocial stress and cortisol 
among FHx and TD children; distress relating to negative life events was negatively 
correlated with the CAR in the TD group whilst a positive correlation was observed 
among FHx children. As described above, the same pattern was observed between 
the CAR and childhood trauma in a sample of individuals with first-episode psychosis 
(Mondelli et al., 2010a); furthermore, this study also reported a negative correlation 
between diurnal cortisol and the number of recent stressful events in the patient 
group but a positive correlation among healthy controls. The different pattern 
observed among FHx and TD children may be influenced by ethnicity; for example, 
cortisol responses to psychosocial stress and perceived discrimination have been 
found to differ across ethnic groups (Chong et al., 2008; Suglia et al., 2010; Fuller-
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Rowell et al., 2012). However, ASz children were also significantly different to TD 
children on ethnicity, but did not show the same pattern of association between the 
CAR and distress relating to negative life events as FHx children. Furthermore, 
although it has been observed that the lapse of time between stressor exposure and 
cortisol measurement influences the extent to which morning cortisol levels are 
positively or negatively associated with stress exposure (Miller et al., 2007), the 
negative life events experienced by TD children did not occur more recently than 
those experienced by FHx children. Thus, one possible explanation for the observed 
dissociation is that psychosis (and psychosis vulnerability) influences the effect of 
psychosocial stress on HPA axis function. This may relate to how these stressful 
events are appraised; for example, the degree to which stressors are viewed as 
potentially controllable or uncontrollable has been associated with higher and lower 
morning cortisol levels, respectively (Miller et al., 2007). Alternatively, genetic 
mechanisms may have contributed to the divergent pattern of findings observed 
among FHx and TD children. 
5.4.3 Methodological considerations 
As previously, this section describes the methodological issues that are relevant to 
the data presented in this chapter only. A more comprehensive discussion of the 
issues that influence the overall study is provided in the final chapter of this thesis. 
One potential limitation relates to the fact that saliva samples were collected at 
weekends or during school holidays to improve the likelihood of protocol 
compliance. Studies in adults have shown that the CAR is more pronounced on 
weekdays compared to weekends (Kunz-Ebrecht et al., 2004; Schlotz et al., 2004); 
however, as all participants collected samples at weekends or during school holidays, 
this would not affect group differences (although, it is possible that the unstructured 
nature of the homes of FHx children at weekends was more pronounced than in TD 
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children). As acknowledged above, a further limitation relates to the fact that 
psychosocial stressors (particularly daily hassles) were not always assessed on the 
day of cortisol collection. Again, as the groups did not differ on the lapse of time 
between psychosocial stress assessment and saliva sample collection, this would 
have affected all groups equally. Finally, the study was not able to examine the 
relationship between HPA axis function and more severe forms of psychosocial stress 
such as childhood maltreatment, which has been implicated in the development of 
psychosis (Schafer & Fisher, 2011) and associated with a blunted cortisol response to 
stress (Ouellet-Morin et al., 2011). 
5.4.4 Conclusions  
The current study provides evidence that HPA axis dysfunction, as indexed by a 
blunted CAR, characterises children at elevated risk for psychosis who are not 
currently exhibiting help-seeking behaviour. That this was only observed among FHx 
and not ASz children, and was more pronounced among FHx children with a first-
degree relative with schizophrenia, raises the possibility that the blunted CAR may be 
a genetically-mediated effect; although environmental factors may also have 
contributed to this finding. In contrast to the findings in older samples of UHR youth 
and adolescents with SPD, neither FHx nor ASz children displayed elevated diurnal 
cortisol levels. Thus, the blunted CAR may be an early (possibly genetically-
mediated) marker of HPA axis dysfunction, whilst elevated diurnal cortisol levels 
may emerge later, closer to disease onset. Longitudinal follow-up of this cohort is 
necessary to confirm this hypothesis. The results described in this chapter are 
consistent with previous studies of patients with first-episode psychosis, and thus 
further support the notion that at least some HPA axis changes precede the onset of 
illness, rather than being a subsequent epiphenomenon.  
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CHAPTER 6 Pituitary volume in children at elevated risk for 
schizophrenia 
6.1 Introduction 
Pituitary gland volume has also been used as an index of HPA axis function among 
individuals with psychosis. Cross-sectional studies have reported enlarged pituitary 
volumes in individuals with first-episode psychosis relative to healthy controls 
(Pariante et al., 2004; Pariante et al., 2005; Büschlen et al., 2011; Takahashi et al., 
2011), and smaller volumes among patients with established schizophrenia (Pariante 
et al., 2004; Upadhyaya et al., 2007). However, not all studies have observed this 
pattern of findings (Nicolo et al., 2010; Gruner et al., 2012; Klomp et al., 2012), and 
inconsistencies may relate to differences in illness stage and antipsychotic use.  
Studies examining individuals at elevated risk for schizophrenia have also yielded 
conflicting findings, which may again relate to differences in medication use and 
proximity to illness onset. Relative to healthy controls, enlarged pituitary volume has 
been observed among adults with a family history of schizophrenia (Mondelli et al., 
2008) and patients with SPD (Takahashi et al., 2009). However, other studies have 
shown no differences between adult relatives and controls (Habets et al., 2012), and 
smaller pituitary volumes among males with SPD (Romo-Nava et al., 2013). Studies of 
youth at UHR indicate that pituitary volumes across the total sample of UHR youth do 
not differ to healthy controls (Garner et al., 2005; Büschlen et al., 2011), but that 
those who later transition to psychosis show enlarged pituitary volumes. Whilst 
these studies provide some evidence to suggest that high-risk individuals are 
characterised by abnormal pituitary volume, the extent to which this reflects stress-
induced HPA axis dysfunction is unclear. Previous studies of young adults with a 
family history of psychosis (Habets et al., 2012) and youth at UHR (Thompson et al., 
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2007) have observed no relationship between pituitary volume and cortisol during 
the day. Furthermore, the only study of high-risk individuals to examine the 
relationship between pituitary volume and psychosocial stress reported only a weak 
association between pituitary volume and emotional stress reactivity (Habets et al., 
2012). However, pituitary volume has been associated with exposure to childhood 
maltreatment in youth with PTSD and borderline personality disorder (Thomas & De 
Bellis, 2004; Garner et al., 2007). One consistent finding across all high-risk groups is 
that pituitary volumes do not appear to be associated with psychotic symptoms. 
Chapter aims 
This chapter examines pituitary gland volume in medication-naive children at 
elevated risk for schizophrenia. The aim was to determine whether children 
presenting multiple antecedents of schizophrenia (ASz) and those with a family 
history of illness (FHx) are characterised by abnormal pituitary volumes relative to 
typically-developing (TD) children. An additional aim was to determine the extent to 
which pituitary volume is associated with cortisol levels and experiences of 
psychosocial stress among at-risk children. 
Hypotheses 
3a. Both ASz and FHx children will show abnormal pituitary gland volume 
relative to TD children.  
3b.  Among ASz and FHx children, pituitary volume will be correlated with 
salivary cortisol levels.  
3c.  Pituitary volume will be associated with exposure to psychosocial stressors 
and distress related to these exposures in ASz and FHx children. 
3d.  No relationship between pituitary volume and current psychopathology will 




6.2.1 Participants and procedure 
As described in detail in Chapter 3, a novel community-screening procedure was used 
to identify ASz and TD children (Laurens et al., 2007; Laurens et al., 2011). FHx 
children were identified either via the caregiver screening questionnaire, which 
included items assessing family mental health difficulties, or as child relatives of 
individuals with schizophrenia or schizoaffective disorder identified via medical 
records. ASz, FHx, and TD children were invited to participate in a longitudinal study 
of child development. This chapter examines pituitary volume obtained from 
structural MRI scans collected at the 24-month assessment.  
6.2.2 Pituitary gland measurement 
Image acquisition  
Participants completed a one hour MRI scanning session which included a structural 
scan and four functional MRI tasks. Scans were conducted on a 3T General Electric 
Medical Systems MRI scanner (General Electric, Milwaukee, Wisconsin, USA) based at 
the Centre for Neuroimaging Sciences, Institute of Psychiatry. An 8-channel coil was 
used for radio detection frequency. Structural images were acquired using a five 
minute, three-dimensional Spoiled Gradient Recalled Echo (SPGR) sequence yielding 
196 slices of 1.1 mm thickness. Imaging parameters were as follows: time-to-
repetition = 6.0 msec, time-to-echo = 2.8 msec, flip angle = 20°, field-of-view = 28 x 21 
cm, acquisition matrix = 256 x 256. 
Measure software and image processing 
Pituitary gland volume was obtained using Measure (version 0.8, John Hopkins 
University, Baltimore, MD, USA), a structural MRI processing and analysis software 
programme. Anonymised scans were imported into Measure and the pituitary gland 
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was then manually traced on each scan using the stereological Cavalieri method 
employing a point counting procedure. In brief, the Cavalieri method uses parallel 
plane sections, beginning at a randomly chosen start point, to create equally-spaced 
sections throughout the brain; the surface area on each slice is then estimated and 
multiplied by the section thickness to provide a volume for the structure (Sonmez et 
al., 2010). Appling the Cavalieri method in conjunction with the point counting 
procedure is considered to be an unbiased method and more reliable and efficient 
than traditional region-of-interest drawing techniques (Howard et al., 2000).  
Structural MRI data were processed according to an established procedure 
(Measure Standardised Operating Procedures, Institute of Psychiatry, London, UK). 
Images were first aligned to the anterior commissure - posterior commissure (AC-PC) 
line and standard contrast settings applied. For each scan slice, a grid of pixels was 
then superimposed on the image and pixels that fell within the pituitary gland 
(defined as more than 60% of the pixel falling within the boundary of the structure) 
were selected. Figure 11 shows the pituitary gland, as visualised in Measure, in the 
coronal, axial, and sagittal view. Measure guidelines specify that the minimum 
number of pixels needed to reliably estimate the volume of a given structure is 200, 
thus, the smallest grid setting (1x1x1) was used in order to ensure sufficient pixels 
within the pituitary gland. Traces were performed in the coronal view, using 
information from the sagittal and axial view for clarification. Pixels were selected on 
each slice on which the pituitary gland could be visualised. Total volumes (mm3) 







Figure 11. The pituitary gland as visualised in Measure 
Note. Coronal (top), sagittal (middle), and axial (bottom) view of 
a structural MRI image in Measure with superimposed pixel 
grid. Pixels falling within the boundaries of the pituitary gland 




Anatomical boundaries of the pituitary gland were determined using a protocol 
implemented in previous studies (Pariante et al., 2004; Pariante et al., 2005; Mondelli 
et al., 2008). The measurements excluded the pituitary stalk but included the 
posterior bright spot (where visible) which is thought to correspond to the posterior 
pituitary. The superior and inferior boundaries of the pituitary were defined by the 
diaphragma sellae and the sphenoid sinus, respectively. The cavernous sinuses were 
used to indicate the lateral boundaries. Training was provided by an experienced 
researcher (FD, see acknowledgements) with expertise in tracing the pituitary gland 
in youth at UHR for psychosis. The inter-rater reliability (based on 10 scans) was 
0.97, indicating a high level of reliability with other raters.  
Total intracranial volume 
Total intracranial volume (ICV) was obtained using Statistical Parametric Mapping 5 
software (SPM5; www.fil.ion.ucl.ac.uk/spm/software/spm5). Images were first 
segmented in SPM5 using a study-specific template created within the Template-O-
Matic (TOM) toolbox (https://irc.cchmc.org/software/tom.php). Specifically, brain 
images used to create the template were derived from reference data obtained from 
404 healthy children (Wilke et al., 2008), who were selected according to the age and 
sex characteristics of the total sample of participants in the current study. Total grey 
matter, white matter, and cerebrospinal fluid volumes were obtained from 
segmented images and summed to derive a total ICV for each participant.  
6.2.3 Salivary cortisol    
Salivary cortisol assessments were completed within six months of scanning (mean 
lapse of time assessments: ± 0.9 months). Full details of the cortisol sampling 
protocol are provided in Chapter 5. In brief, participants collected six saliva samples 
throughout the day on two consecutive days: upon awakening, at 15, 30, and 60 min 
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after awakening, and at 12:00 pm and 20:00 pm. Cortisol data obtained at individual 
time-points were summarised using two area under the curve (AUC) computations 
(Pruessner et al., 2003): (i) AUC with respect to the increase in cortisol levels 
following awakening (AUCi-CAR), and (ii) AUC with respect to ground of cortisol 
levels during the day (AUCg-DAY).  
6.2.4 Psychosocial stress 
As described in Chapter 4, participants completed measures assessing exposure and 
distress relating to a range of child-appropriate negative life events and school-
related daily hassles (Heubeck & O’Sullivan, 1998). Physical punishment was 
assessed using the corporal punishment scale of the Alabama Parenting 
Questionnaire [APQ (Shelton et al., 1996)], completed by children and their 
caregivers at both the baseline and 24-month assessment phases. Whilst salivary 
cortisol levels show rapid fluctuations in response to environmental stimuli, pituitary 
volume is thought to provide a more stable measure of HPA axis activity; thus, in 
order to provide a more comprehensive index of exposure to physical punishment, 
both baseline and 24-month assessment data were examined in this chapter. As 
previously described, a dichotomous variable was created from the three physical 
punishment items (spanking, slapping, and hitting with an object) in order to 
incorporate information from both informants (child and caregiver) and both 
assessment phases (baseline and 24-month).  
6.2.5 Current psychopathology  
As described in Chapter 3, externalising and internalising symptoms were assessed 
using the Child Behaviour Checklist [CBCL (Achenbach & Rescorla, 2001)] and the 
Youth Self-Report (YSR), completed by the caregiver and the child, respectively. 
Children also re-completed the nine-item PLE measure (Laurens et al., 2012), with 
scores on each item summed to provide a total PLE score (range: 0-18).  
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6.2.6 Growth and pubertal status 
Body Mass Index (BMI; kilograms/metres2) was computed from height and weight 
data obtained by a researcher at the MRI session. As described in Chapter 5, pubertal 
development was assessed using the self-report Pubertal Developmental Scale 
(Carskadon & Acebo, 1993). An average score was created from the five items, with 
higher scores indicating more advanced pubertal development. Scores on three of the 
items were summed and used to assign participants to a Tanner stage (Tanner, 1962) 
and a dichotomous variable was subsequently created (pubertal: Tanner stage 1-4 vs. 
post-pubertal: Tanner stage 5), based on previous studies (Ekelund et al., 2006).  
6.2.7 Statistical analyses 
Group differences on demographic variables, cortisol levels, psychosocial stress 
measures, and current psychopathology were examined using independent samples 
t-tests, Mann-Whitney U tests, chi-squared tests, and Fisher’s exact tests. 
Independent samples t-tests, one-way ANOVAs, and correlation analyses were used 
to explore associations between pituitary volume and demographic variables. 
As pituitary gland volumes were approximately normally distributed, the effect of 
risk status on pituitary gland volume was examined using linear regression analyses. 
As previously, the effect of each high-risk group was tested independently (i.e., ASz 
and FHx groups were examined relative to the TD group but were not directly 
compared to each other). Analyses were subsequently adjusted for factors that were 
associated in preliminary analyses with group status or pituitary volume. 
Unstandardised regression coefficients from both unadjusted and adjusted analyses 
were used to derive standardised mean differences (d) as indices of effect size 
(Lipsey & Wilson, 2001). Where adjustment for demographic factors led to a 
substantial change in the effect size associated with risk status (change in d > 0.30), 
stratified analyses were performed to further explore the effect of these variables.  
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Within-group correlation analyses were conducted to examine the extent to 
which pituitary volume was associated with cortisol levels, psychosocial stress, and 
current psychopathology. Pearson’s ‘r’ correlation analyses were used for normally 
distributed variables (cortisol AUC values, total daily hassle frequency and distress 
scales, number of negative life events, and YSR scores) and Spearman’s rho ‘ρ’ 
correlation analyses for non-normally distributed variables (negative life event 
distress scales, and CBCL and PLE scores). Within-group independent samples t-tests 
were used to examine the relationship between physical punishment and pituitary 
volume. All analyses were conducted using the Statistical Package for the Social 
Sciences (SPSS) version 20.  
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 ASz vs. TD FHx vs. TD 
Age (years); mean ± SE 13.1 ± 0.2 13.3 ± 0.2 13.0 ± 0.2 t=-0.49 p=0.62 t=-1.16 p=0.25 
Time lapse: screening to MRI scan (years); mean ± SE 2.8 ± 0.2 2.6 ± 0.2 2.7 ± 0.1 t=-0.77 p=0.45 t=0.36 p=0.72 
Pubertal development scale score; mean ± SE a 2.4 ± 0.1 2.4 ± 0.1 2.3 ± 0.1 t=-0.97 p=0.34 t=-0.80 p=0.43 
Weight (kg); mean ± SE 54.8 ± 2.7 51.7 ± 2.6 49.1 ± 1.9 U=314.0 p=0.07 U=265.0 p=0.45 
BMI (kg/m2); mean ± SE 20.7 ± 0.6 19.7 ± 0.7 19.7 ± 0.5 t=-1.19 p=0.24  t=-0.01 p=0.99 
Total intracranial volume (L3); mean ± SE 2.0 ± 0.0 2.0 ± 0.0 2.0 ± 0.0 t=-0.20 p=0.84  t=1.00 p=0.32  
Sex (male); n (%) 20 (67) 11 (50) 15 (47) χ2=2.47 p=0.13 χ2=0.05 p=1.00 
Ethnicity; n (%)       FE=11.44 p=0.008 FE=21.79 p<0.001 
White British 6 (20) 2 (9) 18 (56)     
White other 7 (24) 2 (9) 8 (25)     
Black  4 (13) 9 (41) 2 (6)     
Other 13 (43) 9 (41) 4 (13)     
Socioeconomic status; n (%) b        FE=11.43 p=0.002 FE=12.82 p=0.001 
Higher managerial, administrative, and professional 13 (43) 10 (45) 27 (84)     
Intermediate  11 (37) 3 (14) 4 (13)     
Routine and manual  6 (20) 9 (41) 1 (3)     
Note. Five ASz+FHx cases are included in both groups. BMI: Body Mass Index; FE: Fisher’s exact. a Mean scores in all groups equate to mid-pubertal stage.           




6.3.1 Sample characteristics  
Pituitary volumes were obtained for 79 children in total; of these, 25 met ASz criteria 
only, 17 met FHx criteria only, 5 met both ASz and FHx criteria, and 32 met TD 
criteria. The five ASz+FHx cases were included in both the ASz and FHx groups, 
yielding data for 30 ASz and 22 FHx children in total. Sample characteristics are 
presented by group in Table 26. Neither the ASz nor FHx group were different to the 
TD group on age, lapse of time between screening and MRI scan, sex, pubertal status, 
BMI, or total ICV (p>0.10); however, the mean weight of the ASz group was higher 
than that of the TD group which was significant at the trend level (p=0.07). Relative 
to the TD group, both the ASz and FHx group were found to differ significantly on 
ethnicity (p≤0.008) and socioeconomic status (p≤0.001).     
6.3.2 Factors associated with pituitary gland volume 
Preliminary analyses were conducted in the total sample to identify 
sociodemographic factors that were associated with pituitary gland volume. 
Correlation analyses indicated that pituitary volume was not significantly associated 
with age or total ICV (p>0.10). However, pituitary volume was significantly 
correlated with weight (ρ=0.26, p=0.02) and pubertal status (r=0.38, p=0.001), and 
with BMI at the trend level (ρ=0.21, p=0.07). As anticipated, females had significantly 
larger pituitary gland volumes than males (mean ± SE: 504.8 ± 27.4 vs. 372.8 ± 26.4, 
respectively; t=-3.47, p=0.001). There was no significant main effect of ethnicity           
(F[3, 75]=1.17, p=0.33) or socioeconomic status (F[2, 76]=0.05, p=0.96) on pituitary 




6.3.3 Group differences in pituitary gland volume 
Pituitary volumes are presented by group in Figure 12 and Table 27. No differences 
in pituitary volume were observed when either ASz children (d=-0.12, p=0.64) or FHx 
children (d=0.04, p=0.89) were compared to the TD group. A substantial change in 
the effect size associated with FHx status was observed after adjustment for 
demographic factors (d=-0.29, p=0.46). As sex and pubertal status were found to be 
significantly associated with pituitary volume in preliminary analyses, stratified 
analyses were conducted to examine the influence of these variables on the 
relationship between risk status and pituitary volume. As shown in Table 28, neither 
ASz nor FHx children differed to the TD group on pituitary volume when males and 
females were examined separately (p>0.80). Similarly, analyses conducted within 
pubertal strata (pubertal vs. post-pubertal) indicated that there were no group 
differences in pituitary volume when either ASz or FHx children were compared to 
the TD group (p>0.40).  
 
            
Figure 12. Pituitary volume by group 































                  ASz                     FHx                          TD 
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Table 27. Linear regression analyses examining the effect of risk status on pituitary volume 








ASz vs. TD FHx vs. TD 
 d B (95% CI) p d B (95% CI) p 
Pituitary volume (mm3); 
mean ± SE 
418.7 ± 29.2 447.7 ± 40.4 440.5 ± 35.3 Unadjusted -0.12 -21.8 (-114.1 – 70.5) 0.64  0.04 7.3 (-101.5 – 116.0) 0.89 
   Adjusted -0.26 -45.0 (-151.4 – 61.4) 0.40 -0.29 -54.3 (-199.4 – 90.8) 0.46 
Note. Five ASz+FHx cases are included in both groups. d: standardised effect size; B: unstandardised regression coefficient. a Linear regression analyses without 
adjustment for potential confounders (unadjusted) and adjusted for sex, ethnicity, socioeconomic status, pubertal developmental scale score, and weight 
(adjusted).  
 
Table 28. Stratified analyses examining risk status and pituitary volume 
 Note. d: standardised effect size. * Independent samples t-tests. Pubertal strata based on Tanner stages (Tanner, 1962); pubertal: includes pre-pubertal to late-
pubertal (Tanner stage 1–4); post: post-pubertal (Tanner stage 5).














 ASz vs. TD FHx vs. TD  ASz vs. TD FHx vs. TD 
       d p    d p       d p d p 
Male 375.7 ± 27.8 379.3 ± 54.5  360.0 ± 56.2 0.09 0.80 0.10 0.81 Pubertal  387.5 ± 27.5 369.2 ± 48.8 403.4 ± 46.4 -0.09 0.76 -0.17 0.63 
Female 504.5 ± 61.2 516.2 ± 54.3  511.5 ± 38.0 -0.04 0.92 0.03 0.94 Post 521.1 ± 79.3 561.2 ± 51.0 502.3 ± 51.3 0.10 0.84 0.35 0.44 
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6.3.4 Pituitary volume and salivary cortisol 
Consistent with the data presented in Chapter 5, AUCi-CAR values were significantly 
lower in the FHx group relative to the TD group (p=0.004), reflecting a blunted CAR 
among FHx children. There were no significant group differences in AUCg-DAY values 
when either the ASz or FHx group were compared to the TD group (p>0.40). 
Correlation analyses were conducted to examine the relationship between pituitary 
volume and cortisol AUC measures (Table 29). There was a strong, positive 
correlation between AUCi-CAR values and pituitary volume in the ASz group (r=0.52, 
p=0.005), indicating that a larger pituitary volume was associated with a greater CAR. 
Positive correlations between AUCi-CAR values and pituitary volume were also 
observed in the FHx and TD groups, although these associations were weaker and not 
statistically significant. In contrast, no relationship was observed between pituitary 
gland volume and AUCg-DAY values in any of the groups (p>0.30).  
 
Table 29. Correlations between pituitary volume and salivary cortisol 








AUCi-CAR (cortisol awakening response) 0.52**   0.21   0.17 
AUCg-DAY (cortisol levels during the day) 0.04 -0.27 -0.03 




6.3.5 Pituitary volume and psychosocial stress 
Consistent with the pattern of group differences observed in Chapter 4, ASz and FHx 
children were exposed to a greater number of negative life events than the TD group 
(p<0.04) and ASz children also reported that they more frequently experienced daily 
hassles and were more distressed by these hassles than TD children (p<0.004). 
Correlation analyses were conducted to determine the extent to which pituitary 
gland volume was associated with negative life events and daily hassles within each 
group (Table 30). Pituitary volume was not significantly associated with the number 
of negative life events experienced in any of the three groups. However, among FHx 
children only, there was a significant negative correlation between pituitary gland 
volume and current distress relating to negative life events (ρ=-0.42, p=0.05), 
indicating that smaller pituitary volume was associated with greater distress relating 
to these events. Pituitary volume was not significantly associated with either daily 
hassles frequency or distress scores in any group.  
 
Table 30. Correlations between pituitary volume and psychosocial stress 








Total number of negative life events  0.20 -0.33 -0.15 
Distress at the time of negative life event  0.04 -0.18 -0.11 
Current distress related to negative life event         -0.22 -0.42* -0.05 
Frequency of daily hassles       -0.06 0.10 -0.19 
Distress related to daily hassles         0.06 0.29  0.17 





6.3.6 Pituitary volume and physical punishment 
As previously, physical punishment was more common among ASz (p=0.002) and 
FHx children (p=0.002) than TD children. Within-group independent samples t-tests 
were performed to compare pituitary volumes between those who had been exposed 
to physical punishment and those who had not (Table 31). Among FHx children, 
those who had experienced physical punishment had significantly smaller pituitary 
volumes compared to children who had not, equating to a large effect size (d=-1.01, 
p=0.03). In the ASz and TD groups, however, there was no association between 
pituitary volume and exposure to physical punishment (p>0.60).  
Table 31. Pituitary volume and physical punishment 
 Pituitary gland volume (mm3)    
Risk group  





d Statistics * 
ASz (16/14); mean ± SE 405.5 ± 43.9   433.8 ± 38.8 -0.18 t=0.48 p=0.64 
FHx (12/10); mean ± SE 367.1 ± 55.5   544.6 ± 44.1 -1.04 t=2.43 p=0.03 
TD (5/27); mean ± SE 463.7 ± 114.0   436.2 ± 37.3  0.14 t=-0.28 p=0.78 
Note. d: standardised effect size. a Parentheses indicate number exposed to physical 
punishment / number not exposed. * Independent samples t-tests.  
 
Sensitivity analyses were conducted to explore the association between pituitary 
volume and more severe forms of physical punishment. Severe physical punishment 
was experienced by 8 (27%) ASz children, 8 (36%) FHx children, and none of the TD 
group; prevalence rates were significantly higher among both ASz (χ2=9.80, p=0.002) 
and FHx children (Fisher’s exact, p<0.001) compared to TD children. As illustrated in 
Figure 13, FHx children exposed to severe physical punishment had significantly 
smaller pituitary volumes compared to FHx children who had not (t=2.58, p=0.02), 
equating to an even larger effect size (d=-1.11). Again, pituitary volume was not 




            Figure 13. Pituitary volume and severe physical punishment 
Note. nSPP: not exposed to severe physical punishment; SPP: exposed 
to severe physical punishment; d: standardised effect size. 
   
6.3.7 Pituitary volume and current psychopathology  
Relative to the TD group, ASz children were characterised by significantly higher 
scores on all psychopathology measures (p<0.03) whilst FHx children obtained 
higher PLE scores (p=0.05). Within-group correlation analyses conduced to explore 
the association between pituitary volume and current psychopathology did not 
identify any significant relationships in any group (Table 32).  
 
Table 32. Correlations between pituitary volume and current psychopathology 








YSR Internalising scale (child-report)  0.04 0.05 0.09 
YSR Externalising scale (child-report) -0.26 0.06 -0.16 
CBCL Internalising scale (caregiver-report) -0.10 0.11 -0.09 
CBCL Externalising scale (caregiver-report) -0.08 0.21 -0.28 
Psychotic-like experiences (child-report) -0.03 0.07 0.04 





































6.4 Discussion  
This is the first study to examine pituitary volume among children at elevated risk for 
schizophrenia. In contrast to hypotheses, neither children with a family history of 
illness nor children presenting antecedents of schizophrenia were characterised by 
abnormal pituitary volume relative to their typically-developing peers. Pituitary 
volume was not generally associated with salivary cortisol levels, although a positive 
correlation was observed with the CAR in the ASz group only. Furthermore, among 
FHx children, pituitary volume was negatively associated with current distress 
relating to negative life events and with exposure to physical punishment. However, 
as anticipated, no significant associations between pituitary volume and current 
psychopathology were observed in any group. 
6.4.1 Comparison with previous research  
Pituitary volume 
The finding that neither FHx nor ASz children were characterised by abnormal 
pituitary volume relative to the TD group is consistent with some previous studies of 
individuals at elevated risk for schizophrenia, but not all. Mondelli and colleagues 
observed significantly larger pituitary volumes among adult relatives of patients with 
schizophrenia (Mondelli et al., 2008), yet a subsequent study found no differences 
between adult relatives and controls (Habets et al., 2012). Relatives in the former 
study were often the parents of patients and were older than those examined in the 
study by Habets and colleagues (mean age: 49.7 vs. 28.3 years, respectively). Thus, 
age-related changes in pituitary volume may have contributed to the differences 
across studies. Inconsistent findings have also been reported by studies of young 
adults with SPD. Takahashi et al. (2009) observed significantly larger pituitary 
volumes in individuals with SPD relative to healthy controls, yet a further study 
observed smaller pituitary volumes among males, but not females, with SPD (Romo-
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Nava et al., 2013). The contrast in findings is likely to reflect differences in sample 
characteristics. Whilst the SPD groups in both studies were of a similar age (mean 
age: 25.0 vs. 29.4 years, respectively), individuals with SPD in the former study were 
psychiatric patients, the majority of whom were receiving antipsychotic medication, 
however, individuals in the latter study were recruited from the community and 
were all medication-naive. Thus, differences in age, illness severity, and medication 
status may explain why the current findings do not support previous studies 
reporting abnormal pituitary volume among high-risk individuals. In contrast, two 
studies of UHR youth observed no differences in pituitary volume between at-risk 
youth and healthy controls (Garner et al., 2005; Büschlen et al., 2011), although both 
studies observed pituitary volume increases among UHR youth who later 
transitioned to psychosis compared to both UHR youth who did not transition and 
healthy controls. These findings suggest that, among UHR youth at least, pituitary 
volume abnormalities may be specific to those who later go on to develop psychosis. 
This may also account for the lack of pituitary volume abnormalities observed among 
ASz and FHx children (i.e., as these groups are likely to include both individuals who 
will develop illness and those who will not).  
Pituitary volume and cortisol 
The current study observed that pituitary gland volumes were not significantly 
associated with diurnal cortisol levels, although a positive association was observed 
with the CAR among ASz children only. The relationship between pituitary volume 
and cortisol levels has scarcely been examined among individuals at elevated risk for 
schizophrenia, or indeed among healthy individuals. Previous studies of individuals 
with a family history of psychosis (Habets et al., 2012) and youth at UHR (Thompson 
et al., 2007) similarly observed no relationship between pituitary volume and cortisol 
levels during the day. However, a recent study of healthy adolescents observed 
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positive associations between pituitary volume and the CAR, and negative 
associations between pituitary volume and diurnal cortisol levels (Kaess et al., 2013); 
though both relationships were present only when boys were examined in isolation. 
Thus, it is possible that the significant correlation identified between pituitary 
volume and the CAR among only ASz children may reflect the fact that a larger 
proportion of this group were male compared to the FHx and TD groups.  
Pituitary volume and psychosocial stress 
Among FHx children, a significant negative correlation was observed between 
pituitary volume and current distress relating to negative life events. Only one 
previous study of high-risk individuals has examined the relationship between 
pituitary volume and psychosocial stress; Habets and colleagues (2012) reported 
that pituitary volume among patients with psychosis, and to a lesser extent their 
adult siblings and healthy controls, was positively associated with emotional stress 
reactivity (i.e., the increase in negative affect in response to daily stressful 
experiences). Whilst these findings appear to contrast with those of the current 
study, of note, pituitary volume was positively associated with distress relating to 
daily hassles among FHx, ASz, and TD children, although none of these effects 
reached statistical significance. The conflicting pattern of findings may reflect the 
type of stressor examined; whilst greater distress relating to major traumatic events 
appears to be associated with smaller pituitary volume (at least among children with 
a family history of schizophrenia), emotional reactivity to minor stressors may be 
related to larger pituitary volume.  
The current study also observed that FHx children who had experienced physical 
punishment had significantly smaller pituitary volumes than those who had not, 
equating to a large effect size. The same pattern was observed when more severe 
forms of physical punishment were examined in isolation, with an even larger 
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magnitude of effect. This finding is consistent with a previous study of adolescents 
with borderline personality disorder (BPD) which found that whilst there were no 
differences in pituitary volume between adolescents with BPD and healthy controls, 
among those with BPD, those who had been exposed to childhood maltreatment 
(most commonly, physical abuse) were characterised by smaller pituitary volumes 
compared to those who had not experienced maltreatment (Garner et al., 2007). The 
current findings suggest that the relationship between pituitary volume and 
childhood maltreatment may extend to less severe forms of physically abusive 
parenting. 
Pituitary volume and current psychopathology  
As hypothesised, pituitary volumes were not significantly correlated with PLEs in any 
group or with internalising or externalising symptoms. Previous studies of UHR 
youth (Garner et al., 2005) and patients with SPD (Takahashi et al., 2009) have also 
reported no relationship between pituitary volume and psychotic symptoms. 
Furthermore, a study of adult relatives of patients with schizophrenia reported that 
pituitary volume was not significantly correlated with schizotypal symptoms 
(Mondelli et al., 2008). Consistent with these findings, a study of healthy adolescents 
observed no relationship between current psychopathology (total CBCL scores) and 
pituitary volume (Zipursky et al., 2011). Thus, the current study adds to existing 
literature showing that pituitary volume is unrelated to current symptomology. 
6.4.2 Potential mechanisms 
Pituitary volume abnormalities in psychosis 
One possible explanation for why ASz and FHx children were not characterised by 
abnormal pituitary volume relative to the TD group is that this neuroanatomical 
feature is associated with more severe clinical presentation. Enlarged pituitary 
volume has been observed among patients who have recently experienced their first 
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psychotic episode (Pariante et al., 2004; Pariante et al., 2005; Büschlen et al., 2011; 
Takahashi et al., 2011) and individuals with SPD who exhibit symptoms of sufficient 
severity to warrant antipsychotic treatment (Takahashi et al., 2009). Furthermore, 
two studies reported that youth at UHR who developed psychosis within 1-4 years 
had significantly larger pituitary volumes compared to UHR who did not (Garner et 
al., 2005; Büschlen et al., 2011). Thus, pituitary volume abnormalities may emerge in 
response to the onset of acute illness. However, the fact that enlarged pituitary 
volumes have also been observed among relatives of patients with schizophrenia 
who are not acutely unwell (Mondelli et al., 2008), suggests that genetic liability may 
play some role in the expression of pituitary volume abnormalities among individuals 
with psychosis. Whilst the current findings and those of a previous study of young 
adult relatives (Habets et al., 2012) do not support this hypothesis, it is possible that 
the larger pituitary volumes characterising older adult relatives reflects a genetic 
predisposition to HPA axis hyperactivity that emerges with increasing age following 
accumulated life stress.  
Relationship between physical punishment and pituitary volume 
A novel finding was that FHx children who were exposed to physical punishment had 
significantly smaller pituitary volumes compared to those who had not. Whilst a 
similar relationship between childhood maltreatment and pituitary volume has been 
reported among adolescents with BPD (Garner et al., 2007), the same pattern of 
findings was not observed among ASz and TD children. Furthermore, this did not 
appear to be due to the fact that FHx children had simply experienced more severe 
forms of physical punishment. One possible explanation for the findings is that FHx 
children may have been more distressed by experiences of physical punishment, 
which may in turn have had a greater effect on pituitary volume in this group. Indeed, 
as shown in Chapter 4, physical punishment was positively associated with 
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internalising symptoms and PLEs among FHx children, but not in ASz or TD children. 
Consistent with this hypothesis, current distress relating to negative life events was 
also negatively associated with pituitary volume among FHx children only.  
It has been suggested that elevated cortisol levels, resulting from stress-induced 
HPA axis hyperactivity, may have an inhibitory action on pituitary corticotrophs (i.e., 
the cells within the anterior pituitary that are responsible for ACTH production), 
eventually leading to pituitary volume reduction (Sassi et al., 2001). Thus, whilst 
stressful experiences might have been associated with increased cortisol levels and 
enlarged pituitary volume at the time that they occurred, enduring distress relating 
to these experiences among FHx children might feasibly result in pituitary volume 
reduction. However, as cortisol levels were only assessed at one time-point, not 
necessarily coinciding with stress exposure, this explanation is speculative. 
Alternatively, smaller pituitary volumes may predispose some FHx children to 
experience greater distress in response to negative life events and physical 
punishment. For example, a longitudinal study of adolescents observed no 
relationship between pituitary volume and psychopathology at baseline, but found 
that larger pituitary volumes predicted an increase in internalising symptoms over 
time (Zipursky et al., 2011). Unfortunately, the cross-sectional nature of these 
analyses means that it is not possible to disentangle the temporal relationship 
between experiences of psychosocial stress and pituitary gland volume.  
6.4.3 Methodological considerations 
Chapter 8 provides a more detailed discussion of the methodological issues that 
influence the overall study. Specific issues that are relevant to the data presented in 
this chapter are described in this section. One potential limitation relates to the 
characteristics of children who were not able to complete an MRI scan. Given that 
pituitary volume data was obtained for only 71% of children who participated in the 
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24-month assessment phase, it is possible that children who were not scanned were 
characterised by higher levels of stress reactivity (and perhaps pituitary volume 
abnormalities) which may have precluded the ability to detect group differences in 
pituitary volume. However, within-group analyses confirmed that children who 
provided pituitary volume data did not differ from those who did not on 
psychopathology scores at screening (Chapter 3). A further limitation relates to the 
fact that whilst biological indices of HPA axis function were collected during the same 
assessment phase, these measures were not always completed on the same day. This 
might explain why cortisol levels were not associated with pituitary gland volume 
across the groups.  
6.4.4 Conclusions 
The current study indicates that children at elevated risk for schizophrenia are not 
characterised by abnormal pituitary gland volume compared to their typically-
developing peers. These findings are consistent with the work presented in Chapter 
5, and imply that the biological markers of HPA axis hyperactivity (i.e., elevated 
cortisol levels during the day and enlarged pituitary volume) that have been 
observed in older samples of high-risk individuals may emerge later, more 
proximally to disease onset. Among FHx children only, pituitary volume was 
negatively associated with current distress relating to negative life events and 
exposure to physical punishment. This may reflect a genetically-mediated effect 
which predisposes FHx children to experience more distress in response to 
psychosocial stressors. Alternatively, these experiences may have caused an initial 
increase in HPA axis activity, which due to enduring distress, subsequently leads to a 
reduction in pituitary volume. Longitudinal studies of children at elevated risk for 
developing schizophrenia are needed to establish the temporal relationship between 
psychosocial stress exposure, cortisol levels, and pituitary volume abnormalities. 
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CHAPTER 7 Exploratory associations of neurocognitive function 
with psychosocial stress and cortisol 
7.1 Introduction 
Neurocognitive dysfunction is a core feature of schizophrenia. Relative to healthy 
individuals, patients with schizophrenia are characterised by moderate-to-large 
deficits across multiple neurocognitive domains, with the most severe impairments 
observed in memory and executive function (Reichenberg & Harvey, 2007). Similar 
impairments, albeit smaller in magnitude, have also been observed among youth with 
a family history of schizophrenia (Agnew-Blais & Seidman, 2013) and UHR youth 
(Fusar-Poli et al., 2012b). Whist it is likely that these neurocognitive deficits are to a 
large extent driven by genetic factors (Kahn & Keefe, 2013), there is some evidence to 
suggest that psychosocial stress exposure and abnormal HPA axis function may 
contribute to some of the neurocognitive features of schizophrenia.  
Animal studies indicate that stress-induced HPA axis dysfunction can lead to 
structural abnormalities in the hippocampus and medial prefrontal cortex, regions 
which play a crucial role in mediating HPA axis function (Herman et al., 2005). 
Specifically, studies of rodents have observed that chronic stress and persistently-
elevated glucocorticoid levels can cause hippocampal cell damage (Sapolsky, 2000), 
and that behavioural stress is associated with structural changes in the medial 
prefrontal cortex (Cerqueira et al., 2008). Thus, the deficits in memory and executive 
function that have been consistently observed among individuals with schizophrenia, 
may, at least in part, be due to the adverse effects of psychosocial stress and cortisol 
on the brain regions that support these neurocognitive functions. In support of this 
notion, elevated cortisol levels have been associated with poorer performance on 
tests of memory and executive function among individuals with schizophrenia 
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(Walder et al., 2000), and a more blunted CAR has been found to correlate with 
greater deficits in verbal memory in first-episode patients (Aas et al., 2011b). 
However, the extent to which the observed associations between these 
neurocognitive functions and cortisol are triggered by psychosocial stress exposure 
is currently unclear. Whilst some studies of individuals with schizophrenia have 
reported greater impairments in memory and executive function among those 
exposed to childhood maltreatment (Lysaker et al., 2001; Shannon et al., 2011), other 
studies have observed no association between psychosocial stress exposure 
(including childhood maltreatment) and these neurocognitive functions (Schenkel et 
al., 2005; Aas et al., 2011b; Sideli et al., in press). Further investigations employing 
concurrent measures of neurocognitive function, psychosocial stress, and cortisol 
levels are therefore required to elucidate this relationship. Moreover, it is not yet 
known whether the neurocognitive deficits that characterise individuals at elevated 
risk for schizophrenia are also associated with experiences of psychosocial stress and 
HPA axis dysfunction. 
Chapter aims 
This chapter aimed to explore the extent to which neurocognitive function is 
associated with experiences of psychosocial stress and cortisol levels in children at 
elevated risk for schizophrenia who present multiple antecedents of the disorder 
(ASz) or a family history of illness (FHx), and typically-developing (TD) children. 
Hypotheses 
4a. Experiences of psychosocial stress (exposure and reactivity) will be 
negatively associated with neurocognitive function in ASz and FHx children.  
4b.  Among ASz and FHx children, more abnormal cortisol levels will be 




7.2.1 Participants and procedure 
As described in Chapter 3, ASz and TD children were recruited using a novel 
community-screening procedure (Laurens et al., 2007; Laurens et al., 2011), and FHx 
children were identified either via the caregiver screening questionnaire or as 
relatives of patients with schizophrenia or schizoaffective disorder. Children meeting 
ASz, FHx, or TD criteria were invited to participate in a longitudinal study of child 
development. This chapter examines data from assessments of neurocognitive 
function, psychosocial stress, and salivary cortisol obtained at the 24-month 
assessment phase.  
7.2.2 Neurocognitive assessments 
Participants completed a battery of neurocognitive assessments with a trained 
researcher within six months of completing psychosocial stress measures and 
salivary cortisol collection (median lapse of time between neurocognitive tests and 
completion of psychosocial stress measures and salivary cortisol assessments: ± 0.5 
months for both). Selected subtests from the Wide Range Assessment of Memory and 
Learning 2nd Edition [WRAML2 (Sheslow & Adams, 2003)] and the Delis–Kaplan 
Executive Function System [D-KEFS: (Delis et al., 2001)] were used to assess memory 
(verbal memory, visual memory, attention and working memory) and executive 
function (verbal fluency, inhibition, and planning ability). These neurocognitive 
domains were examined as indices of functioning in the hippocampus and medial 
prefrontal cortex (Antonova et al., 2004; Reichenberg & Harvey, 2007; Euston et al., 
2012; Orellana & Slachevsky, 2013), which are known to mediate HPA axis function 
(Herman et al., 2005). Subtests are described in Table 33; standardised scores were 




Table 33. Neurocognitive measures 
Domain Subtest  Test description 
WRAML2 subtests   
Verbal memory Story memory a Immediate recall of two short stories presented orally 
 Verbal learning a Immediate free recall of a list of words presented orally 
Visual memory Design memory b  Drawing five visually-presented geometric designs 
 Picture memory b Identifying differences between four similar picture pairs 
Attention and working 
memory  
Number-letter Repeating strings of numbers and letters presented orally 
Verbal working memory  Immediate recall of word lists by category (animal vs. non-animal)  
D-KEFS subtests   
Verbal fluency Letter fluency  Generating words beginning with F, A, and S within 60 seconds 
 Category fluency  Generating items from categories (animals and boys names) within 60 seconds 
 Category switching  Generating words from alternate categories (fruit and furniture) within 60 seconds 
Inhibition/attention CWIT – Inhibition condition Naming the ink colour of colour-words presented in contrasting coloured ink (Stroop, 1935) 
 CWIT – Inhibition/switching Alternating between the above instruction or naming the colour-word (ignoring ink colour) 
Planning Towers test (total achievement)  Building towers using one to five disks in the fewest possible moves 
Note. WRAML2: Wide Range Assessment of Memory and Learning 2nd Edition (Sheslow & Adams, 2003); D-KEFS: Delis–Kaplan Executive Function System 
(Delis et al., 2001); CWIT: colour-word interference test. a Standardised scores on the story memory and verbal learning subtests summed to derive a verbal 




7.2.3 Psychosocial stress  
Psychosocial stress measures were described in detail in Chapter 4. In brief, children 
completed questionnaires assessing negative life events and school-related daily 
hassles (Heubeck & O’Sullivan, 1998). Physical punishment was assessed using the 
corporal punishment scale of the Alabama Parenting Questionnaire [APQ (Shelton et 
al., 1996)], completed by the child at the 24-month assessment phase. 
7.2.4 Salivary cortisol 
The saliva collection protocol was described in detail in Chapter 5. Briefly, 
participants collected six saliva samples throughout the day on two consecutive days: 
upon awakening, at 15, 30, and 60 min after awakening, and at 12:00 pm and 20:00 
pm. Cortisol data obtained at individual time-points were summarised using two area 
under the curve (AUC) computations (Pruessner et al., 2003); (i) AUC with respect to 
the increase in cortisol levels following awakening (AUCi-CAR), and (ii) AUC with 
respect to ground of cortisol levels during the day (AUCg-DAY).  
7.2.5 Statistical analyses 
As neurocognitive test scores were approximately normally distributed, independent 
samples t-tests were used to examine group differences (ASz vs. TD and FHx vs. TD) 
on these measures. As previously, children meeting both ASz and FHx criteria were 
retained in both groups, thus, ASz and FHx groups were not compared directly. 
Within-group correlation analyses were conducted to examine associations between 
neurocognitive test scores and psychosocial stress measures and cortisol AUC values. 
Pearson’s ‘r’ correlation analyses were used for normally distributed variables 
(number of negative life events, daily hassles scales, and cortisol AUC values) and 
Spearman’s rho ‘ρ’ correlations for non-normally distributed variables (negative life 
event distress scales and APQ physical punishment scores). All analyses were 




7.3.1 Sample characteristics 
As described previously, 95 children (ASz=29, FHx=19, ASz+FHx=5, TD=42) 
completed psychosocial stress measures and 91 children (ASz=29, FHx=18, 
ASz+FHx=4, TD=40) completed the saliva collection protocol; sociodemographic 
characteristics of these samples are provided in Chapters 4 and 5, respectively. In 
brief, in both the psychosocial stress sample and the salivary cortisol sample, there 
were no significant group differences (i.e., ASz vs. TD or FHx vs. TD) in age, pubertal 
status, BMI, tobacco use, or lapse of time between antecedent screening and 
completion of psychosocial stress measures and salivary cortisol collection (p>0.20). 
Additionally, the groups did not differ on the lapse of time between neurocognitive 
testing and psychosocial stress measure completion or saliva collection (p>0.20). In 
both samples, ASz children were more likely to be male than TD children (p<0.04), 
and the ASz and FHx groups were both found to differ significantly from TD children 
on ethnicity (p≤0.05) and socioeconomic status (p≤0.006).  
7.3.2 Group differences in neurocognitive function  
All participants who provided psychosocial stress data and/or salivary cortisol data 
completed tests of memory (WRAML2) and executive function (D-KEFS) yielding 
neurocognitive data for 99 children in total (87 children provided both psychosocial 
stress and salivary cortisol data, 8 provided psychosocial stress data only, and 4 
provided salivary cortisol data only). Neurocognitive data are shown for the total 
sample of children by risk group in Table 34. Relative to TD children, the ASz group 
showed poorer performance on the WRAML2 number-letter subset (t=2.39, p=0.02) 
and the D-KEFS verbal fluency – category switching subtest (t=2.20, p=0.03). FHx 
children obtained lower scores on the D-KEFS colour-word interference – inhibition 
subtest compared to TD children (t=2.14, p=0.02).  
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Table 34. Group differences in neurocognitive function 
Note. Five ASz+FHx cases are included in both groups. WRAML2: Wide Range Assessment of Memory and Learning 2nd Edition; D-KEFS: Delis–Kaplan Executive 








 ASz vs. TD FHx vs. TD 
Memory (WRAML2); mean ± SE        
Number-letter 11.3 ± 0.5 11.7 ± 0.7 13.0 ± 0.4 t=2.39 p=0.02 t=1.58 p=0.12 
Verbal memory 22.1 ± 0.7 21.1 ± 0.8 23.2 ± 0.8 t=0.94 p=0.35 t=1.68 p=0.10 
Visual memory 16.1 ± 0.8 16.6 ± 1.0 17.8 ± 0.6 t=1.70 p=0.09 t=1.07 p=0.29 
Working memory 9.5 ± 0.4 9.9 ± 0.5 10.5 ± 0.4 t=1.80 p=0.08 t=1.00 p=0.32 
Executive functioning (D-KEFS); mean ± SE        
Verbal fluency ‒ Letter fluency 10.5 ± 0.5 10.6 ± 0.6 10.9 ± 0.4 t=0.67 p=0.50 t=0.37 p=0.71 
Verbal fluency ‒ Category fluency 12.4 ± 0.6 11.5 ± 0.7 12.5 ± 0.5 t=0.23 p=0.82 t=1.29 p=0.20 
Verbal fluency ‒ Category switching 9.8 ± 0.5 10.8 ± 0.7 11.5 ± 0.6 t=2.20 p=0.03 t=0.76 p=0.45 
Colour-word interference ‒ Inhibition 11.0 ± 0.4 10.4 ± 0.5 11.7 ± 0.3 t=1.38 p=0.17 t=2.14 p=0.04 
Colour-word interference ‒ Inhibition / switching 10.7 ± 0.3 10.5 ± 0.5 11.0 ± 0.4 t=0.64 p=0.53 t=0.89 p=0.38 
Tower test  ‒ Total achievement score 11.1 ± 0.3 11.4 ± 0.3 11.4 ± 0.3 t=0.78 p=0.44 t=-0.05 p=0.96 
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7.3.3 Neurocognitive function and psychosocial stress  
Correlations between neurocognitive function and psychosocial stress measures 
(exposure and distress relating to negative life events, total daily hassles frequency 
and distress scales, and APQ physical punishment scale scores) are presented in 
Table 35. Among ASz children, the number of negative life events experienced was 
positively correlated with scores on the D-KEFS verbal fluency – category switching 
(r=0.44, p=0.008) and colour-word interference – inhibition switching subtests 
(r=0.35, p=0.05). Additionally, previous distress relating to negative life events was 
positively associated with scores on the D-KEFS colour-word interference – 
inhibition switching subtest in the ASz group (ρ=0.35, p=0.04). Among TD children, 
the number of negative life events experienced was moderately positively correlated 
with WRAML2 verbal memory performance (ρ=0.35, p=0.02), whilst previous 
distress relating to negative life events was positively associated with WRAML2 
visual memory performance (ρ=0.33, p=0.03). In contrast, none of the neurocognitive 
measures were associated with the number of life events experienced or with 
distress relating to these events (either previous or current) in FHx children. 
Total daily hassles frequency scores were moderately positively correlated with 
D-KEFS verbal fluency ‒ letter fluency (r=0.37, p=0.03) and category fluency subtest 
scores (r=0.35, p=0.05) among ASz children, and were also positively correlated with 
performance on the WRAML2 verbal memory index in the FHx group (r=0.41, 
p=0.05). Scores on the daily hassles frequency and distress scales were not 
significantly associated with any measure of neurocognitive functioning in the TD 
group. Finally, among ASz children only, child-reported scores on the APQ physical 
punishment scale were positively correlated with performance on the D-KEFS verbal 
fluency – letter fluency subtest (ρ=0.37, p=0.03).  
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Table 35. Correlations between neurocognitive function and psychosocial stress 
Note. * p<0.05; ** p<0.01; WRAML2: Wide Range Assessment of Memory and Learning 2nd Edition; Exec Func: executive function; D-KEFS: Delis–Kaplan 
Executive Function System; NLE No: total number of negative life events; NLE prev: previous distress relating to negative life events; NLE curr: current distress 













































Memory (WRAML2)                   
Number-letter 0.09 0.24 0.26 -0.03 0.21 0.09 -0.08 0.29 0.35 0.16 0.00 0.04 0.25 0.08 -0.06 -0.08 -0.15 -0.01 
Verbal memory -0.09 0.13 -0.01 -0.06 -0.03 -0.08 -0.14 0.20 0.37 0.41* -0.10 0.00 0.35* 0.27 0.11 0.17 -0.19 -0.28 
Visual memory 0.15 0.16 -0.05 0.15 -0.16 0.26 0.33 0.16 0.06 0.16 0.16 -0.08 0.22 0.33* 0.21 -0.13 -0.27 -0.22 
Working memory 0.08 0.10 0.04 -0.11 0.19 0.04 0.01 0.19 0.35 0.15 0.12 0.08 0.08 0.14 -0.01 0.02 -0.27 0.18 
Exec Func (D-KEFS)                   
Letter fluency 0.08 0.09 0.22 0.37* 0.15 0.37* 0.28 0.15 0.17 0.31 0.25 0.23 0.05 -0.04 -0.10 0.27 0.24 0.15 
Category fluency 0.24 0.15 0.14 0.35* -0.13 0.00 0.24 0.10 0.19 0.36 0.41 0.22 0.07 0.06 0.02 0.11 -0.12 -0.14 
Category switching 0.44** 0.31 0.11 0.05 -0.10 0.00 -0.10 0.07 0.06 0.02 0.03 -0.33 0.21 0.16 0.07 -0.01 -0.09 -0.09 
Inhibition 0.27 0.26 0.01 -0.02 -0.12 -0.27 0.00 0.13 0.19 0.15 0.05 -0.20 0.22 0.01 -0.10 -0.02 -0.26 -0.13 
Inhibition/switching 0.35* 0.35* 0.22 -0.03 0.12 -0.13 0.14 0.24 0.20 0.14 0.26 -0.05 0.20 0.14 0.14 -0.10 0.06 -0.22 
Towers test 0.28 -0.06 0.08 0.00 0.10 0.30 0.31 -0.09 0.10 0.02 0.03 0.03 0.04 0.14 0.07 0.24 0.08 0.16 
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7.3.4 Neurocognitive function and cortisol  
Correlation analyses were performed to examine the relationship between 
neurocognitive function and cortisol AUC measures (Table 36). AUCi-CAR values 
were positively correlated with scores on the D-KEFS verbal fluency – letter fluency 
subtest among ASz children (r=0.41, p=0.02) and with WRAML2 verbal memory 
index scores in the FHx group (r=0.46, p=0.04), but were not significantly associated 
with any neurocognitive measure in the TD group. In contrast, among FHx children, 
AUCg-DAY values were negatively correlated with scores on the WRAML2 verbal 
memory index (r=-0.47, p=0.05), WRAML2 number-letter subtest (r=-0.62, p=0.008), 
and the D-KEFS Towers test (r=-0.55, p=0.02). Relationships between verbal memory 
and cortisol AUC values are further illustrated in Figure 14.  
 








 AUCi-CAR AUCg-DAY AUCi-CAR AUCg-DAY AUCi-CAR AUCg-DAY 
Memory (WRAML2)       
Number-letter 0.19 -0.01 0.29 -0.62** -0.22 0.16 
Verbal memory 0.04 0.17 0.46* -0.47* 0.03 -0.12 
Visual memory -0.05 0.22 0.05 -0.31 0.24 -0.02 
Working memory 0.09 0.26 0.08 -0.36 -0.09 -0.06 
Exec Func (D-KEFS)       
Letter fluency 0.41* -0.30 0.23 -0.43 -0.14 0.27 
Category fluency 0.22 0.06 0.02 -0.30 0.18 0.15 
Category switching -0.14 0.16 0.22 0.05 0.06 0.11 
Inhibition -0.16 0.09 0.27 -0.06 0.01 0.03 
Inhibition/switching -0.06 -0.05 0.27 0.02 -0.03 -0.04 
Towers test 0.22 -0.27 0.18 -0.55* 0.10 0.17 
Note. * p<0.05; ** p<0.01. WRAML2: Wide Range Assessment of Memory and Learning 2nd 
Edition; Exec Func: executive function; D-KEFS: Delis–Kaplan Executive Function System. 
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             ASz (n=33)                                            FHx (n=22)                                            TD (n=40)    
               
               
Figure 14. Scatterplots illustrating the relationship between verbal memory performance and cortisol levels
R2 = 0.00 R2 = 0.21 R2 = 0.00 




This chapter explored the extent to which neurocognitive function among children at 
elevated risk for schizophrenia is associated with experiences of psychosocial stress 
and salivary cortisol. As hypothesised, among FHx and ASz children, more abnormal 
HPA axis function (that is, higher diurnal cortisol levels and a more blunted CAR) was 
associated with poorer performance on tests of verbal memory and executive 
function. Neurocognitive function was not associated with cortisol levels in the TD 
group. In contrast to predictions, experiences of psychosocial stress (both higher 
levels of exposure and greater distress in relation to these exposures) were 
associated with better performance on neurocognitive measures in all three groups.    
7.4.1 Comparison with previous research  
Neurocognitive function and psychosocial stress  
The current study observed that among ASz children, better performance on 
executive function tasks was associated with higher levels of psychosocial stress 
exposure (negative life events, daily hassles, and physical punishment). Furthermore, 
verbal memory was positively associated with exposure to daily hassles and negative 
life events in FHx and TD children, respectively. These findings are in contrast with 
previous studies which have reported that adults with schizophrenia who have been 
exposed to severe forms of psychosocial stress, namely, childhood maltreatment, 
show poorer performance on tests of working memory, episodic memory, and 
executive function (Lysaker et al., 2001; Shannon et al., 2011). However, other 
studies have observed no association between psychosocial stress exposure 
(including childhood maltreatment) and these neurocognitive deficits among 
individuals with psychosis (Schenkel et al., 2005; Aas et al., 2011b; Sideli et al., in 
press). Indeed, Aas and colleagues reported that psychosocial stress exposure 
(childhood trauma, stressful life events, and perceived stress) was associated with 
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poorer neurocognitive function among healthy individuals but not among individuals 
with first-episode psychosis (Aas et al., 2011b), a finding that was replicated in a 
larger investigation of first-episode patients recruited to this study (Sideli et al., in 
press). A similar association was observed in a study of individuals with established 
schizophrenia (McCabe et al., 2012), in which a negative relationship was reported 
between exposure to childhood adversity and IQ among healthy controls but not 
among patients. However, in a different sample of first-episode patients, Aas and 
colleagues observed that childhood trauma was correlated with poorer 
neurocognitive performance, but only among male patients and those with affective 
psychosis (Aas et al., 2011a). Thus, previous studies investigating the relationship 
between psychosocial stress exposure and neurocognitive function among 
individuals with psychosis have yielded inconsistent findings. This may relate to 
differences in the specific psychosocial stressors examined (discussed below) and/or 
variability in patient characteristics across studies.  
Among ASz and TD children, the level of distress experienced in relation to 
negative life events at the time of the event was positively associated with executive 
function (specifically, the inhibition/switching condition of the Stroop colour-word 
interference test) and visual memory, respectively. Although unexpected, these 
findings are, in fact, consistent with two previous studies which examined the 
relationship between neurocognitive function and stress reactivity in individuals 
with psychosis using the ESM technique (Myin-Germeys et al., 2002; Morrens et al., 
2007). In both studies, greater reactivity to stressful events throughout the day (i.e., 
greater decreases in positive affect and greater increases in negative affect) was 
associated with better performance on a verbal memory test and the Stroop colour-
word interference test.  
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Neurocognitive function and cortisol  
Exploratory analyses were also conducted to examine the relationship between 
neurocognitive function and cortisol levels. These analyses demonstrated that 
neurocognitive deficits are associated with more abnormal cortisol levels in children 
at elevated risk for schizophrenia. Specifically, a greater blunting of the CAR was 
associated with poorer verbal memory and letter fluency among FHx and ASz 
children, respectively; moreover, in the FHx group only, higher diurnal cortisol was 
correlated with poorer performance on the number-letter subtest and Towers test, 
and lower verbal memory index scores. In contrast, cortisol levels were not 
associated with neurocognitive performance among TD children. Whilst this is the 
first study to have examined the relationship between neurocognitive deficits and 
HPA axis function in a sample of high-risk individuals, the current findings are 
consistent with studies of adults with established illness. A previous study examining 
individuals with chronic schizophrenia, patients with other psychiatric disorders, and 
healthy controls, found that higher cortisol levels during the day were correlated 
with poorer performance on tasks of memory and executive function when 
associations were examined across the total sample (Walder et al., 2000). A 
subsequent study observed that a more blunted CAR was associated with deficits in 
verbal memory and processing speed among individuals with first-episode psychosis 
but not healthy controls (Aas et al., 2011a), although none of the neurocognitive 
measures were associated with cortisol levels during the day. The reason for this 
slight difference in findings is unclear, but again, may relate to differences in patient 
characteristics and/or the neurocognitive tests employed. Nonetheless, these studies, 
and the current investigation, concur in showing that more abnormal cortisol levels 
are associated with poorer performance on specific measures of neurocognitive 
function in individuals with schizophrenia and those at elevated risk for the disorder.   
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7.4.2 Potential mechanisms 
Relationship between psychosocial stress and neurocognitive function 
The finding that experiences of psychosocial stress (both higher levels of exposure 
and greater distress in relation to these exposures) were associated with better 
performance on tests of executive function and memory was unexpected. Indeed, 
trauma exposure has been consistently associated with poorer performance on tests 
of memory and executive function in children and adults without schizophrenia 
(Porter et al., 2005; Gould et al., 2012; Spann et al., 2012). Previous studies indicate 
that the extent to which experiences of psychosocial stress impair or enhance 
neurocognitive function may depend on the specific type of stress exposure. A study 
of older adults reported that whilst some psychosocial stressors (namely, serious 
injury or illness in a friend and greater distress in relation to this experience) were 
associated with better performance on memory and executive function tasks, other 
stressful experiences (i.e., recent financial difficulties and distress relating to being a 
victim of crime) were associated with poorer neurocognitive function (Rosnick et al., 
2007). Similarly, a subsequent study of older adults reported that the death of a 
relative was associated with poorer neurocognitive function whilst illness in a 
partner or relative was positively correlated with neurocognitive performance 
(Comijs et al., 2011). It has been hypothesised that the effect of stressful life events on 
neurocognitive function may be mediated by long-term changes in arousal (Rosnick 
et al., 2007; Feeney et al., 2013). Thus, whilst some psychosocial stressors may 
increase arousal to a degree that allows the individual to perform optimally, other 
stressors may cause hyper- or hypo-arousal which impairs neurocognitive abilities 
(Rosnick et al., 2007). Thus, the psychosocial stressors examined in the current study 
(i.e., negative life events, daily hassles, and physical punishment) may have led to an 
optimal increase in arousal that in turn enhanced neurocognitive function. 
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Relationship between cortisol levels and neurocognitive deficits 
This is the first study to investigate the relationship between cortisol levels and 
neurocognitive function among individuals at elevated risk for schizophrenia. The 
current findings indicate that the deficits in memory and executive function that have 
been found to characterise ASz and FHx children (Cullen et al., 2010; Dickson et al., in 
press-b) are associated with more abnormal HPA axis function. One possible 
explanation for this finding is that stress-induced HPA axis dysfunction may have a 
direct effect on these cognitive abilities (i.e., via the effects of cortisol on the brain 
structures supporting these functions). In support of this hypothesis, animal studies 
indicate that chronic stress exposure and persistently-elevated glucocorticoid levels 
cause hippocampal damage, including, dendrite atrophy, inhibition of neurogenesis, 
and neuronal loss (Sapolsky, 2000; Corcoran et al., 2003), and that behavioural stress 
leads to structural changes in the medial prefrontal cortex (Cerqueira et al., 2008). 
Similar associations have been observed in human populations. For example, 
negative correlations between cortisol levels and hippocampal volume have been 
observed among individuals with first-episode psychosis (Mondelli et al., 2010b), and  
childhood maltreatment has been associated with reduced grey matter volume in the 
prefrontal cortex and hippocampus in both child and adult populations (Hart & 
Rubia, 2012). However, the positive associations observed between experiences of 
psychosocial stress and neurocognitive function in the current study suggest that, if 
abnormal cortisol levels do directly contribute to neurocognitive deficits in ASz and 
FHx children, this is not driven by increased exposure or reactivity to psychosocial 
stressors.  
Alternatively, the association between neurocognitive function and cortisol levels 
observed among children at elevated risk for schizophrenia may be indirect. Indeed, 
it is possible that the association reflects underlying dysfunction in the hippocampus 
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and medial prefrontal cortex, regions which are densely populated with 
glucocorticoid receptors and known to play a crucial role in mediating HPA axis 
function (Herman et al., 2005). Thus, among children at elevated risk for 
schizophrenia, abnormal neurodevelopmental processes (possibly triggered by 
genetic factors or early environmental insults) may have affected the functional 
integrity of the brain structures that mediate both HPA axis function and 
neurocognitive performance. 
7.4.3 Methodological considerations 
As previously, methodological issues pertinent to the data presented in this chapter 
are discussed here; issues that are of relevance to the study as a whole are described 
in the following chapter. One potential limitation relates to the use of self-report 
measures to assess psychosocial stress. It is possible that the positive correlations 
observed between neurocognitive performance and experiences of psychosocial 
stress may reflect the fact that children with poorer neurocognitive function were 
less able to recall past events and reflect on their own levels of distress. However, in 
the ASz group, positive correlations were observed between psychosocial stress 
measures and performance on executive function tasks, but not with memory 
performance (which would be expected if better recall was contributing to this 
effect). A further limitation relates to the fact that for some children, the lapse of time 
between the collection of psychosocial stress and salivary cortisol data and the 
completion of neurocognitive assessments was as long as six months. However, 
neurocognitive function was found to be significantly associated with both 
psychosocial stress and salivary cortisol measures. Moreover, the groups did not 
differ in the lapse of time between any of the assessments and so this would not have 




The current study demonstrates for the first time that more abnormal HPA axis 
function (i.e., greater blunting of the CAR and higher diurnal cortisol levels) is 
associated with poorer neurocognitive function among children at elevated risk for 
schizophrenia. One possible interpretation of these findings is that HPA axis 
abnormalities, caused by increased exposure and reactivity to psychosocial stress, 
directly participate in the development of neurocognitive impairments in high-risk 
individuals. However, the positive associations observed between experiences of 
psychosocial stress and neurocognitive function do not support this hypothesis. Thus, 
it seems likely that common neurodevelopmental mechanisms may contribute to 
both HPA axis abnormalities and neurocognitive impairments among children at 




CHAPTER 8 Discussion 
8.1 Overview 
This thesis examined psychosocial stress and HPA axis function among children who 
are at putatively elevated risk of developing schizophrenia in later life because they 
present multiple antecedents of the disorder or a family history of illness. A 
significant methodological advance on previous studies of high-risk youth was that 
all children were antipsychotic-naive and were not currently seeking treatment for 
their symptoms. Moreover, this is the first study of individuals at elevated risk for 
schizophrenia to examine the CAR and also the first to investigate the extent to which 
experiences of psychosocial stress and cortisol levels are associated with 
neurocognitive function. Finally, this thesis aimed to address methodological issues 
identified in the existing literature by employing concurrent measures of 
psychosocial stress and HPA axis function and investigating the extent to which 
demographic factors influence the effect of risk status on these measures.  
Chapter aims 
This chapter provides an overview of the findings and discusses the implications of 
the work presented in this thesis. The specific aims were as follows: 
1. Review the main findings of the study and evaluate the extent to which the 
results support a priori hypotheses.  
2.  Identify methodological issues that are relevant to the overall study.  
3. Describe how the work presented in this thesis contributes to existing 
scientific knowledge. 
4. Discuss the implications of the findings for theories of schizophrenia, clinical 
practice, and future research.  
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8.2 Review of the study findings 
8.2.1 Principal findings 
Table 37 summarises the principal findings of this thesis and indicates the extent to 
which the results provide support for the original study hypotheses. Of the twelve 
hypotheses tested, four were fully supported, five were partially supported, and three 
were not supported. A more detailed description of the findings is provided below. 
Psychosocial stress 
In Chapter 4, it was observed that FHx and ASz children are more frequently exposed 
to major negative life events and milder daily hassles respectively compared to TD 
children, and that both groups are more distressed by these experiences. These 
findings supported the a priori hypotheses and also provided evidence to suggest 
that ASz and FHx children may be susceptible to different types of psychosocial 
stressors. The results are consistent with previous studies which show that, relative 
to healthy controls, individuals at elevated risk for schizophrenia on account of their 
clinical presentation (i.e., UHR youth, individuals with SPD, and those reporting PLEs) 
are more likely to experience psychosocial stressors such as major life events, 
trauma, and daily hassles (De Loore et al., 2007; Kelleher et al., 2008; Tessner et al., 
2011; Addington et al., 2013; Kelleher et al., 2013c; Sahin et al., 2013; Tikka et al., 
2013). These findings also converge with studies which have observed that UHR 
youth (Palmier-Claus et al., 2012) and adult relatives of individuals with psychosis 
(Myin-Germeys et al., 2001) exhibit greater emotional reactivity to stressful 
experiences than healthy controls. A novel finding was that physical punishment was 
more common among ASz and FHx children compared to TD children. As discussed in 
the following section, subsequent analyses indicated that the relationship between 
risk status and exposure to physical punishment may be influenced by ethnicity and 
socioeconomic status.  
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The analyses conducted in Chapter 4 also indicated that exposure to psychosocial 
stress (negative life events, daily hassles, and physical punishment) was more 
strongly associated with PLEs among ASz and FHx children compared to TD children. 
However, larger correlations were observed between daily hassles and internalising 
and externalising symptoms in the TD group than in the ASz and FHx groups. Thus, 
whilst risk status appeared to influence the relationship between psychosocial stress 
and current psychopathology, the hypothesis that this association would be stronger 
among at-risk children was only partially supported.  
Salivary cortisol  
It was observed in Chapter 5 that FHx children, but not ASz children, are 
characterised by a blunted CAR relative to the TD group; an effect that appeared to be 
influenced by ethnicity (discussed in the following section). Neither FHx nor ASz 
children showed elevated diurnal cortisol levels relative to the TD group. Thus, only 
partial support was found for the hypothesis that ASz and FHx children would be 
characterised by abnormal cortisol levels. Whilst this is the first study to have 
examined the CAR among those at elevated risk for schizophrenia, a blunted CAR has 
also been observed in individuals with first-episode psychosis relative to healthy 
controls (Mondelli et al., 2010a; Pruessner et al., 2013b). The finding that neither FHx 
nor ASz children were characterised by elevated diurnal cortisol levels relative to 
their typically-developing peers is surprising given that higher cortisol levels during 
the day have been observed consistently among UHR youth (Sugranyes et al., 2012; 
Walker et al., 2013) and adolescents with SPD (Weinstein et al., 1999; Walker et al., 
2001; Mittal et al., 2007). The lack of group differences may be due to the participants 
in the current investigation being slightly younger than those examined in previous 
studies of high-risk youth (i.e., it may not be possible to detect elevations in diurnal 
cortisol till later in adolescence).  
225 
 
Whilst there was partial support for the hypothesis that cortisol levels would be 
associated with experiences of psychosocial stress among ASz and FHx children, the 
pattern of findings was not as expected. The CAR was positively correlated with 
distress relating to negative life events among FHx children but negatively correlated 
in the TD group. Thus, the blunted CAR observed among FHx children was not 
explained by the fact that these children experienced greater distress in relation to 
negative life events. Interestingly, a similar pattern of findings was observed in a 
study of patients with first-episode psychosis (Mondelli et al., 2010a). There was no 
support for the hypothesis that cortisol levels would be associated with current 
psychopathology among ASz and FHx children. Indeed, no association was observed 
between cortisol levels and psychopathology in any group. Previous studies of youth 
at elevated risk for schizophrenia have yielded inconsistent findings; some studies 
have shown that cortisol levels are associated with psychotic (Weinstein et al., 1999), 
schizotypal (Walker et al., 2001), and prodromal symptoms (Walker et al., 2013) 
whilst others have not (Thompson et al., 2007; Corcoran et al., 2012; Sugranyes et al., 
2012). However, the lack of association between cortisol levels and internalising and 
externalising psychopathology is in contrast to previous studies of youth who are not 
at elevated risk for psychosis (Susman, 2006; Lopez-Duran et al., 2009).  
Pituitary gland volume 
In contrast to hypotheses, analyses conducted in Chapter 6 indicated that there were 
no differences in pituitary volume when either ASz or FHx children were compared 
to the TD group. As noted in Chapter 2, pituitary volume abnormalities have not been 
consistently observed among individuals at elevated risk for schizophrenia. Enlarged 
pituitary volume has been reported among adults with a family history of 
schizophrenia (Mondelli et al., 2008) and patients with SPD (Takahashi et al., 2009). 
However, other studies have shown no differences between young adult relatives and 
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healthy controls (Habets et al., 2012), or smaller pituitary volumes among males with 
SPD recruited from the community (Romo-Nava et al., 2013). Furthermore, studies of 
UHR youth indicate that enlarged pituitary volume characterises those who go on to 
transition to psychosis (Garner et al., 2005; Büschlen et al., 2011), but that pituitary 
volumes across the total sample of UHR youth do not differ from healthy controls. 
Thus, differences in age, medication status, and proximity to illness onset may 
explain the inconsistency of findings across studies. 
Pituitary volume was positively correlated with the CAR in the ASz group only, yet 
diurnal cortisol levels were not associated with pituitary volume in any group. Whilst 
these findings only partially support hypotheses, studies of individuals with a family 
history of psychosis (Habets et al., 2012) and youth at UHR (Thompson et al., 2007) 
have also reported no relationship between pituitary volume and cortisol levels 
during the day. There was some evidence to support the notion that pituitary volume 
is associated with experiences of psychosocial stress among high-risk individuals. 
Specifically, pituitary volume was negatively correlated with current distress relating 
to negative life events in the FHx group only; furthermore, FHx children who had 
experienced physical punishment had smaller pituitary volumes than FHx children 
who had not. Whilst these findings contrast with the positive association between 
pituitary volume and emotional stress reactivity that was observed among young 
adult siblings of individuals with psychosis (Habets et al., 2012), a study of 
adolescents with borderline personality disorder reported that those who had been 
exposed to childhood trauma had smaller pituitary volumes than those who had not 
(Garner et al., 2007). Finally, as predicted, no association was observed between 
pituitary volume and current psychopathology in any group. Previous studies of UHR 
youth (Garner et al., 2005) and patients with SPD (Takahashi et al., 2009) have also 
found no relationship between pituitary volume and psychotic symptoms. 
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Exploratory associations with neurocognitive function 
Chapter 7 explored the extent to which experiences of psychosocial stress (exposure 
and reactivity) and cortisol levels are associated with neurocognitive function among 
children at elevated risk for schizophrenia. In contrast to hypotheses, greater 
exposure to psychosocial stress was associated with better performance on tests of 
memory and executive function in all three groups. Whilst some previous studies of 
individuals with psychosis have reported that childhood trauma is associated with 
greater impairments in memory and executive function (Lysaker et al., 2001; 
Shannon et al., 2011), other studies have observed no association between 
psychosocial stress exposure (including childhood maltreatment) and poorer 
performance in these domains (Schenkel et al., 2005; Aas et al., 2011b; Sideli et al., in 
press). Differences across studies may relate to the specific types of psychosocial 
stressor examined and/or variability in patient characteristics. Among ASz and TD 
children, distress relating to negative life events at the time of the event was 
positively associated with executive function and memory performance, respectively. 
Whilst this pattern of results was not predicted, the findings are consistent with two 
previous studies which examined the relationship between neurocognitive function 
and stress reactivity in individuals with psychosis using the ESM technique (Myin-
Germeys et al., 2002; Morrens et al., 2007).  
As hypothesised, among FHx and ASz children, more abnormal HPA axis function 
(that is, higher diurnal cortisol levels and a more blunted CAR) was associated with 
poorer performance on tests of verbal memory and executive function. This pattern 
of findings is consistent with studies of adults with established psychosis, in which 
higher diurnal cortisol levels have been associated with poorer memory and 
executive function (Walder et al., 2000) and a greater blunting of the CAR with 
poorer verbal memory (Aas et al., 2011b). 
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Table 37. Support for study hypotheses 
Hypothesis Supported? Evidence 
Hypothesis 1a 
Chapter 4  
ASz and FHx children will be exposed to 
higher levels of psychosocial stressors 
compared to the TD group 
Yes  FHx and ASz children reported a greater number of negative life events than 
TD children  
 Relative to the TD group, daily hassles more frequently experienced by ASz 
(peer- and teacher-related) and FHx children (home-related)  
 Physical punishment more common among ASz and FHx children 
Hypothesis 1b 
Chapter 4 
Relative to TD children, both ASz and FHx 
children will be more distressed by 
psychosocial stressors 
Yes  FHx children more distressed currently by negative life events than TD 
children 
 ASz children more distressed by daily hassles across all domains than TD 
children; FHx children more distressed by home-related hassles 
Hypothesis 1c 
Chapter 4 
Experiences of psychosocial stress will be 
more strongly associated with current 
psychopathology among ASz and FHx 
children than in TD children 
Partially  PLEs more strongly associated with daily hassles frequency in ASz and FHx 
children than in TD children; correlated with negative life events in ASz only   
 Daily hassles frequency and distress scores related to internalising and 
externalising symptoms in FHx and TD children 
 Physical punishment associated with internalising symptoms and PLEs 
among FHx children and with externalising symptoms in the TD group  
Hypothesis 2a 
Chapter 5 
ASz children and FHx children will show 
elevated diurnal cortisol levels and a blunted 
CAR relative to TD children 
Partially  FHx children showed a blunted CAR relative to TD children that was not 
observed among ASz children 
 Neither ASz nor FHx children showed elevated diurnal cortisol levels 
compared to TD children 
Note. PLEs: Psychotic-like experiences; CAR: cortisol awakening response.  
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Table 37. (continued) 
Hypothesis Supported? Evidence 
Hypothesis 2b 
Chapter 5 
Cortisol levels will be associated with 
exposure to psychosocial stressors and 
distress related to these exposures in ASz 
and FHx children 
Partially  CAR positively associated with distress relating to negative life events 
among FHx children but negatively correlated in the TD group  
 Diurnal cortisol levels not associated with negative life events, daily hassles, 
or  physical punishment in any group  
Hypothesis 2c 
Chapter 5 
Among ASz and FHx children, cortisol levels 
will be correlated with current 
psychopathology 
No  No association between cortisol levels (CAR or diurnal cortisol) and 
psychopathology in any group 
Hypothesis 3a 
Chapter 6 
Both ASz and FHx children will show 
abnormal pituitary gland volume relative to 
TD children 
No  Pituitary volume abnormalities not observed among ASz or FHx children 
relative to TD children 
Hypothesis 3b 
Chapter 6 
Among ASz and FHx children, pituitary 
volume will be correlated with salivary 
cortisol levels 
Partially  Pituitary volume positively correlated with the CAR among ASz children 
only 
 Pituitary volume not associated with diurnal cortisol levels in any group 
Hypothesis 3c 
Chapter 6 
Pituitary volume will be associated with 
exposure to psychosocial stressors and 
distress related to these exposures in ASz 
and FHx children 
Partially  Pituitary volume negatively correlated with current distress relating to 
negative life events in FHx children only 
 FHx children exposed to physical punishment had smaller pituitary volumes 
than FHx children not exposed 





Table 37. (continued) 
Hypothesis Supported? Evidence 
Hypothesis 3d 
Chapter 6 
No relationship between pituitary volume 
and current psychopathology will be 
observed among ASz and FHx children 




Experiences of psychosocial stress (exposure 
and reactivity) will be negatively associated 
with neurocognitive function in ASz and FHx 
children 
No  Experiences of psychosocial stress (exposure and reactivity) associated 
with better executive function among ASz children and with better memory 
performance among FHx and TD children 
Hypothesis 4b 
Chapter 7 
Among ASz and FHx children, more 
abnormal cortisol levels will be associated 
with poorer neurocognitive function 
Yes  Greater blunting of the CAR associated with poorer verbal memory and 
executive function among FHx and ASz children, but not TD children  
 Higher diurnal cortisol levels associated with poorer verbal memory and 
executive function among FHx children only 
Note. CAR: cortisol awakening response.  
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8.2.2 Influence of demographic factors 
As described in Chapter 2, a number of demographic factors have been associated 
with psychosocial stress exposure and HPA axis function, including, age, sex, pubertal 
status, ethnicity, socioeconomic status, tobacco use, and substance use. An additional 
aim of this thesis was to examine the role that these demographic factors play in the 
relationship between risk status and psychosocial stress susceptibility/HPA axis 
function. All primary analyses were therefore adjusted for demographic factors that 
differed significantly between the groups or that were associated with psychosocial 
stress/HPA axis function in preliminary analyses. Stratified analyses were conducted 
when adjustment for demographic factors led to a substantial change in the effect 
size associated with risk status.  
Physical punishment, ethnicity, and socioeconomic status 
Adjustment for demographic factors indicated that ethnicity and socioeconomic 
status may influence the relationship between risk status and physical punishment. 
Stratified analyses showed that among children of white ethnicity, physical 
punishment was more commonly experienced by ASz and FHx children compared to 
the TD group, yet there was no effect of ASz and FHx status on physical punishment 
among those of non-white ethnicity. A similar pattern was observed when analyses 
were conducted within socioeconomic strata; among children of higher 
socioeconomic class, but not those of lower social class, ASz and FHx children were 
more likely than TD children to experience physical punishment. These findings may 
reflect the fact that physical punishment was more commonly experienced by 
children of non-white ethnicity and those from low socioeconomic backgrounds. 
Thus, the extent to which physical punishment is associated with risk for 
schizophrenia in children from different ethnic and socioeconomic backgrounds may 
depend on how prevalent these experiences are in particular demographic groups.  
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Cortisol awakening response, gender, and ethnicity 
There was also evidence that ethnicity may influence the relationship between risk 
status and the cortisol awakening response. Specifically, among children of non-white 
ethnicity, FHx children were characterised by a blunted CAR relative to the TD group, 
but there was no difference in the CAR when white FHx children were compared to 
white TD children. Stratified analyses showed that the blunted CAR observed among 
FHx children relative to the TD group was present in both males and females, thus, 
the effect of FHx status on the CAR was not influenced by gender. It is possible that 
the modifying effect of ethnicity may have reflected the fact that the proportion of 
FHx children with a first-degree relative with schizophrenia was higher among those 
who were of non-white ethnicity compared to those of white ethnicity. In Chapter 5, 
it was also demonstrated that the blunted CAR observed among FHx children relative 
to the TD group was more pronounced among FHx children with a first-degree 
relative with schizophrenia compared to those with an affected second-degree 
relative. Importantly, the stratified analyses demonstrate that the blunted CAR 
observed among FHx children is not simply due to the fact that these children are 
more likely to be of non-white ethnicity. 
Pituitary volume, sex, and pubertal status 
Stratified analyses were also conducted to examine the influence of sex and puberty 
on the relationship between risk status and pituitary volume. These analyses 
demonstrated that neither ASz nor FHx children differed to the TD group on pituitary 
volume when males and females were examined separately, or when analyses were 
conducted within pubertal strata (pubertal vs. post-pubertal). Thus, there was no 
evidence to suggest that sex or pubertal status modified the relationship between 




8.3 Methodological considerations 
Methodological issues relating to the specific analyses conducted in Chapters 4, 5, 6, 
and 7 have been discussed previously. The following section provides a more 
comprehensive description of the issues that are relevant to the overall study.  
8.3.1 Sample constraints 
The current study was limited by the small sample size, which may have impaired the 
ability to detect significant group differences. This was a particular concern for the 
pituitary volume analyses, as the sample size was further reduced owing to the fact 
that some children did not wish to complete an MRI scan or were unable to do so due 
to contraindicators (e.g., metal braces). Small sample sizes are not uncommon in 
high-risk studies, particularly those examining biological indices of HPA axis function. 
This reflects the inherent difficulties in identifying and recruiting high-risk youth, as 
well as the relative intrusiveness of obtaining biological measures compared to self-
report questionnaire data. Despite the small sample, the current study was able to 
detect differences between the at-risk groups and the TD group on measures of 
psychosocial stress (exposure and reactivity) and the CAR. Furthermore, within the 
FHx group, significant differences in pituitary volume were observed between those 
who had experienced physical punishment and those who had not.  
A further limitation relates to the extent to which the groups examined in the 
current study are representative of the underlying populations from which they were 
sampled. Potential ASz and TD cases who declined participation did not differ on age, 
sex, ethnicity, or psychopathology at screening to ASz and TD children who 
participated in the overall study respectively, with the exception that ASz 
participants were less likely to present SDQ emotional symptoms in the ‘abnormal’ 
range than children meeting ASz criteria who did not participate. Given that 
depression has been associated with HPA axis abnormalities, it is possible that the 
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under-representation of ASz children reporting emotional problems may have 
influenced the results of the study. A related concern is whether the study findings 
can be extended to other populations. Within the inner-city London boroughs from 
which the participants were sampled, environmental risk factors for psychosis (for 
example, urbanicity and migration) are likely to be particularly prevalent. Indeed, the 
incidence of psychosis in south-east London (where many of the participants reside) 
is higher than the incidence in other parts of the UK (Kirkbride et al., 2012). It is 
possible that these environmental risk factors may have acted in combination with 
ASz and FHx status, thereby contributing to the observed associations between risk 
status and psychosocial stress susceptibility/HPA axis function.  
The fact that the groups were not matched on key demographic variables might 
also be considered a potential limitation of the study. Compared to the TD group, ASz 
and FHx children were more likely to be of black or other ethnicity and tended to be 
from lower socioeconomic backgrounds. This pattern is consistent with the elevated 
rates of psychosis observed among African-Caribbean and black African adults in the 
UK (Kirkbride et al., 2012), and with population-based studies showing that low 
socioeconomic status in childhood is associated with increased risk for psychosis 
(Wicks et al., 2005; Corcoran et al., 2009). ASz children were also more likely to be 
male than TD children, which again, is in accordance with the finding that males are 
at greater risk of developing schizophrenia (Tandon et al., 2009). Thus, the 
demographic factors that distinguished ASz and FHx children from the TD group are 
also factors on which individuals with schizophrenia and healthy controls differ. It is 
also important to note that the TD group do not represent a ‘super-healthy’ control 
group. By definition, TD children could present scores in the ‘borderline’ range on the 
SDQ psychopathology scales (i.e., scores within the 80-90th percentile on UK 
population norms) and could report multiple ‘somewhat-true’ PLEs. 
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8.3.2 Measurement issues 
The current study examined a range of child-appropriate negative life events and 
school-related daily hassles. A potential limitation is that more severe forms of 
psychosocial stress such as childhood trauma (i.e., abuse and neglect) were not 
examined. Childhood trauma is associated with increased risk for schizophrenia 
(Varese et al., 2012; Matheson et al., 2013a) and has also been related to HPA axis 
abnormalities in adolescents, as indexed by a blunted cortisol response to 
psychosocial stress (Ouellet-Morin et al., 2011) and reduced pituitary volume 
(Garner et al., 2007). Thus, childhood trauma might have explained the blunted CAR 
observed among FHx children. However, the ability to examine physical punishment, 
which lies on a continuum with childhood maltreatment, is a potential strength of the 
study. The findings indicate that even at lower levels of severity, physically abusive 
parenting is associated with pituitary volume reduction among vulnerable youth.  
Salivary cortisol was used to index HPA axis function. Given that cortisol levels 
show substantial variation from day-to-day, the measurement of cortisol in hair 
samples may have provided a more stable indication of HPA axis hyperactivity 
(Russell et al., 2012). However, the reliability and validity of hair cortisol measures 
are yet to be determined, and the current study observed that salivary cortisol values 
were stable across the two testing days. Additionally, the saliva sampling protocol 
permitted the examination of the CAR and diurnal cortisol variation, neither of which 
can be captured using hair samples. An alternative to using cortisol to assess HPA 
axis function is to examine adrenocorticotropic hormone (ACTH) levels. Indeed, 
elevated ACTH levels have also been observed among individuals with schizophrenia 
relative to healthy controls (Walker et al., 2008). However, ACTH is typically 
examined in blood plasma, and the invasiveness of venipuncture limits the ability to 
collect plasma samples in child populations.  
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Pituitary gland volume was used as an additional proxy measure of HPA axis 
activity. However, pituitary volume was unrelated to cortisol levels in the current 
study, which is consistent with previous studies of high-risk individuals (Thompson 
et al., 2007; Habets et al., 2012). Whilst an alternative would have been to examine 
hypothalamic volume, the few studies that have compared hypothalamic volume in 
individuals with schizophrenia and healthy controls have yielded inconsistent 
findings (Goldstein et al., 2007; Koolschijn et al., 2008; Klomp et al., 2012), and no 
study has yet examined the relationship between hypothalamic volume and cortisol 
levels. It has also been suggested that hippocampal volume might be used to index 
HPA axis activity (Walker et al., 2008; Aiello et al., 2012). Indeed, studies of 
individuals with first-episode psychosis have reported an inverse relationship 
between cortisol levels and hippocampal volume (Mondelli et al., 2010b). However, 
other factors, including pregnancy and birth complications, cannabis use, and genetic 
variation may also contribute to reduced hippocampal volume (Stefanis et al., 1999; 
Hass et al., 2013; James et al., 2013).  
8.3.3 Analytical issues  
Multiple testing is a major limitation of the current study. Given the small group sizes, 
a reasonably liberal statistical threshold was employed for all analyses (p≤0.05, 
uncorrected); thus, statistically significant results may have arisen by chance. In total, 
30 regression analyses examining group differences (ASz vs. TD and FHx vs. TD) in 
psychosocial stress and HPA axis function were conducted. Employing this statistical 
threshold, two significant results might be expected by chance; in fact, significant 
differences were observed in 12 analyses. However, a large number of correlation 
analyses were conducted with no corrections applied to reduce the risk of type 1 
errors, so some of the significant correlations observed may have been spurious. 
These investigations are exploratory in nature, and must be interpreted with caution.  
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The cross-sectional analyses employed in the current study limit the extent to 
which causal inferences can be made regarding the observed associations. Whilst the 
effect of risk status on psychosocial stress susceptibility and HPA axis function was 
examined prospectively (i.e., these factors were assessed approximately two years 
after initial identification of at-risk children), for the ASz group in particular, these 
factors may have contributed to schizophrenia vulnerability. As such, it is not clear 
whether exposure to stressful events in early life led to the psychopathology which 
characterised ASz children at identification (i.e., internalising and externalising 
symptoms and PLEs), or whether these symptoms increased the likelihood that ASz 
children would encounter psychosocial stressors. The cross-sectional nature of these 
analyses means that it is not possible to disentangle the temporal relationship 
between risk status and psychosocial stress exposure. Although as noted previously, 
these associations are likely to be bidirectional. 
A final limitation of the current study relates to the fact that the ASz and FHx 
groups were not mutually exclusive and so could not be directly compared to each 
other. The decision was taken to include children meeting ASz and FHx criteria in 
both groups in order to most accurately reflect the ASz and FHx populations from 
which these participants were sampled. Owing to the small sample size, there were 
insufficient numbers to examine children meeting both ASz and FHx criteria as a 
separate group. It is possible that children who present both developmental and 
genetic risk factors may be at even greater risk of developing schizophrenia than 
children who present either feature in isolation, therefore ASz+FHx children might 
show even more pronounced differences in psychosocial stress susceptibility and 
HPA axis function relative to the TD group. Regrettably, it was not possible to test this 
hypothesis in the current study. 
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8.4 Scientific contribution 
8.4.1 Characterising individuals at elevated risk for schizophrenia  
The current study examined a range of psychosocial stressors and biological markers 
of HPA axis function, some of which had not been previously assessed in a high-risk 
sample. The work presented in this thesis therefore provides new information on the 
characteristics of children at elevated risk for schizophrenia and identifies features 
that these children share with adults with established illness.  
Children with a family history of schizophrenia  
Individuals with a family history of schizophrenia have been intensively studied over 
the past fifty years; however, few studies have examined experiences of psychosocial 
stress in this population. The current study demonstrates that FHx children are 
characterised by increased exposure to psychosocial stressors (major negative life 
events and physical punishment) relative to their typically-developing peers, and that 
they are more distressed by these experiences. In contrast, two previous studies, one 
of youth with a family history of schizophrenia (Miller et al., 2001), and the other of 
adult siblings (Myin-Germeys et al., 2001), found no evidence that relatives were 
more likely than healthy controls to experience major life events or minor stressors 
throughout the day. However, the latter study reported that relatives showed greater 
emotional reactivity to stressful events, which is consistent with the current findings.   
The current study is the first to examine the CAR among individuals with a family 
history of schizophrenia. The finding that FHx children were characterised by a 
blunted CAR relative to the TD group is consistent with previous studies showing 
that individuals with a family history of illness share a number of neurobiological 
characteristics with their affected relatives, including, neuromotor abnormalities 
(Niemi et al., 2003), cognitive deficits (Sitskoorn et al., 2004; Agnew-Blais & Seidman, 
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2013), and structural brain abnormalities (Fusar-Poli et al., in press). In contrast, FHx 
children did not show elevations in diurnal cortisol levels or pituitary volume 
abnormalities compared to the TD group. Whilst some previous studies have 
observed these features among adult relatives of individuals with psychosis 
(Mondelli et al., 2008; Collip et al., 2011; Yıldırım et al., 2011) others have not 
(Marcelis et al., 2004; Spelman et al., 2007; Brunelin et al., 2008; Yıldırım et al., 2011; 
Habets et al., 2012; Yang et al., 2012). The reason for the inconsistency across studies 
is unclear, although it is possible that demographic factors and the presence of 
‘schizotypal’ psychopathology among relatives may play a role.   
This study also demonstrated for the first time that the neurocognitive 
impairments observed among youth with a family history of schizophrenia (Agnew-
Blais & Seidman, 2013) may be associated with more abnormal HPA axis function. 
Among FHx children, a more blunted CAR was associated with poorer verbal memory 
and higher diurnal cortisol was negatively correlated with performance on measures 
of memory and executive function. These findings are consistent with those of 
previous studies that have observed a relationship between neurocognitive 
performance and HPA axis function among adults with psychosis (Walder et al., 
2000; Aas et al., 2011b).  
Children presenting multiple antecedents of schizophrenia  
The current study also examined children at putatively elevated risk for 
schizophrenia who present multiple antecedents of the disorder. These children were 
identified using a novel community-based screening method that was designed to 
enable the identification of high-risk youth at an earlier stage of illness than the UHR 
approach (Laurens et al., 2007; Laurens et al., 2011). It was additionally hoped that 
this identification strategy would address the generalisability issues associated with 
studies of individuals with a family history of illness. The current study demonstrates 
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that, like individuals with schizophrenia, ASz children are more likely to experience 
psychosocial stressors than their typically-developing peers (daily hassles, negative 
life events, and physical punishment) and show greater reactivity to these 
experiences. These findings are consistent with previous studies of youth at 
‘symptomatic-risk’ for schizophrenia (De Loore et al., 2007; Kelleher et al., 2008; 
Tessner et al., 2011; Palmier-Claus et al., 2012; Phillips et al., 2012; Addington et al., 
2013; Kelleher et al., 2013c; Sahin et al., 2013; Tikka et al., 2013).  
In contrast, ASz children were not characterised by abnormal HPA axis function 
(either a blunted CAR, elevated diurnal cortisol levels, or pituitary volume 
abnormalities) relative to TD children; although greater blunting of the CAR was 
associated with poorer verbal fluency in this group. These findings contrast with 
previous investigations by our group which show that ASz children present several 
neurobiological features that characterise adults with schizophrenia, including, 
functional brain abnormality following commission of behavioural errors (Laurens et 
al., 2010), neurocognitive impairments (Cullen et al., 2010), involuntary dyskinetic 
movement abnormalities (Macmanus et al., 2012), and structural brain abnormalities 
encompassing the temporal lobe (Cullen et al., 2013), relative to TD children. It is 
possible that these features represent markers of abnormal neurodevelopment 
caused by genetic and early environmental risk factors and that HPA axis 
abnormalities may not emerge till later in the disease process.  
Potential mechanisms  
It is likely that a range of co-occurring environmental factors, including, social 
disadvantage and ethnic minority status, contribute to the higher levels of 
psychosocial stress experienced by ASz and FHx children. For those FHx children 
who have an unwell parent, additional factors, such as parental substance abuse and 
social isolation (Campbell et al., 2012), may facilitate some of these experiences. As 
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such, these children may be living in environments which have contributed to both 
their elevated risk state and to the probability of stressful events occurring. However, 
ASz and FHx status may play a more active role in increasing the risk for psychosocial 
stress exposure. For example, the higher levels of psychopathology presented by ASz 
children may influence the way in which they interact with their peers, teachers, and 
family members, and increase the likelihood that they will experience daily hassles in 
their lives. It is also possible that the characteristics of ASz and FHx children in some 
way contributes to the higher levels of physical punishment that they experience. 
Thus, schizophrenia risk status may lead to greater exposure to psychosocial 
stressors via both indirect and direct pathways.  
The finding that FHx children exhibited greater levels of distress currently in 
relation to negative life events than TD children, but that their ratings of distress at 
the time of the event were not significantly higher, may imply that FHx children used 
less adaptive coping mechanisms following exposure to these events, causing their 
distress to persist at higher levels over time. For example, lower levels of social 
support (Ozer et al., 2003) and impairments in attention and executive functioning 
(Aupperle et al., 2012) have been associated with the subsequent development of 
PTSD symptoms among people exposed to trauma. It is possible that these factors 
may contribute to poorer coping abilities among FHx children. The heightened 
sensitivity to daily hassles that characterised ASz children relative to the TD group 
may be caused by different factors. One possible explanation is that dopamine 
dysregulation, which is thought to underlie hallucinatory and delusional experiences 
by contributing to aberrant attribution of salience to environmental stimuli (Kapur, 
2003), may cause these minor events to be more salient to ASz children. Thus, both 
neurobiological and cognitive mechanisms may contribute to the increased reactivity 
to psychosocial stressors that was found to characterise both FHx and ASz children.    
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The blunted CAR observed among FHx children, but not ASz children, relative to 
the TD group may reflect a genetically-mediated effect. Several lines of evidence lend 
support to this hypothesis. Firstly, the current study observed that the effect of FHx 
status was twice as large among those with a first-degree relative with schizophrenia 
compared to those with an affected second-degree relative. Secondly, the blunted 
CAR observed among FHx children was not explained by any of the environmental 
stressors examined in the current study. Thirdly, there is evidence that the CAR 
(Wust et al., 2000) and awakening and post-awakening cortisol levels (Bartels et al., 
2003) are influenced by genetic factors. Moreover, a single-nucleotide polymorphism 
that plays a role in the aetiology of depression (rs2522833 within the PCLO gene) has 
also been associated with a blunted CAR (Kuehner et al., 2011). However, the 
presence of a blunted CAR among FHx children does not necessarily imply that this is 
a genetically-mediated effect; this characteristic might equally be driven by other 
environmental exposures that were not examined in the current study.   
One possible explanation for the finding that more abnormal cortisol levels were 
associated with poorer memory and executive function among FHx and ASz children 
is that stress-induced HPA axis dysfunction has a direct effect on the brain structures 
supporting these functions. However, the positive correlations observed between 
psychosocial stress exposure and neurocognitive function (and indeed, the lack of 
association between cortisol levels and psychosocial stress) suggests that the 
relationship between neurocognitive function and cortisol is not driven by an excess 
of psychosocial stressors. Instead, it seems likely that the relationship between 
neurocognitive function and cortisol is indirect. It is possible that abnormal 
neurodevelopmental processes (commencing in early life) may have affected the 
functional integrity of the brain structures mediating both HPA axis function and 
neurocognitive performance (i.e., the hippocampus and medial prefrontal cortex).  
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8.4.2 Aetiology of schizophrenia 
One of the primary motivations for studying individuals at elevated risk for 
schizophrenia is that it offers the opportunity to identify disease characteristics that 
precede illness onset and contribute to the development of psychosis. The current 
study provides further insights into the nature and timing of psychosocial stress 
susceptibility and HPA axis abnormalities in schizophrenia.  
Early markers of psychosis vulnerability  
Studies examining youth at UHR, individuals with SPD, and adult relatives of 
individuals with schizophrenia indicate that these populations are characterised by 
increased exposure and reactivity to psychosocial stress and HPA axis dysfunction. 
Whilst these studies provide some evidence to suggest that psychosocial stress and 
HPA axis abnormalities precede psychosis onset, characteristics of the high-risk 
samples examined to date limit the ability to draw this conclusion. The current study 
aimed to address these limitations by examining high-risk children who are 
antipsychotic-naive and not currently seeking help for their symptoms. The current 
findings indicate that some of the psychosocial stress and HPA axis abnormalities 
that characterise older samples of high-risk youth are present during the early stages 
of illness, whilst others are not. Specifically, there is evidence that high-risk children 
are more likely to experience psychosocial stress than healthy children and show 
increased reactivity to these events, and that FHx children are characterised by a 
blunted CAR. However, neither ASz nor FHx children showed elevated diurnal 
cortisol levels or pituitary volume abnormalities. These findings imply that increased 
susceptibility to psychosocial stress (i.e., increased exposure and greater reactivity) 
and a blunted CAR may constitute early markers of psychosis vulnerability, whilst 
other indices of HPA axis dysfunction (i.e., elevated diurnal cortisol levels and 
abnormal pituitary volume) may not emerge till closer to disease onset. 
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Potential mechanisms leading to disease onset 
According to cognitive models, psychosocial stress may lead to psychosis via 
emotional and cognitive pathways (Garety et al., 2007). It is proposed that among 
vulnerable individuals, stress can trigger emotion dysregulation (heightened anxiety 
and depression) and cognitive dysfunctions (e.g., negative beliefs about the self and 
others) which lead to anomalous experiences; psychosis results when these 
anomalous experiences are attributed to external causes. In support of the model, a 
study of young adults found that the association between childhood trauma and PLEs 
was partially mediated by negative beliefs about the self and others (Gracie et al., 
2007). Furthermore, a large prospective study observed that the relationship 
between psychosocial stress exposure in childhood (harsh parenting, bullying, and 
domestic violence) and PLEs in adolescence was mediated by anxiety, depressive 
symptoms, external locus of control, and low self-esteem (Fisher et al., 2013b). 
Exposure to childhood trauma may also contribute to the deficits in social functioning 
that characterise individuals with schizophrenia (Stain et al., in press); it is possible 
that traumatic experiences impair the ability to develop key social skills necessary for 
developing and maintaining relationships.  
Of course another mechanism by which psychosocial stress may contribute to the 
onset of psychosis is via the HPA axis. It has been proposed that stress-induced HPA 
axis dysfunction leads to dopamine dysregulation which in turn gives rise to 
psychosis (Walker et al., 2008). Although abnormal HPA axis function has been 
observed among individuals with schizophrenia and those at elevated risk for the 
disorder, it is not clear whether these abnormalities are triggered by psychosocial 
stress exposure. However, in support of this model, a study using the ESM technique 
observed that the effect of stressful events on psychotic symptoms among adult 
relatives of individuals with psychosis was modified by homovanillic acid reactivity 
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(indexing dopamine responsivity), yet this relationship was not observed among 
healthy controls (Myin-Germeys et al., 2005b). These findings suggest that, among 
individuals at elevated risk for schizophrenia, abnormal dopamine reactivity may 
contribute to psychotic symptoms following exposure to psychosocial stress.  
Finally, it has been acknowledged that psychosocial stress may contribute to 
psychosis indirectly by increasing substance use behaviours, which in turn confer 
risk for psychosis (Fisher, 2013). Indeed, a large population-based study of adults 
reported that the association between childhood trauma and hallucinations was 
partially mediated by substance use (Whitfield et al., 2005). However, a significant 
relationship between childhood trauma and hallucinations was observed among 
individuals with substance use histories and those without, suggesting that substance 
use is not the only mechanism by which psychosocial stress leads to psychosis.  
Very little is known about the functional significance of the blunted CAR. One 
suggestion is that the CAR reflects anticipation of the demands of the upcoming day 
(Fries et al., 2009), although it is not clear whether the CAR directly influences the 
ability to deal with stressors. Alternatively, the CAR can be interpreted as the cortisol 
response to a minor stressor (i.e., awakening). As such, the blunted CAR observed 
among individuals with first-episode psychosis (Mondelli et al., 2010a; Pruessner et 
al., 2013b), and in the current study, among FHx children, may be similar to the 
blunted cortisol responses to psychosocial stressors reported in individuals with 
schizophrenia (Jansen et al., 2000; Brenner et al., 2009) and youth at UHR (Pruessner 
et al., 2013a). It has been suggested that among those who are at elevated risk for 
psychosis, attenuated cortisol responses to stress might aggravate underlying 
vulnerability and eventually lead to psychosis (Pruessner et al., 2013a). However, a 
comprehensive explanation for how a blunted CAR might contribute to the 
development of schizophrenia is currently lacking.    
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Specificity for schizophrenia outcome 
This thesis has focused on the extent to which psychosocial stress and HPA axis 
abnormalities are early vulnerability markers for schizophrenia and psychotic 
disorders. However, it is possible that these markers may also confer vulnerability 
for other psychiatric disorders. FHx and ASz children may develop other psychiatric 
disorders in later life, not just schizophrenia. For example, a large population-based 
study observed that offspring of individuals with psychosis are at greater risk for a 
number of adult outcomes, including, psychosis, bipolar disorder, depression, anxiety 
disorders, personality disorders, and substance misuse disorders (Dean et al., 2010). 
Thus, the risk conferred by having a family history of psychosis is not limited to 
concordant disorders. Whilst the diagnostic outcomes for ASz children are not yet 
known, it seems likely that these children are also at risk for a number of mental 
health problems. Longitudinal studies show that PLEs predict non-psychotic 
outcomes, including, major depression, anxiety disorders, and mania (Kaymaz et al., 
2012), although the association with psychotic disorder is much stronger. Similarly, 
internalising and externalising problems in childhood are associated with a range of 
adult mental problems (Cannon et al., 2002; Kim-Cohen et al., 2003). Speech and 
motor problems in infancy, however, appear to be more specifically related to 
psychosis (Isohanni et al., 2001; Cannon et al., 2002). Thus, the individual 
antecedents that comprise the triad confer risk for a number of mental health 
problems, although using a combination of antecedents may provide a more specific 
and sensitive means of identifying children who will later develop schizophrenia.  
Psychosocial stress susceptibility and HPA axis abnormalities have likewise been 
implicated in other psychiatric disorders. Studies have consistently observed that 
childhood trauma and major life events are associated with increased risk for major 
depression (Young & Korszun, 2010; Nanni et al., 2012; Lindert et al., in press), and 
247 
 
studies employing the ESM technique show that individuals with depression are 
characterised by increased emotional reactivity to daily stressors relative to healthy 
controls (aan het Rot et al., 2012). Furthermore, studies conducted over the past four 
decades indicate that individuals with depression are characterised by elevated 
diurnal cortisol levels (Stetler & Miller, 2011), although there is some evidence to 
suggest that the depression sub-types (melancholic vs. atypical) are associated with 
different patterns of HPA axis function, with increased cortisol being a feature of 
melancholic depression specifically (O'Keane et al., 2012). Whilst the CAR has been 
less frequently examined in this population, several studies have observed an 
increased CAR among both adolescents and adults with depression relative to 
healthy controls (Bhagwagar et al., 2003; Dienes et al., 2013; Ulrike et al., 2013). 
Thus, the combination of HPA axis abnormalities in major depression (elevated 
diurnal cortisol levels and an increased CAR) is different to that observed among 
individuals with psychosis (elevated diurnal cortisol levels and a blunted CAR). 
Another disorder that has been associated with HPA axis abnormalities is PTSD, 
which, by definition, involves exposure to trauma. There is evidence that individuals 
with PTSD, like those with psychosis, are characterised by a blunted CAR (Chida & 
Steptoe, 2009). However, studies have also consistently shown that PTSD is 
associated with decreased cortisol levels during the day relative to healthy controls 
(Morris et al., 2012). Crucially, although psychosocial stress and HPA axis 
abnormalities have been implicated in other psychiatric disorders, the pattern of HPA 
axis abnormalities is not the same as that observed among individuals with 
psychosis. Thus, the blunted CAR that was found to characterise FHx children (in the 
absence of decreased diurnal cortisol levels, as would be consistent with PTSD) may 
constitute a relatively specific marker of psychosis risk. It is possible that genetic 
influences contribute to the distinct pattern of HPA axis dysfunction observed among 
individuals with psychosis.  
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8.5 Implications  
8.5.1 Implications for existing theories  
Neural diathesis-stress model of schizophrenia  
The neural diathesis-stress model has emerged as one of the leading aetiological 
theories of schizophrenia (Walker & Diforio, 1997; Walker et al., 2008). The model 
proposes that individuals with an underlying vulnerability for the disorder are more 
susceptible to experiences of psychosocial stress, and that the HPA axis (via the 
augmenting effects of cortisol on dopamine activity) mediates the relationship 
between these experiences and the development of psychosis. Studies examining 
individuals with schizophrenia and those at elevated risk for the disorder have 
provided some evidence to support the model, yet few have employed multiple 
measures of psychosocial stress and HPA axis function. By addressing this limitation, 
the current study was able to directly test several key components of the model.  
The current study provides support for the notion that children at elevated risk 
for schizophrenia are more susceptible to psychosocial stress than children who are 
at low risk for the disorder. However, there was no evidence to suggest that these 
experiences led to increased HPA axis activity (i.e., elevated diurnal cortisol levels 
and enlarged pituitary volume), as would be proposed by the model. Indeed, the 
blunted CAR observed among FHx children was not explained by any of the 
psychosocial stressors examined, and the pattern of association between 
psychosocial stress and HPA axis function was not as expected (i.e., among FHx 
children, the CAR was positively correlated with distress relating to negative life 
events whilst pituitary volume was negatively associated with distress relating to 
negative life events and exposure to physical punishment). However, it is important 
to stress that the current findings do not preclude the possibility that stress-induced 
HPA axis hyperactivity contributes to the onset of psychosis; as none of the children 
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in the current study have yet experienced a psychotic episode, this could not be 
examined. Given that the brain undergoes significant structural changes during 
adolescence and that HPA axis activity also increases during this time, it is possible 
that psychosocial stressors experienced in later adolescence have a greater impact on 
HPA axis function, and that these experiences are thus able to trigger psychosis onset.  
Clinical staging model of psychosis 
The current findings are also relevant to the clinical staging model of schizophrenia 
(McGorry et al., 2006; Yung & McGorry, 2007; Wood et al., 2011), which proposes 
that the development of psychosis can be conceptualised as a series of stages that 
correspond to the extent, progression, and impact of the illness. A key feature of the 
model is that advancement through the clinical stages should correspond to 
progressive neurobiological changes, such that the later stages of illness are 
characterised by more pronounced neurobiological abnormalities. 
ASz children would be classed within Stage 1a of the model (Table 2, Chapter 1), 
as would some FHx children (i.e., those presenting some or all of the developmental 
antecedents), although children with a family history of illness without 
accompanying psychopathology would currently be classified as Stage 0. Given that 
ASz and FHx children were not characterised by elevated diurnal cortisol levels and 
pituitary volume abnormalities, but that these features have been observed among 
some UHR youth and individuals with SPD, it is tempting to speculate that HPA axis 
hyperactivity does not emerge until at least Stage 1b of illness (which includes UHR 
youth and thus some individuals with SPD). In contrast, the blunted CAR observed 
among FHx children may be a genetically-mediated liability marker that is not 
necessarily associated with disease progression. Although tentative, the current 
study lends support to the idea that more advanced stages of psychosis are 
associated with more abnormal HPA axis function.  
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8.5.2 Clinical implications  
The finding that ASz and FHx children showed increased exposure and reactivity to 
psychosocial stress, but were not yet characterised by HPA axis hyperactivity, 
indicates that this may be a crucial time to implement early intervention strategies. 
Broadly speaking, there are two ways to approach this. One strategy is to focus on 
interventions aimed at helping vulnerable youth to deal more effectively with 
psychosocial stress, which may help to reduce the impact of these psychosocial 
stressors on HPA axis function. Alternatively, preventative interventions may help to 
reduce the risk of exposure to psychosocial stressors among these youth.  
Psychological therapies to promote coping strategies 
A number of psychological therapies have been found to help children cope with 
major traumatic events. For example, child-parent psychotherapy has been shown to 
reduce PTSD symptoms and internalising and externalising problems among children 
exposed to trauma (Ghosh Ippen et al., 2011), and there is evidence that cognitive 
behavioural therapies are effective in reducing psychopathology among children who 
have experienced sexual abuse (Ramchandani & Jones, 2003). The current study 
indicates that the death of a loved one is a particularly common experience in 
childhood. Whilst the effect sizes are relatively small, bereavement interventions for 
children have been associated with improvements in coping behaviours, with music 
therapy emerging as a promising treatment model (Rosner et al., 2010).  
School-based stress education programmes 
An intervention strategy which is particularly relevant to the current study is a novel 
school-based education programme (DeStress for Success) designed to reduce the risk 
of depression in adolescents (Lupien et al., 2013). The programme has been informed 
by recent research into the relationship between HPA axis function and depression, 
and aims to enable adolescents to deal more effectively with psychosocial stress. The 
251 
 
intervention was recently trialled in a sample of 504 high school students, and was 
found to lead to a reduction in cortisol levels among adolescents who exhibited high 
levels of anger at baseline (Lupien et al., 2013). Moreover, adolescents who showed a 
decrease in cortisol levels over the treatment period were at lower risk of 
experiencing depression at a three-month follow-up than adolescents who did not. 
These promising findings suggest that psychosocial interventions might be used to 
target HPA axis abnormalities in individuals at elevated risk for psychosis. 
Preventative programmes 
An alternative strategy is to employ preventative interventions to reduce the risk of 
exposure to psychosocial stressors. For example, studies in the United States have 
consistently shown that home-visitation programmes targeting vulnerable families 
(i.e., low-income families, first-time mothers, and families experiencing stress and 
difficulties) can successfully prevent childhood maltreatment (Macmillan et al., 
2009). In addition, a number of school-based prevention programmes have been 
found to reduce levels of bullying in schools (Rigby & Slee, 2008). Thus, there is 
evidence that intervention programmes can successfully prevent some of the 
psychosocial stressors that are most strongly associated with psychosis vulnerability. 
8.5.3 Directions for future research 
Further investigations in ASz and FHx children 
The work presented in this thesis has generated several hypotheses that can be 
tested within this cohort of at-risk children. An important finding was that more 
abnormal HPA axis function is associated with poorer performance on memory and 
executive function tasks among ASz and FHx children. It is assumed that this 
relationship is largely mediated by the hippocampus and the medial prefrontal cortex 
(which play a major role in regulating HPA axis function), although this has not yet 
been directly tested. Work has already commenced on the study to obtain 
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hippocampal volumes from structural brain images using semi-automated extraction 
techniques. The current findings indicate that it will be important to examine this 
data in conjunction with measures of HPA axis function and neurocognitive function 
(particularly memory) in order to determine whether hippocampal volume mediates 
the relationship between these measures. 
None of the psychosocial stress measures examined in the current study were 
able to explain the blunted CAR observed among FHx children relative to the TD 
group. For ethical reasons, participants were not asked about experiences of 
maltreatment whilst aged less than 16 years. However, we have recently commenced 
a fourth assessment phase (age 17-18 years) where we will collect information on a 
range of victimisation experiences which will allow us to retrospectively ascertain 
exposure to abuse and neglect in early life. Thus, it will be possible to determine 
whether more severe forms of psychosocial stress can explain the blunted CAR 
observed among FHx children. 
The findings of the current study suggest that HPA axis hyperactivity (as indexed 
by elevated diurnal cortisol levels and enlarged pituitary volume) is a feature that 
may emerge closer to psychosis onset. At the fourth assessment phase, we will assess 
UHR status using the CAARMS (Yung et al., 2005); an important question arising from 
the current study is whether HPA axis hyperactivity is present among FHx and ASz 
children who meet UHR criteria at follow-up. For example, longitudinal studies of 
UHR youth have shown that those who later transitioned to psychosis (but not those 
who did not) showed enlarged pituitary volume at baseline (Garner et al., 2005; 
Büschlen et al., 2011). The current findings also emphasise the importance of 
examining cortisol levels at the next assessment phase in order to determine whether 
HPA axis hyperactivity increases over time in those who progress to more advanced 
stages of illness.  
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Epidemiological studies  
The current investigation has identified a number of associations which require 
replication in a larger epidemiological study. Studies conducted in small, enriched 
samples of high-risk individuals are limited in the extent to which they can examine 
causal mechanisms. Such studies also impose categorical constructs (i.e., high-risk vs. 
low-risk individuals), when in reality, liability for schizophrenia is distributed 
throughout population. A large ‘unselected’ population cohort would provide the 
opportunity to more definitively determine whether antecedents of schizophrenia 
increase the risk for experiences of psychosocial stress and HPA axis dysfunction. For 
example, a continuous measure of liability (i.e., the number of antecedents) could be 
used to determine whether there is a dose-response relationship between the triad 
components and these outcomes. In a larger sample, it would also be possible to 
investigate whether those presenting antecedents and a family history of illness are 
at even greater risk for psychosocial stress/HPA axis abnormalities. 
Sample constraints also limited the ability to examine the role that demographic 
factors may play in the relationship between risk status and psychosocial stress/HPA 
axis function. One novel finding of the current study was that ethnicity and 
socioeconomic status appear to influence the effect of risk status on physical 
punishment and the CAR. Although the current sample was not sufficiently large to be 
able to adequately test for effect modification, these exploratory analyses suggest 
that the role of demographic factors should be investigated further.  
Despite the limitations, it is important to stress that studies conducted in small, 
enriched high-risk samples provide the opportunity to conduct assessments that 
cannot be easily employed in large samples (e.g., MRI scans). The current study has 
generated a number of intriguing findings that can inform future investigations in 
larger population-based cohorts.  
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8.6 Final conclusions 
The work presented in this thesis suggests that increased susceptibility to 
psychosocial stress and a blunted cortisol awakening response may constitute early 
markers of psychosis vulnerability. By examining children with different 
vulnerability profiles for schizophrenia, the current study also provided evidence 
that might be interpreted to suggest that the blunted CAR may be a genetically-
mediated marker of vulnerability. The current study also demonstrated that the 
effect of risk status on psychosocial stress susceptibility and HPA axis function may 
be influenced by ethnicity and socioeconomic status. These preliminary findings 
require replication in larger ‘unselected’ population cohorts. Given that the current 
study found no evidence that children at elevated risk for schizophrenia were 
characterised by HPA axis hyperactivity, it is speculated that this feature may not 
emerge until more advanced stages of illness. Interventions aimed at helping at-risk 
youth to cope more effectively with psychosocial stress might prevent the 
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Appendix 3.  Negative life events and daily hassles measure  
Note. Negative life events and daily hassles were assessed in a single measure which 
















Appendix 4.  Alabama parenting questionnaire (child version) 












Appendix 5.  Saliva collection form 
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